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Redox chemistry is the basis for biological energy generation and anabolism. Redox conditions 
also serve as critical cues that modulate the development of many organisms. Roles for redox 
chemistry in the control of gene expression have been well characterized in multicellular 
eukaryotes, where oxygen availability in particular is a major developmental cue. As a gaseous 
metabolic substrate, oxygen becomes limiting as cellular communities grow, and can act as an 
indicator of aggregate size or developmental stage. In many of these cases, there are 
dedicated sensory and signal transduction networks that link oxygen and other redox signals 
to changes in gene expression and morphogenesis.

The opportunistic pathogen Pseudomonas aeruginosa, like many species of microbes, forms 
multicellular structures called biofilms. Cells in biofilms can assume physiological states that 
differ from cells grown in well-mixed, homogeneous liquid cultures. They often exhibit 
increased resistance to environmental stresses and antibiotics, rendering biofilm physiology an 
important focus in the study of microbial pathogens. Biofilm development and architecture are 
tuned by environmental conditions. In turn, growth and survival in the community, and the 
specific structure of that community, give rise to internal microenvironments that are 
experienced by cells within a biofilm. Mechanisms that tune biofilm developmental programs in 
response to redox conditions are not well understood. This is due to challenges presented by 
most popular laboratory models of biofilm formation, which are not amenable to perturbation, 
characterization at the microscale, or high-throughput screening or analysis.

In this thesis, I describe a standardized colony morphology assay for the study of P. aeruginosa 
PA14 biofilm development and use this model to address fundamental questions about the 
relationships between electron acceptor availability, biofilm cell physiology, and the regulation 
of biofilm morphogenesis. In the colony morphology assay, PA14 grows as ~1cm-diameter 
biofilms on agar-solidified media under controlled conditions, and displays a developmental 
pattern that is predictably influenced by changes in redox conditions. Microscale heterogeneity 
in chemical ecology can be profiled using microelectrodes, and the effects of specific 
mutations on development can be rigorously tested through high-throughput screening and the 
application of metabolic assays directly to biofilm samples. Prior to the work described here, 
application of the colony morphology assay had revealed that endogenous redox-active 
antibiotics called phenazines influence PA14 biofilm development such that defects in 
phenazine production promote colony wrinkling and the formation of a distinct wrinkle pattern. 
As phenazines can act as alternate electron acceptors for cellular metabolism, this provided an 
early clue to the role of redox conditions in determining biofilm architecture. 

The introduction to this thesis (Chapter 1) provides an overview of observations in P. 
aeruginosa and other microbes, drawing parallels between the physiology of colony biofilm 
development across phylogeny and highlighting specific preliminary studies that hint at redox-
sensing mechanisms and signaling pathways that drive community morphogenesis. The 
associated Appendix A examines the effects of CORM-2, a synthetic compound that releases 
the respiratory poison carbon monoxide, on P. aeruginosa biofilm development. The inhibitory 
effects of CORM-2 are ameliorated by reducing agents and increased availability of electron 
donors for P. aeruginosa metabolism.

Chapter 2 describes the foundational characterization of the P. aeruginosa PA14 colony 
morphology assay model, which showed that colony wrinkling is invoked under high 
intracellular NADH levels and electron acceptor-limiting conditions, suggesting that it is an 
adaptive strategy to increase access to electron acceptor. The associated Appendices B and 
C describe (i) a mathematical modeling approach demonstrating that wrinkle geometry is 
indeed optimized for efficient access to electron acceptors, and (ii) a study investigating the 
effects of phenazine antibiotics on the multicellular development of a eukaryotic microbe.

Chapter 3 details the identification and characterization of a candidate mediator of the 
multicellular response to electron acceptor availability in PA14 called RmcA. RmcA contains 
domains that have been implicated in redox-sensitive developmental control in eukaryotic 
systems and domains that modulate intracellular levels of cyclic di-GMP (c-di-GMP). C-di-GMP 
is an important secondary messenger that controls social behaviors, including the secretion of 
factors required for colony biofilm structure formation, in diverse bacteria. RmcA thus bridges 
the gap between sensing of redox signals and colony morphogenesis. Appendix D outlines my 
approaches to purification and attempts to crystallize this and one other protein contributing to 
PA14 redox-driven colony morphogenesis. Finally, Appendix E describes the role of another 
protein that modulates c-di-GMP in response to metabolite-dependent signaling and 
physiological effects during interactions between P. aeruginosa and the fungus C. albicans. 
Together, the findings presented in this thesis have expanded our knowledge about the role 
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CHAPTER 1 
Introduction and Background 
This chapter is adapted from two review articles that I co-wrote: 
1.	 Okegbe C, Sakhtah H, Sekedat MD, Price-Whelan A, Dietrich LEP:  
Redox eustress: roles for redox-active metabolites in bacterial signaling and behavior. 
Antioxidants & Redox Signaling 2012, 16:658–667. 
2.	 Okegbe C, Price-Whelan A, Dietrich LEP: 
Redox-driven regulation of microbial community morphogenesis. 
Current Opinion in Microbiology 2014, 18:39–45. 
In this introduction, I integrate elements from each review that are relevant to the studies 
described in my thesis. I have also elaborated on some topics addressed in the reviews to 
provide additional context for my thesis work. 
 1
1-1 REDOX CHEMISTRY IN BACTERIAL PHYSIOLOGY AND BEHAVIOR 
As the energy that fuels life is derived from electron transfer reactions, redox chemistry is a 
fundamental feature of every known metabolism that supports life. Strong reductants and 
oxidants are thought to have enabled the origin of life and the evolution of complex life forms, 
respectively (Fig. 1-1). While the energy provided by redox chemistry is required for life, 
unchecked redox activity and changes in electron availability alter the intracellular redox state 
and are a common source of intracellular damage. Organisms have therefore evolved well-
studied mechanisms that allow them to cope with, avoid or combat potentially destructive 
fluctuations in redox potential that can compromise protein function and the stability of nucleic 
acids and lipids. In characterizing these mechanisms, researchers in many fields have 
traditionally focused on the high metabolic activity or exposure to strong oxidants that can 
generate toxic, enzyme-damaging species [1,2]. However, biologists are uncovering cases 
where organisms utilize unusually redox-active compounds for functions such as signaling and 
survival, which are not directly part of metabolism during active growth. They are also finding 
that compounds that are often viewed as toxins due to their high level of redox activity in some 
cells play roles that facilitate communication and/or survival in others, and that their effects 
may vary qualitatively as a function of concentration. These findings emphasize the context- 
and organism-dependent effects of compounds that participate in redox chemistry in vivo. 
Traditionally, certain redox-active compounds have been categorized as “stressors” because 
they stimulate protective responses, without which organisms of interest would not be able to 
survive in the molecule’s presence. The term “stressor” originated with the work of Hans Selye, 
a physiologist who, in the late 1930s, devised the concept of the “stress response” during his 
work examining recovery from harsh treatments in rats [3]. This work established a paradigm 
increasingly applied by biologists describing responses to environmental stimuli. Although 
Selye recognized that the response to a stressor can be positive (“eustress”) or negative 
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(“distress”), this dual nature of stress is often overlooked [4]. The word “stress” typically has a 
negative connotation, and agents that induce pathology in a particular biological context are 
often treated categorically as negative stressors. However, the mechanisms that have evolved 
to respond to these signals do not always bear the hallmarks of “distress”. In these cases, the 
organism is not negatively affected by exposure to the stressor. 
Stress has been defined as a “threat to homeostasis” [5]. This definition was originally applied 
in the context of animal physiology and psychology, but can also apply to responses to stimuli 
in bacteria. An abstract representation of this concept is depicted in Fig. 1-2. An organism 
maintaining homeostasis, with respect to parameters such as metabolic flux and internal pH, is 
depicted as a ball sitting on a plateau. When the organism is exposed to a stressor that causes 
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Figure 1-1. Redox chemistry is essential for life. 
Selected redox couples with major roles in biological 
chemistry are shown organized according to their redox 
potentials. Major events and responses associated with 
these couples are listed. Source: Okegbe et al 
Antioxidants & Redox Signaling., 2012
distress, it can no longer maintain a functional physiological state, and this is represented as 
the ball rolling down the slope. However, when the organism is exposed to a stressor that 
causes eustress, it enters a qualitatively different physiological state, but still maintains 
homeostasis. This is represented as a different area atop the same hill. 
There are several examples of sensing mechanisms and stimuli involved in eustress in the form 
of bacterial survival and development. These examples concern molecules that are typically 
referred to as “redox-active metabolites.” This is a misleading term, because most of the 
compounds produced during metabolism are technically “redox-active” in the sense that they 
readily undergo enzyme-mediated redox transformations within the cell, but the majority of 
these are unlikely to cause stress. Despite this, biologists use this term for compounds that are 
unusually reactive and therefore more likely to cause damage in the form of irreversible 
reactions that inactivate enzymes or the generation of additional reactive species. Some of 
these molecules are also called “redox-cycling compounds” because they enter the cell in a 
relatively harmless state, but are readily reduced by endogenous enzymes and catalyze 
downstream reactions producing highly-reactive toxic species (Fig. 1-3). These downstream 
reactions are oxidizing and regenerate the original compound, which can again react with the 
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Figure 1-2. The influence of stressors on 
physiology. The normal functional state of a 
biological system can be likened to a ball on a 
plateau. Endogenous and exogenous stressors 
can push the ball to the edge of the precipice, 
but biological systems are robust and actively 
maintain the functional state. This sometimes 
requires the organism to transition to a new, 
qualitatively different functional state, as can 
occur when the stressor is a source of eustress. 
Source: Okegbe et al Antioxidants & Redox 
Signaling., 2012
endogenous enzyme and continuously cycle between reductant and oxidant. I will adhere to 
convention and refer to unusually redox-active metabolites as simply “redox-active” or “redox-
cycling” compounds, as their high level of redox activity is what distinguishes them from the 
myriad redox couples present within the cell. However, although these terms carry negative 
connotations, our use of them does not imply that these compounds are universal sources of 
distress. In specific contexts, their effects on bacterial physiology are neutral or beneficial. 
They can transition the organism to a physiological state that is different from the default, but 
still conducive to survival and community development (Fig. 1-2). 
1-2 MICROBIAL MULTICELLULARITY 
Most bacteria are able to aggregate into multicellular communities called biofilms [6-9]. The 
formation of biofilms is an active process that involves the coordinated action of billions of 
bacterial cells encased in excreted matrices. This mode of growth is a strategy that is 
employed by bacteria to ward off challenging environmental stimuli such as nutrient depletion 
or the presence of antibiotics, detergents, or other potentially harmful environmental insults 
[10,11]. Although the mechanisms that govern biofilm formation can differ between species 
and even between strains of the same species, it seems to be an adaptation common to most 
bacterial species for surviving in hostile environments . 
Biofilms can form on any type of surface and under diverse conditions in the laboratory and in 
the wild. This ability poses a huge clinical concern due to biofilm formation in the host during 
various infections (e.g., in lungs, burn wounds, or urinary tracts and on teeth or skin) [12-15] or 
on equipment and medical devices such as catheters and implantations [16-19]. In the wild, 
biofilms tend to consist of multiple microbial species and may represent a strategy to compete 
for scarce resources. Still, there are instances where biofilms are beneficial and confer 
advantages to the host organism– biofilms of Actinobacteria on the backs of ants provide 
protection from fungal and protozoan pathogens [20], while P. chlororaphis biofilms on roots 
protect plants from invaders [21]. 
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Biofilms have complex architectures and chemical compositions. In static cultures, biofilms 
grow at air-gel interfaces, forming colonies, or at air-liquid interfaces, forming pellicles [22]. 
Probably as long as these culture techniques have been in use, microbiologists have marveled 
at the elaborate morphologies, visible to the naked eye, that are often formed by such 
communities [23]. The wrinkled structures of rugose colonies and pellicles have strikingly 
similar appearances in phylogenetically disparate organisms. Wrinkle-forming organisms that 
have become models for the study of biofilm morphogenesis include representatives from the 
genera Bacillus [24-28], Candida [29,30], Escherichia [31,32], Pseudomonas [33-38], 
Rhodospirillum [39], Saccharomyces [40-42], Salmonella [43], Serratia [44] Vibrio [45-48] and 
members of the phylum Actinobacteria [49,50] (Fig. 1-4). Regardless of species, the defining 
feature of a biofilm is the self-produced matrix, which is composed of polysaccharides, 
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Figure 1-3. (A,B) The distinction between “redox-active” and “redox-cycling” metabolites. The 
term “redox-active metabolite” typically refers to compounds that do not participate constructively in 
primary metabolism during growth. These compounds react with metabolites, nucleic acids, proteins, 
and/or lipids without the aid of enzymes. The term “redox-cycling metabolite” is used to describe 
compounds that enter the cell in an oxidized state, participate in enzyme-mediated redox 
transformations to become reduced, then react with other substrates without the aid of enzymes. 
Source: Okegbe et al Antioxidants & Redox Signaling., 2012
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Figure 1-4. Wrinkled morphologies are formed by diverse microbial communities at the interface with air. 
(a): Coccobacteria septic pellicle (T. Billroth, 1874). (b): Cyst-forming Rhodospirillum centenum (J. Berleman and C. 
Bauer). (c) Escherichia coli K-12 derivative AR3110 (R. Hengge). (d) Saccharomyces cerevisiae SK1 (C. Sison, B. 
Miller, and L. Dietrich). (e) Streptomyces coelicolor M145 (left) and Amycolatopsis sp. AA4 (right) (M. Traxler and R. 
Kolter). (f) Serratia marcescens strain CHASM, isolated from a backyard compost heap (R.  Shanks). (g) Bacillus 
subtilis NCIB3610 (M. Cabeen and R. Losick). (h) Pseudomonas oryzihabitans, isolated from a bench in Riverside 
Park, New York, NY (S. Jordan and L. Dietrich). (i) Candida albicans (D. Morales and D. Hogan). (j) Pseudomonas 
aeruginosa PA14 ∆phz mutant (D. Murphy and L. Dietrich). (k) Mycobacterium smegmatis (A. Balachandran and G. 
Hatfull). (l) Vibrio cholerae rugose colony variant (N. Fong, F. Yildiz, and H. Sakhtah). Source: Okegbe et al Current 
Opinion in Microbiology., 2014
proteins, and extracellular DNA [25,51-56].  
Biofilms harbor metabolically heterogenous populations of cells that experience gradients of 
resources. This leads to distinct populations of cells that occupy various niches within the 
biofilm [57,58]. A well-studied gradient in biofilms is that of oxygen, which is characterized by 
high levels at the top of the biofilm exposed to the atmosphere or flowing liquid medium and 
low levels at the bottom of the biofilm where oxygen cannot reach [59,60]. Oxygen gradients in 
biofilms not only affect metabolism and survival of resident cells [61,62], but also their behavior 
and community morphogenesis. Multicellular communities can cope with the threat of redox 
imbalance through the utilization of redox-active metabolites as alternate electron acceptors or 
structural modulation that increases access to oxygen for cells in the community [63-66] 
(Chapter 2, Appedix B). 
This thesis describes the physiological characterization of biofilms formed by the opportunistic 
pathogen Pseudomonas aeruginosa PA14, grown primarily in a standardized assay of colony 
morphogenesis. This biofilm model system is amenable to perturbation, in situ profiling of 
chemical ecology, and high-throughput screening. I have leveraged this model in the 
application of mutational anlysis and quantitative techniques that measure intracellular redox 
state, levels of an intracellular secondary messenger, and production of biofilm matrix. The 
following sections of this introduction provide an overview of the conditions that influence, and 
mechanisms that control, biofilm development in P. aeruginosa and other bacteria with an 
emphasis on their relevance to colony biofilm morphogenesis. 
1-3 PHENAZINES: REDOX-ACTIVE ANTIBIOTICS WITH ROLES IN SIGNALING AND 
METABOLISM 
Bacteria produce both inorganic and organic redox-active metabolites (Fig. 1-5). Intermediates 
in the full reduction of molecular oxygen and nitrate can be produced both as side-products of 
essential metabolic reactions and by the activities of organic redox-cycling compounds. 
Despite their high reactivity and potential to damage protein cofactors, DNA, and cellular lipids 
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Figure 1-5. Examples of inorganic and organic redox-active metabolites. Source: Okegbe et al Antioxidants & 
Redox Signaling., 2012
[67], some of these compounds have been shown to serve signaling functions in a diversity of 
organisms.  
Production of inorganic redox-active metabolites is more likely to occur during active growth. 
The production of redox-active organic compounds, however, is often growth phase- and 
condition-dependent, occurring in the stationary phase of the growth curve of a batch culture 
and during limitation for specific nutrients [57,68]. In fact, this is one of the properties that have 
lead to their categorization as “secondary metabolites.” Production of secondary metabolites is 
not directly required for the growth of microbes in laboratory batch cultures. Historically, the 
major functions ascribed to these compounds have been related to their antibiotic activity and 
competition between divergent microbes in soil.  
Selman Waksman initiated the use of the term ‘antibiotic’ as a noun in the early 1940s when his 
team discovered that the small molecule streptomycin, isolated from the soil actinomycete 
Streptomyces griseus, was effective against tuberculosis [69]. At the time, the term was meant 
to describe any substance produced by a microbe that is antagonistic to microbial growth [70], 
but it has evolved to include all compounds that prevent the growth of microbes [71]. This 
definition implies that antibiotic-producing organisms excrete these compounds at levels high 
enough to kill competing microbes. In recent years, however, levels of canonical antibiotics in 
soil have been reported that are insufficient for biocidal activity, suggesting that sublethal 
effects of antibiotics are environmentally relevant. Indeed, many “antibiotics” have been shown 
to affect gene expression at subinhibitory concentrations [72]. It must therefore be considered 
that the primary roles for these stressors in bacteria are related to the survival of the producing 
organism rather than the killing of competing organisms. This interpretation puts a dramatic 
new spin on bacterial stress responses. In the next section, I will discuss the physiological 
roles that have been described for a class of antibiotics called phenazines.

Phenazines are redox-active, heterocyclic compounds produced by several genera of bacteria 
[73]. Their discovery dates back to the late 19th century when doctors noticed blue-tinted pus 
 10
secreted from purulent wounds in patients [74] and were able to isolate a blue phenazine from 
these secretions, which was named “pyocyanin”. Phenazines have long been categorized as 
antibiotics because their intracellular reduction and re-oxidation generates reactive oxygen 
species [75], leading to cell death in some organisms. Phenazine-producing bacteria are often 
able to tolerate high levels of phenazines, likely through the activities of superoxide 
dismutases. The archaeon Methanosarcina mazei produces a phenazine derivative with a long 
hydrophobic tail. This compound is not excreted, but rather resides in the cell membrane 
where it participates in methanogenic electron transport and plays a primary metabolic role [76] 
Additional phenazines have been subsequently identified from culture supernatants as well as 
chronic P. aeruginosa infections [77,78]. Although most are biosynthetically derived from the 
yellow compound phenazine-1-carboxylic acid (PCA), they display a broad range of chemical 
structures, physical properties, and biological activities (Fig. 1-6). The best-studied phenazine 
biosynthetic pathways are encoded by the phz genes of pseudomonad species. These genes 
encode enzymes required for the biosynthesis of PCA, as well as modifying enzymes that 
derivatize the compound, producing pigments such as the blue pyocyanin, the greenish-yellow 
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Figure 1-6. Chemical properties of phenazines produced by P. aeruginosa. The functional groups and the 
redox potentials at pH 7 are shown. Source: Price-Whelan et al., Nat. Chem. Bio., 2006
phenazine-1-carboxamide, and the orange 1-hydroxyphenazine (Fig. 1-7). Pyocyanin is 
probably the most notorious of these molecules, as lab cultures of many isolates of the 
pathogen P. aeruginosa owe their intense coloration to this pigment. It is also a common 
feature of patients with burn wound and lung infections due to the production of blue 
(pyocyanin-containing) pus and mucus [79]. 
The toxic, redox-cycling effects of bacterial phenazines in non-producing organisms are 
thought to facilitate competition for resources in the soil in cases of environmental isolates, and 
contribute to the pathogenicity of P. aeruginosa. However, these compounds also have effects 
that are beneficial for their producers. Natural phenazines can increase the bioavailability of 
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Figure 1-7. P.seudomonads produces a variety of colorful phenazines.  Top left: Plate of a phenazine-
producing soil isolate. Top right: solutions of individual phenazines. Bottom: Known and postulated steps in the P. 
aeruginosa phenazine biosynthetic pathway.Adapted from Price-Whelan et al., Nat. Chem. Bio., 2006
iron [80,81], transmit intercellular signals to coordinate gene expression across cell populations 
[82] and facilitate maintenance of intracellular redox homeostasis [83]. Here I will focus on the 
roles that phenazines play in respiration and redox balancing as well as their significance in the 
context of biofilm development in P. aeruginosa PA14. 
1-3-1 Phenazines in respiration and redox balancing 
Phenazine-producing bacteria catalyze the reduction of phenazines in addition to their 
biosynthesis. The most striking evidence of bacterial phenazine reduction can be observed in a 
standing P. aeruginosa culture, which will gradually turn from bright blue to bright yellow. This 
process occurs because pyocyanin exhibits a brilliant blue color in its oxidized state, but 
changes to colorless as it is reduced [84], while PCA is a faint yellow in its oxidized form, but 
turns bright yellow when it is reduced. This activity has also been demonstrated in oxygen-
limited cultures of the bacterium P. chlororaphis, which can use its phenazine product, 
phenazine-1-carboxamide (PCN) to reduce extracellular iron oxides [85]. In the 1930s, Ernst 
Friedheim demonstrated that pyocyanin production promotes oxygen consumption in P. 
aeruginosa cell suspensions, and suggested that phenazines could act as electron carriers in 
respiratory or redox-balancing reactions. He would have been excited to learn that an 
unequivocal proof of his hypothesis can be found in the archaeon M. mazei, where the 
hydrophobic membrane-bound compound methanophenazine is required for the electron 
transport that ultimately powers ATP synthesis [76].  
Methanophenazine is the only small organic pigment for which a direct role in respiration has 
been characterized. However, decades after Friedheim proposed that P. aeruginosa phenazines 
could react with “labile hydrogen” inside the bacterium, new studies have shown that 
phenazines facilitate intracellular redox balancing and survival. Planktonic cultures of 
phenazine-deficient P. aeruginosa mutants exhibit a higher NADH/NAD+ ratio in stationary 
phase, suggesting that an inability to produce phenazines at the normal time point of their 
synthesis results in a reduced intracellular environment [83]. The NADH re-oxidation coupled 
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(directly or indirectly) to phenazine reduction may allow primary anabolic reactions to proceed 
under conditions where other terminal electron acceptors are unavailable, as is the case in 
dense, oxygen-limited stationary-phase cultures. Intriguingly, in anaerobic reactors containing 
electrodes poised at phenazine-reducing potentials, the phenazines pyocyanin, PCA, and 1-
hydroxyphenazine promote survival of P. aeruginosa in the absence of any other electron 
acceptor [86]. The bacteria catalyze phenazine-mediated extracellular electron shuttling, using 
the electrodes as the terminal oxidant. It therefore appears that these secondary metabolites 
participate in reactions of primary metabolic significance under some conditions; the specific 
reactions that support bacterial survival in these cases remain to be identified. 
1-3-2 Phenazines modulate community development 
Many bacteria, including those that produce phenazines, frequently exist in nature not as 
unicellular organisms but within complex biofilm communities. Previous studies have 
established the presence of decreasing oxygen gradients in biofilms [62] and I have 
hypothesized that phenazines play an important role in balancing the redox state of cells within 
anoxic zones. Indeed, the effects of phenazine production or exposure on colony biofilm 
development produce dramatic macroscopic effects: wild-type colonies of P. aeruginosa PA14 
are smooth and smaller than those of the phenazine-null mutant, which are highly wrinkled and 
spread over a larger surface area of the agar plate (Fig. 1-8). Although it has been established 
that bacterial cells in cultures and flow-cell biofilms can coordinate their gene expression, the 
ability for 10 billion bacterial cells to organize into a structure like the phenazine-null colony 
suggests that the mechanisms by which they do so are far more complex than previously 
appreciated, and probably involve both cell-cell communication and redox balancing. In 
addition to influencing homogenous cell populations like a bacterial colony, phenazines can 
also mediate interactions between heterogeneous cell populations. This is especially relevant in 
soil environments and during host infections, where phenazine-producers typically live in 
biofilms with a diversity of other species [85,87]. 
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1-4 STRUCTURAL MODULATION AS A RESPONSE TO REDOX IMBALANCE 
The molecular details, mechanics, and physiological relevance of structural development have 
been studied for many models of microbial multicellularity. Large bodies of work describe the 
signaling cascades that control motility and matrix production and thereby affect biofilm 
morphogenesis [31,33,38,48,88,89]. In Bacillus subtilis biofilms, nonuniform cell death has 
been observed to precede and was proposed to determine wrinkle pattern formation when 
mechanical forces, arising from colony growth, promote vertical buckling [90]. Results from an 
additional study in B. subtilis have suggested that wrinkles are actually channels that allow for 
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Figure 1-8. The physiological roles of phenazines. Phenazines play a role in iron 
acquisition, redox balancing, and signaling may contribute to the drastic morphological 
switch observed in phenazine-producing versus phenazine-null colony biofilms in P. 
aeruginosa PA14. Source: Okegbe et al Antioxidants & Redox Signaling., 2012
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Figure 1-9. Strategies to achieve redox homestasis. Electron shuttling, nitrate reduction, and colony wrinkling 
are strategies that can support redox balancing, indicated by the NADH/NAD+ ratio, for microbes in biofilms. The 
model presented here is based on findings from two recent publications concerning colony morphogenesis in P. 
aeruginosa and B. subtilis; whether these strategies are employed in other microbial communities remains to be 
investigated. Source: Okegbe et al Current Opinion in Microbiology., 2014
enhanced liquid transport through the biofilm [91]. Despite these advances, for most models a 
thorough analysis of the response to environmental cues, and especially to changes in redox 
potential, have not been conducted. The significance of redox potential in determining biofilm 
morphology has only become apparent over the last few years with the examination of this 
relationship in P. aeruginosa and B. subtilis. Results from these studies suggest that colony 
wrinkling enhances access to oxygen and maintenance of redox homeostasis for bacteria in 
biofilms.  
The elaborate wrinkles formed by colonies of some P. aeruginosa mutants became a focus of 
the Dietrich lab’s work when it was discovered that the change in morphology--dramatically 
enhanced rugosity--that occurs when this organism is unable to produce antibiotics called 
phenazines [92,93]. Phenazines are redox-active and are reduced and excreted by P. 
aeruginosa [94]. Extracellularly, they react readily with oxidants and can be taken up by the 
bacteria once again, thus acting as mediators that facilitate extracellular electron transfer [95]. 
Such phenazine redox cycling can support survival when P. aeruginosa is incubated in 
suspension with no terminal electron acceptors other than an electrode poised to catalyze 
phenazine oxidation [86]. Work presented Chapter 2 of this thesis further investigates the role 
of colony wrinkling in increasing access to oxygen and enabling redox balancing under 
conditions of redox stress as experienced by the phenazine-null mutant (Fig. 1-9). 
Whether colony wrinkling is a strategy for accessing oxygen in the diversity of rugose colony 
models that have been studied is still unknown. However, a recent publication by Kolodkin-Gal 
et al. indicates that this scenario does hold in the bacterium B. subtilis [63]. B. subtilis does not 
produce phenazines, but, as I have observed in P. aeruginosa, varying the atmospheric oxygen 
concentration modulates the extent of colony wrinkling. Furthermore, adding nitrate to the 
medium also decreases wrinkling. The effects of varying oxygen concentration and adding 
nitrate on both colony systems are consistent with the model that colony wrinkling is a readout 
for redox imbalance. Interestingly, different nitrate reductases appear to be involved in the 
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rugose-smooth morphological change that occurs when P. aeruginosa and B. subtilis are grown 
with nitrate in an aerobic atmosphere. While P. aeruginosa requires the periplasmic nitrate 
reductase Nap for smooth colony formation on nitrate, B. subtilis requires the membrane-
assocated (respiratory), cytoplasmic nitrate reductase Nar. Nevertheless, these results suggest 
that for both P. aeruginosa and B. subtilis, wrinkling to enhance access to oxygen and 
utilization of nitrate (when available) are strategies for balancing the intracellular redox state 
during growth in biofilms (Fig. 1-9). In organisms where additional anaerobic metabolisms, such 
as fermentation, contribute to redox balancing, utilization of such strategies may support the 
survival of bacteria in anoxic biofilm regions [31]. 
Though many additional studies are required to investigate the physiological roles of wrinkling 
in the diverse microbes that adopt this colony morphology, intriguing findings across 
phylogeny point to a theme with respect to the roles of mediator compounds. In early work 
examining respiratory activity in both normal and malignant tissues, biologists observed that 
compounds such as phenazines increased respiration rates [96,97]. They theorized that such 
mediators could act as electron acceptors for cells experiencing oxygen limitation within 
tissues, then diffuse to aerobic zones for re-oxidation. Furthermore, upon observing that such 
electron acceptors are produced by certain species of bacteria, some authors also suggested 
that they could act as endogenous respiratory substrates [98]. It was only recently and with the 
increased appreciation that the biofilm lifestyle is a dominant mode of growth for many 
microorganisms that it became apparent that mediators could support redox balancing for their 
producing cells during residence in multicellular structures. Intriguingly, mutants of 
Streptomyces coelicolor A3(2) unable to produce the diffusible redox-active antibiotic 
actinorhodin form more rugose colonies than their wild-type parent, raising the possibility that 
pigment-dependent electron shuttling occurs in diverse organisms [92]. Microbes that do not 
produce mediators may be able to utilize diffusible redox-cycling compounds produced by 
other organisms in the environment to support redox balancing during multicellular growth. In 
this context it is interesting to note that phenazines induce a rugose-to-smooth morphotypic 
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transformation in colonies of the yeast Candida albicans [30] (and see Appendix C), though 
whether C. albicans communities can use phenazines for extracellular electron transfer and 
cellular redox balancing in biofilms is not known. 
1-5 MECHANISMS LINKING REDOX SENSING TO COMMUNITY OUTPUT 
Metabolism and redox chemistry are tightly linked as anabolic and catabolic processes involve 
reductive and oxidative reactions, respectively. However, the cellular redox balance is 
constantly threatened by changes in the availability of electron donors and acceptors and 
exposure to highly redox-active metabolites. It is monitored by a variety of sensors; some of 
these directly sense stressors, while others sense their effects on the cell. The latter type of 
sensor takes advantage of the redox properties of cofactors, such as iron-sulfur clusters, 
flavins, and hemes. These proteins can couple redox sensing to a variety of outputs, but in 
most cases they ultimately affect transcription [1,99]. 
Though redox sensors have been best studied as mechanisms for protecting the cells from 
distress, there is growing appreciation for the role that these sensors play in the coordination of 
neutral or positive responses to redox-active metabolites. These alternate responses occur 
because different functions for identical redox-sensing systems have evolved to meet the 
needs of specific organisms. Thus, two homologues of the same redox-sensing system that 
detect the same redox signal are linked with different outputs with opposing functions, such as 
coping mechanisms for distress (a.k.a. “stress responses”) in one organism versus 
developmental signaling in another. Two examples that illustrate this concept are (i) the nitric 
oxide (NO) sensor NsrR in Escherichia coli and Neisseria meningitidis and (ii) SoxR, a sensor for 
redox-cycling compounds in E. coli and Pseudomonas aeruginosa. Both NsrR and SoxR are 
transcriptional regulators that sense redox-active signals through iron-sulfur clusters [100-102]. 
1-5-1 NsrR: Stress response to NO vs. utilization of NO in primary metabolism 
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In E. coli, NsrR induces approximately 20 genes that mediate a response to the toxicity of NO 
including hmp, nrfA and ytfE. Hmp converts NO to nitrate in the presence of oxygen [103], NrfA 
converts nitrite to ammonium through an NO intermediate [104], and YtfE is involved in 
repairing iron-sulfur clusters that have been damaged by NO [105]. In this scenario, the regulon 
encodes mechanisms that enable the bacterium to cope with exposure to the redox-active 
compound, suggesting that NO has the potential to cause distress in E. coli. When the stress 
response is fully functional, however, redox homeostasis is maintained. 
In a contrasting scenario, N. meningitidis NsrR regulates a smaller set of genes [106], including 
aniA and norB. AniA reduces nitrite to NO, which is further reduced by NorB to nitrous oxide. 
This was originally interpreted as a way for the bacterium to clear NO that is released from 
macrophages during infection [107]. However, these reactions can also enable the 
maintenance of redox homeostasis by allowing N. meningitidis to utilize NO as an electron 
acceptor. This function may support survival in the microaerobic environments it encounters 
during host infection, due to the abundance of mucus in the nasopharynx [104]. 
1-5-2 SoxR: A sensor of exogenous and endogenous redox-cycling compounds 
SoxR is a well-established stress response regulator in E. coli that senses redox-cycling 
xenobiotics [82,92,108,109]. In E. coli, SoxR activates expression of the transcription factor 
SoxS, which in turn regulates the expression of more than one hundred genes [110]. The 
products of this regulon include transporters of redox-cycling agents and enzymes that 
detoxify the products of redox-cycling, including reactive oxygen species. Induction of the 
SoxRS regulon therefore represents a coping mechanism that protects from the toxicity of 
exogenous redox-cycling agents.  
In non-enteric bacteria such as P. aeruginosa, the mechanism of sensing redox-cycling 
compounds is similar to that of E. coli SoxR, but the response is different. P. aeruginosa SoxR 
is activated by endogenously-produced phenazines [82], which bear structural similarity to 
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some of the compounds that activate E. coli SoxR. However, unlike the E. coli SoxRS system, 
P. aeruginosa SoxR induces transcription of a small set of genes, encoding two transporters 
and a monooxygenase [82,111]. Work from the Dietrich lab would suggest that the transporters 
are needed for the proper shuttling of phenazines [92]. Similar observations have been made in 
Streptomyces coelicolor, where the endogenous antibiotic actinorhodin and/or its biosynthetic 
precursors activate SoxR [92,108,112]. Similar to the case for P. aeruginosa, its regulon 
consists of a small set of genes, encoding transporters and oxygenase-type enzymes. 
The sensors NsrR and SoxR are two examples of the transcription factors that respond to 
redox signals in a context-specific fashion. In E. coli, they provide effective means to ward off 
or recover from redox toxicity and allow bacteria to cope with exposure to these compounds. 
While these mechanisms merely facilitate tolerance to these compounds, there are also cases 
where these sensors allow bacteria to exploit the same compounds as metabolic substrates or 
signals controlling community development and morphogenesis. 
1-5-3 Connecting redox to colony morphogenesis 
The redox signals highlighted in the previous section– nitric oxide and phenazines, have been 
shown to play roles in biofilm development in P. aeruginosa [113,114]. In 2003, Webb and 
colleagues uncovered new roles for reactive oxygen and nitrogen species in cell lysis and cell 
dispersal from microcolony biofilms of P. aeruginosa growing in flow cells, where biofilms grow 
attached to a surface under a constant flow of liquid medium [115]. Soon after, the specific role 
of NO in biofilm development and dispersal was investigated. This work revealed that non-toxic 
levels of NO indicate to the colonies that environmental conditions are favorable for planktonic 
growth, signaling the biofilm communities to strategically disperse into individual cells [116]. 
NO acts via a signaling pathway to upregulate phosphodiesterase activity, leading to 
decreased intracellular levels of cyclic di-GMP (c-di-GMP) [113], an intracellular second 
messenger involved in bacterial switching from sessile to motile states. The role of c-di-GMP in 
biofilm development will be discussed in section 1-6 of this chapter. Work from the Dietrich lab 
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has showed how the different phenazines made by P. aeruginosa PA14 affect biofilm 
development. The redox potentials of phenazines are such that they can be easily reduced by 
the bacterial cell and react extracellularly with higher potential oxidants such as ferric iron and 
oxygen, acting as electron shuttles between the bacterium and an external substrate [80,117]. 
In short, phenazines allow survival in the deepest parts of the colony biofilm where oxygen and 
other usable electron acceptors are unavailable. Their absence therefore triggers colony 
wrinkling as a compensatory mechanism. 
The effects of electron acceptor limitation on P. aeruginosa and B. subtilis colony biofilm 
morphogenesis suggest that regulatory proteins serve to sense redox conditions and regulate 
community behavior. In this section, I discuss what is already known about mechanisms of 
multicellular structure formation in these two species in the context of redox homeostasis. 
In P. aeruginosa PA14, colony wrinkling requires the secretion of a polysaccharide called Pel 
[33]. Colonies formed by a double mutant unable to produce Pel polysaccharide or phenazines 
remain smooth and exhibit a reduced intracellular redox state that persists throughout colony 
development [64]. This finding suggests that the NADH/NAD+ ratio, or another indicator of the 
cellular redox potential, is sensed by regulatory pathways that control features such as Pel 
polysaccharide production that then control colony wrinkling. In B. subtilis, a polysaccharide 
encoded by the eps genes and the amyloid protein TasA are major components of the matrix 
that are required for wild-type wrinkling [25]. Kolodkin-Gal et al. found that expression from the 
promoter controlling the tapA-sipW-tasA or “tapA” operon correlated with wrinkling in the 
context of varying oxygen and nitrate availability. Decreasing the concentration of FeCl3 in the 
medium demonstrated a correlation between wrinkling, expression from PtapA, and oxidation of 
the NAD(H) pool (decreased NADH/NAD+). However, a time course was not conducted, so this 
study does not examine the possibility of a causative relationship between changes in the 
NADH/NAD+ ratio and colony wrinkling. Production of the polysaccharide cellulose and curli 
fimbriae are required for rugosity in E. coli and S. enterica Typhimurium [31,118-120], and a 
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polysaccharide critical for rugosity has also been described for Vibrio cholerae [46,121]. 
Various stresses have been shown to affect the production of these components, though in 
most cases it is not clear whether redox imbalance is one of them. Interestingly, studies 
examining the effects of oxygen limitation on regulatory gene expression, and the abundance 
of NAD+ in wild-type and matrix-deficient strains, in Salmonella suggest that colony 
development could both respond to and affect redox homeostasis in this organism [122,123]. 
If sensing of the internal redox state is directly related to initiation of wrinkling, what signal 
transduction pathways are mediating this response? In B. subtilis, a regulatory cascade, which 
proceeds via expression of the anti-repressor SinI, links matrix gene expression to the master 
regulator Spo0A. The phosphorylation state and activity of Spo0A is determined by a 
phosphorelay, and the histidine kinases KinA-E contribute phosphoryl groups to this relay 
[124]. Kolodkin-Gal et al. reported that wild-type colony wrinkling requires KinA-D. When 
expression from the sinI promoter (expected to correlate with tapA expression and wrinkling) 
was measured for various KinA-D single and double mutants, a kinA kinB double mutant 
showed the most dramatic decrease relative to the wild type. The colony phenotype of this 
double mutant closely resembled that of the wild type grown with 5 µM FeCl3, where no 
wrinkling occurred during the incubation time used for the experiment. KinB is predicted to 
bind to the cell membrane. Immunoprecipitation experiments and mutational analyses 
suggested that KinB interacts with components of the electron transport chain, which may 
allow KinB to sense respiratory activity and transduce this information into a macroscopic 
response. 
In contrast to KinB, KinA is not predicted to interact with the membrane. KinA contains three 
tandem PAS domains, motifs that often bind small molecule ligands. In organisms ranging from 
bacteria to plants and humans, PAS domains (discussed in section 1-7) have been shown to 
sense signals and parameters such as redox potential, oxygen availability, and light intensity 
through conformational changes or phosphorylation events [125]. Associated effector domains 
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on the same protein propagate this signal to downstream targets. The PAS-A and PAS-C 
domains of KinA were found to be necessary for wild-type levels of  PsinI activity and wrinkling. 
Through HPLC and mass spectrometry of extracts from purified KinA, NAD+ was identified as a 
potential ligand for the PAS-A domain. This result suggests that KinA contributes to the 
morphological response to changes in iron levels and oxygen availability by sensing the effects 
of these environmental cues on the cellular NAD(H) pool [63]. 
Work from the Dietrich lab has also indicated a role for PAS domain-containing proteins in P. 
aeruginosa colony morphogenesis. To find the players involved in sensing and initiating the 
response to electron acceptor limitation in colonies, I screened a P. aeruginosa PA14 
transposon mutant library for hyperwrinkled mutants. Focusing on proteins with predicted 
sensory and signal transduction roles, I hypothesized that the mutants hyperwrinkled due to an 
inability to relay information about intracellular redox state; i.e., they wrinkled to alleviate a 
redox stress that didn’t exist. Several mutants representing PAS domain-containing proteins 
were found among the hyperwrinklers. These and additional studies, detailed in Chapter 3, 
suggest that one of these proteins affects Pel polysaccharide production by modulating levels 
of the ubiquitous second messenger c-di-GMP.  
1-6 CYCLIC DI-GMP 
Cyclic di-GMP (c-di-GMP) is a ubiquitous bacterial intracellular second messenger that was 
first described in 1987 by Moshe Benziman and colleagues at The Hebrew University of 
Jerusalem as an allosteric activator of cellulose synthase in the bacterium Acetobacter xylinum 
(now called Gluconacetobacter xylinus) [126,127]. In the years since this discovery, c-di-GMP 
has emerged as an important player modulating an array of processes such as biofilm 
formation, motility, virulence, cell cycle, and differentiation [128-133]. More recently, c-di-GMP 
was found to also regulate cellular differentiation in simple eukaryotes [134].  
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Genomic annotations predict that P. aeruginosa PA14 has 40 proteins with domains involved in 
c-di-GMP metabolism [135-137]. While the physiological roles of these particular proteins 
remain under-characterized, a great amount of effort has gone into elucidating the biochemistry 
of c-di-GMP synthesis, degradation and binding more generally. Domains with digunalyate 
cyclase (DGC) activity, involved in c-di-GMP synthesis, generally contain a characteristic Gly-
Gly-Asp-Glu-Phe (G G D E F) sequence motif (i.e., the active site or “A-site”) and are often 
referred to as “GGDEF domains”. Domains with phosphodiesterase (PDE) activity, involved in 
c-di-GMP hydrolysis, fall into two classes: (i) “EAL domains”, with a highly conserved Glu-Ala/
Val-Leu (E A/V L) active site motif, and (ii) “HD-GYP” domains, which have conserved His-Asp 
(HD) and Gly-Tyr-Pro (GYP) motifs that play roles in cofactor and substrate binding. Though 
these two types of PDE domains are both involved in c-di-GMP hydrolysis, they yield different 
products (Fig. 1-10). The terms described above can also be applied to domains that 
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Figure 1-10. Cyclic di-GMP biosynthesis at a glance. One molecule of c-di-GMP (shown in center) is 
synthesized from two molecules of GTP by enzymes known as diguanylate cyclases (DGCs), which carry a 
conserved GGDEF domain. c-di-GMP can bedegraded by two families of phosphodiesterases (PDEs); those with 
an EAL domain linearize the molecule to produce pGpG, and proteins with an HD-GYP domain generate two 
molecules of GMP. Adapted from: Ha and O'Toole, Microbiol Spectr., 2015.
structurally resemble GGDEF, EAL, and HD-GYP domains but actually contain a degenerate 
sequence in place of their canonical motifs.  
1-6-1 Diguanylate cyclases 
Diguanylate cyclases (DGC) synthesize c-di-GMP from 2 GTP molecules in a two-step process 
involving a 5’-pppGpG reaction intermediate [138]. DGC domains function as homodimers with 
dimerization occurring at the active site interface [139]. The active site or A site of DGC 
domains bind GTP using the first two Gly residues. Two Mg2+ or Mn2+ cations, which are 
coordinated to the fourth Glu residue are required for the phosphodiester bond to form. The 
third Asp or Glu residue is also used for cation coordination and is required for c-di-GMP 
synthesis [140] This third residue is often targeted in mutational studies of DGC domains. 
Overall, the GG(D/E)EF motif is predicted to have a ß-hairpin conformation [141]. Although the 
precise catalytic mechanism of DGC domain activity remains poorly understood, existing 
structural studies have proposed that the successful catalysis of c-di-GMP occurs when active 
homodimers are close enough. This would suggest that conformational arrangements dictated 
by sensory domains and feedback inhibition mechanisms control the formation of DGC 
homodimer complexes by isolating active sites at far enough distances to prevent unwanted c-
di-GMP synthesis [140,142]. 
It is noteworthy that most c-di-GMP metabolizing enzymes are linked to sensory input domains 
at their N-terminus. Such sensory input domains include PAS (first discovered in Per, Arnt, and 
Sim proteins), GAF (found in cGMP-specific phosphodiesterases, adenylyl cyclases, and FhlA), 
and REC (RECeiver) domains [143,144]. These sensory domains sense cues or signals and 
initiate downstream processes and a desired output. A signal such as a residue 
phosphorylation event or cofactor oxidation/reduction causes a conformational change and 
subunit reorganization in the sensory input domains which brings the DGC domains in close 
enough proximity to catalyze c-di-GMP synthesis. This has been shown for the surface sensing 
protein WspR in P. aeruginosa. WspR has a REC-GGDEF domain architecture and is part of the 
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Wsp system, which is activated in response to growth on surfaces [145-147]. Structural studies 
reveal that the DGC domains are closer, and more capable of forming a catalytically competent 
homodimer, in the phosphorylated protein when compared to the nonphosphorylated protein. 
Similar results have been obtained for Caulobacter crescentus PleD [148] and Borrelia 
burgdorferi, Rrp1 [149]. 
Feedback inhibition in DGC domains occurs at the inhibitory (I) site. The conserved 
characteristic I-site motif is RxxD, where "x" is any residue and it is situated five amino acids 
upstream of the GG(D/E)EF motif. In spite of the sequence proximity of the I and A sites, they 
are located diametrically opposite to each other in the domain [148,150]. DGC activity is 
inhibited when the c-di-GMP dimers bind to the I-site. This locks the DGC domain in place and 
prevents the mobility of the DGC domain required for DGC homodimer formation. 
1-6-2 Phosphodiesterases 
There are two classes of phosphodiesterase activity: PDE-A, carried out by EAL domains, and 
PDE-B, carried out by HD-GYP domains (Fig. 1-10). Initial work on PDE-A activity, which 
hydrolyses c-di-GMP to produce the linear di-GMP molecule 5’-pGpG, was done by Benziman 
and colleagues, who purified predicted PDEs from G. xylinus and showed the these proteins 
were able to breakdown c-di-GMP. This activity required either two Mn2+ or Mg2+ cations 
[151,152] and was repressed by Ca2+. Several genetic and biochemical studies using PDEs 
from different organisms showed that EAL domains were required for c-di-GMP hydrolysis 
[153-155]. Interestingly, this reaction was c-di-GMP specific as other phosphoester- and 
phosphodiester-containing compounds tested, including cyclic AMP (cAMP), were unaffected. 
Although EAL domains have been characterized as dimers and multimers in vitro [156,157] 
they are able to retain activity as monomers [154]. A number of studies have solved the 
structures of EAL domains [158-160] yielding insights into the catalytic mechanism. C-di-GMP 
present in the EAL domain during hydrolysis takes on an open conformation (Fig. 1-11) in 
contrast to the U-shape confirmation observed when c-di-GMP is in the I-site of DGC domains. 
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Studies in the BlrP1 protein from Klebsiella pneumoniae showed that the activity of the EAL 
domain proteins depends on the structure of a two-metal cation cluster in which the metals 
coordinate two water molecules, one of which is involved in a hydrolytic attack on a 
phosphoester bond of c-di-GMP. The Glu residue is required for cation coordination [158] and 
is conserved in all active EAL domains. BlrP1 has a BLUF-EAL architecture and its PDE-A 
activity is turned on in response to blue light [161,162], which causes conformational changes 
that stabilize the active site and EAL-EAL dimer interface. 
HD-GYP domains belong to the HD domain superfamily of enzymes, which have been shown 
to catalyse phosphomonoesterase and phosphodiesterase reactions depending on their 
catalytic metal centre being mono- or binuclear respectively [137,144,163,164]. Initial studies 
investigating HD-GYP domain activity were done on RpfG from Xanthomonas campestris. RfpG 
complemented an EAL domain phosphodiesterase mutant and had c-di-GMP-specific activity 
when purified and expressed in Pseudomonas aeruginosa PAO. The main product of this 
activity was however not linear 5’pGpG but GMP [165], showing that, in contrast to PDE-A 
activity, PDE-B activity hydrolyzes c-di-GMP to two GMP molecules. Additional HD-GYP 
proteins from diverse genera such as Pseudomonas and Borrelia have since been 
characterized [137,166]. However, it remains an open question whether linearized 5’-pGpG, the 
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Figure 1-11. Three-dimensional structures of cyclic-
di-GMP, showing one molecule in the the open 
conformation (top) or 2 molecules in the U-shaped 
conformation (bottom). Carbon atoms are shown in 
light blue, oxygen in red, nitrogen in deep blue and 
phosphorous in green. Reprinted by permission 
from Macmillan Publishers Ltd: Nature Reviews 
Microbiology, Schirmer and Jenal, copyright 2009
product of PDE-A activity, is an intermediate in HD-GYP activity. Furthermore, the biological 
significance of having different phosphodiesterase activities is yet to be fully understood. 
1-6-3 Proteins with tandem DGC and PDE domains 
It is interesting that the first DGCs and PDEs discovered by Benziman had tandem GGDEF -
EAL domains [167]. Genome wide-studies have found that 33% of GGDEF domains and 67% 
of EAL domains are arranged in tandem with each other [168]. Given that DGC and PDE 
domains are known to function independently the significance of these tandem domain 
arrangements has remained an interesting but unanswered question. There are two main 
scenarios that may account for tandem arrangements: (1) Both domains are active but are 
regulated differentially by environmental signals; or (2) One domain is degenerate and functions 
to sequester the substrate for the active domain or downstream effectors. 
Thus far, the scenario in which both domains are functional remains a very rare in occurrence 
among c-di-GMP metabolizing enzymes. Examples that have been characterized include 
Rhodobacter sphaeroides BphG1, Mycobacterium smegmatis MSDGC-1, Vibrio 
parahaemolyticus Src, and Legionella pneumophila LpL0329 [157] [169]. The activities of the 
latter two proteins have been shown to be influenced by conditional cues: Src exhibits DGC 
activity under normal conditions but switches to PDE activity during periods of high cell density 
[170], while Lpl03329 loses DGC activity upon phosphorylation of its REC domain [171]. 
GGDEF-HD-GYP tandems are rare especially when compared to GGDEF-EAL tandems. 
Although studies characterizing GGDEF-HD-GYP tandem proteins are scarce, it is expected 
that they function similarly to other well characterized GGDEF-EAL tandem proteins [140]. 
Structural studies coupled with site-directed mutagenesis have given the c-di-GMP field 
substantial insight and ability to predict DGC and PDE domains that are likely to be active or 
inactive. Proteins with degenerate motifs in their DGC or PDE domains are numerous. Genomic 
analyses predict that about 40% of GGDEF-EAL tandem proteins have mutations that abolish 
DGC activity compared to 13% with PDE-abolishing mutations. This suggests that DGC 
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domains are more likely to be degenerate in proteins with GGDEF and EAL domains arranged 
in tandem [168]. Indeed, there is little known about catalytically inactive EAL domains in such 
proteins. Further characterization of tandem proteins is needed to understand the 
intramolecular regulation of c-di-GMP metabolism and its roles in in bacterial physiology. 
1-6-4 Regulation of biofilm development by c-di-GMP 
Numerous studies characterizing the roles of c-di-GMP in P. aeruginosa social behaviors have 
led to a paradigm in which this organism is understood to grow in one of two states: (i) a 
sessile state associated with high c-di-GMP levels, polysaccharide excretion and biofilm 
formation, or (ii) a motile state associated with low c-di-GMP levels and a type of motility on 
semisolid surfaces called swarming [172-174] [140,175,176]. Mutants lacking proteins involved 
in c-di-GMP metabolism or binding tend to fall into one of these two phenotypic categories, 
though exceptions to this trend (i.e., mutants that overproduce polysaccharide yet exhibit 
robust swarming motility) have been described [181]. This section will focus on the role of c-di-
GMP in regulating polysaccharide production, which is required for wrinkle structure formation 
in the colony biofilms and wild-type levels attachment to surfaces in static liquid culture models 
of biofilm formation. 
In P. aeruginosa PA14, the primary model strain used in this work, Pel constitutes the major 
polysaccharide component of the matrix. Pel biosynthesis is regulated by c-di-GMP at the 
transcriptional level via FleQ and post-translational level via PelD. The transcriptional regulator 
FleQ promotes Pel transcription when bound to c-di-GMP [172]. When c-di-GMP is low or 
absent, FleQ complexes with FleN, an ATP-binding protein. This complex binds the Pel 
promoter region to bend the DNA and inhibit Pel transcription [173] (Fig. 1-12). It is speculated 
that the DGC WspR, upon activation through a phosphorylation event initiated by surface 
contact, provides the localized c-di-GMP pool used by FleQ for efficient transcriptional control 
[145,146] 
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At the post-translational level, Pel biosynthesis is regulated by PelD, a c-di-GMP receptor with 
an I-site (RxxD) motif that is allosterically activated by c-di-GMP [177]. Mutation of the I-site 
motif, which leads to loss of c-di-GMP binding, results in an inability to form biofilms properly 
[177-179]. While the exact mechanism of PelD function is yet to be fully elucidated, DGCs and 
PDEs that tune the c-di-GMP level in response to environmental cues probably control Pel 
biosynthesis through PelD. The well-characterized DGCs RoeA and SadC and the PDE BifA 
have all been shown to regulate Pel production [180,181]. 
Biofilms that form on submerged surfaces can also disperse in response to environmental 
signals. Dispersal triggered by NO or glutamate has been attributed to a lowering of cellular c-
di-GMP via the activity of the PDEs DipA and RbdA [182] [183,184]. Studies from Karen Sauer’s 
group characterizing the role of c-di-GMP in dispersal have also described the protein BldA, 
which is required for biofilm dispersal and contains both PAS and chemotaxis-associated 
domains. Although BldA does not contain domains directly associated with c-di-GMP 
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Figure 1-12. Cyclic-di-GMP-dependent regulation of Pel polysaccharide biosynthesis in P. aeruginosa. 
Reproduced from Liang, Natural Product Reports., 2015.permission of The Royal Society of Chemistry.
metabolism, it appears to be cleaved when c-di-GMP levels are high [183,185,186]. DipA-
dependent lowering of c-di-GMP levels inhibits BldA cleavage and allows dispersal to occur. 
Whether the PAS domains of BldA confer redox sensitivity and link redox conditions to the 
regulation of dispersal is not known. 
1-7 PAS DOMAINS 
PAS domains were initially discovered by sequence similarity between three proteins– PER, 
ARNT and SIM—with roles in circadian regulation, the immune response, and cell development 
in complex eukaryotes [125,187,188] [189] [190] [191]. The first structure of a PAS domain was 
published in the late 90s and since then, structures of many more have improved our 
understanding of their cofactor binding and other features. PAS domains are usually about 100 
residues in length [192,193] and have a characteristic five-stranded antiparallel beta sheet with 
alpha helices that form the ligand binding pocket on the beta sheet [187]. 
PAS domains are found in all domains of life [194,195] (Fig. 1-13) and are widely abundant in 
bacterial proteomes [196]. PAS domains are typically found in sensory and signal transduction 
proteins as they are able to sense a variety of signals such as redox potential, oxygen, light 
[195]. In order to sense such diverse signals, PAS domains are usually coordinated to ligands 
such as heme and flavins [125] which are often the site of signal sensing within these domains. 
Although some ligands that are bound to PAS domains are known, deciphering precisely what 
environmental stimuli and substrates are sensed by individual PAS domains is often 
challenging [125] because there is low primary sequence similarity between PAS domains 
although the three-dimensional structure is conserved [195,197]. However, for proteins with 
solved structures, the conserved 3-D fold of PAS domains has allowed the identification of 
cofactors and ligands because the residues in the ligand-binding pockets are usually 
conserved [125,198]. 
PAS domain-containing proteins often play critical roles in development and survival in specific 
environmental contexts. An example from complex eukaryotes is the well-studied PAS domain 
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proteins Hypoxia Inducible Factor-1 (HIF-1), involved in tumor development. Rapidly growing 
cancer cells quickly outpace oxygen availability needed for survival and therefore must activate 
adaptive mechanisms such as angiogenesis and glucose metabolism to meet the increased 
demand for oxygen [199,200]. In bacteria, PAS domain-containing proteins have been 
implicated in an array of important cellular processes such as photosynthesis, circadian 
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Figure 1-13. The diversity of PAS proteins. Examples of PAS-domain-containing proteins from all domains of life 
and their domain archtecture. PAS domains are usually linked to output domains, which can have diverse 
functions. Reprinted from Structure, 17(10), Möglich et al, Structure and Signaling Mechanism of Per-ARNT-Sim 
Domains, 1283-1294, copyright 2009, with permission from Elsevier
regulation, biofilm formation, chemotaxis, sporulation, and nitrogen fixation 
[63,184,185,201-203]. Bacterial PAS domain-containing proteins can also harbor diverse 
effector or output domains involved in phosphorylation, DNA-binding and cyclic-di-GMP 
metabolism [125] (Fig. 1-14). As such, PAS domains are crucial to sensory and signal 
transduction networks that allow bacteria to readily adapt to ever-changing and potentially 
harmful environmental conditions. 
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Figure 1-14. Predicted domains contained in bacterial PAS proteins. Most common domains associated with 
PAS proteins are associated with sensory input, transduction or output. Adapted from: Henry and Crosson, Annu. 
Rev. Microbiol 2011.
1-8 AIMS OF THIS WORK 
Colony biofilms form captivating patterns that are strongly influenced by growth conditions. 
How do the billions of microscopic residents in these communities coordinate their activities to 
produce a macroscopic response? My thesis approaches this fundamental question through 
the application of diverse techniques to colony biofilms formed by the opportunistic pathogen 
P. aeruginosa PA14. PA14 colony biofilm architecture is dramatically altered by changes in 
redox conditions. While much is known about the molecular mechanisms underpinning biofilm 
structure formation, the relationships between conditions and morphological output, and the 
regulatory mechanisms that support these relationships, are not well understood. The work 
described in this thesis has been motivated by the following two aims: 
Aim 1: Characterize the relationship between electron acceptor availability and colony biofilm 
development 
This goal is addressed by the work presented in Chapter 2 and Appendices B and C. Chapter 2 
describes the characterization of PA14 colony development under different redox regimes. 
Results from microelectrode-based profiling, measurement of cellular NADH/NAD+ levels, 
fluorescence microscopy of colony thin sections, and mutant analyses support the conclusions 
that phenazines act as alternate electron acceptors to support the survival of cells in anoxic 
biofilm subzones and that redox imbalance is a major determinant of the colony developmental 
program in P. aeruginosa PA14. Indeed biofilm maturation is hampered by the presence of 
redox stressors like carbon monoxide (Appendix A), and mathematical modeling shown in 
Appendix B supports the hypothesis that the colony takes on optimal geometry and 
architecture to ensure survival in specific redox regimes. Finally, aspects of the influence of 
phenazines on PA14 biofilm development are paralleled in colonies formed by the fungus 
Candida albicans (Appendix C). 
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Aim 2: Determine the sensory link(s) between cues, such as altered redox conditions and 
environmental stressors, and colony biofilm morphogenesis 
This goal is addressed in Chapter 3 and Appendix D, which describe the identification, 
characterization, and purification of PAS domain-containing redox sensors that regulate biofilm 
development through the modulation of c-di-GMP levels. An additional study characterizing the 
effects of C. albicans-produced ethanol, described in Appendix E, showed that it affects biofilm 
matrix production via the modulation of c-di-GMP levels. 
Overall, this work has furthered our understanding of fundamental principles that govern PA14 
community behavior and revealed mechanisms that allow this bacterium to respond to electron 
acceptor availability at the population level. These results show that in bacterial biofilms, as in 
multicellular eukaryotic organisms, electron acceptor availability influences and is influenced by 
collective structure and that cellular redox state is an important driver of community 
morphogenesis. The matrix-encased cells in bacterial biofilms, like those in complex 
multicellular eukaryotes, employ PAS-domain-dependent signaling cascades to mediate the 
community response to redox conditions. I predict that, as the role of relative electron donor 
and acceptor availability in shaping populations is determined for additional and diverse 
microbial species, the importance of redox chemistry, not just to metabolism but also to 
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2-1 ABSTRACT 
Many microbial species form multicellular structures comprising elaborate wrinkles and 
concentric rings, yet the rules govern- ing their architecture are poorly understood. The 
opportunistic pathogen Pseudomonas aeruginosa produces phenazines, small molecules that 
act as alternate electron acceptors to oxygen and nitrate to oxidize the intracellular redox state 
and that influence biofilm morphogenesis. Here, we show that the depth occupied by cells 
within colony biofilms correlates well with electron acceptor availability. Perturbations in the 
environmental provision, endogenous production, and utilization of electron acceptors affect 
colony development in a manner consistent with redox control. Intracellular NADH levels peak 
before the induction of colony wrinkling. These results suggest that redox imbalance is a major 
factor driving the morphogenesis of P. aeruginosa biofilms and that wrinkling itself is an 
adaptation that maximizes oxygen accessibility and thereby supports metabolic homeostasis. 




The ubiquity of multicellularity—a property observed in all three domains of life— 
underscores the advantages conferred on organisms that assume this lifestyle (1, 2). 
Multicellularity allows division of labor, as well as protection from environmental insults, but 
also presents a significant challenge by exacerbating limitations for growth substrates. 
Eukaryotic macroorganisms alleviate this problem in part through (i) internal circulation that 
allows delivery of substrates to specific locations and (ii) metabolic differentiation. Although 
the significance of the multicellular lifestyle for metabolism and pathogenicity of 
microorganisms is well recognized (3–5), the mechanisms enabling microbial communities to 
cope with substrate limitation are poorly defined.

Pseudomonas aeruginosa is a leading causative agent of nosocomial infections that forms 
biofilms (i.e., surface-attached communities) on indwelling medical devices or tissues within the 
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host. It is also the primary cause of morbidity and mortality among people with cystic fibrosis, 
in whom it aggregates within accumulated mucus, causing chronic lung infections (6). The fact 
that P. aeruginosa forms biofilms in a variety of model laboratory systems has allowed 
researchers to identify mechanisms important for biofilm and aggregate formation. Our 
research has focused on the intricate structures formed by communities of P. aeruginosa as 
they grow on the surfaces of rich media solidified with agar (“colony biofilms”). Colony 
morphogenesis is highly dependent on the presence of endogenously produced redox-active 
small molecules called phenazines; colonies that produce phenazines are relatively smooth as 
they develop, while mutants that are unable to produce phenazines are more rugose and start 
wrinkling earlier in the incubation period (7) (Fig. 2-1A). Similar results have been obtained for 
flow cell biofilms (8). The phenazines produced by P. aeruginosa vary in structure and chemical 
properties (9, 10), but their redox potentials are such that they all can be reduced by the 
bacterial cell and react extracellularly with higher-potential oxidants, such as ferric iron and 
oxygen, acting as electron shuttles between the bacterium and an external substrate (11).

In the early 20th century, E. S. Guzman Barron, Ernst Friedheim, and others postulated that 
redox-cycling compounds such as phenazines are “accessory respiratory pigments” that can 
sustain bacterial “respiration” based on their ability to stimulate oxygen consumption in 
suspensions of many different types of cells (12–14). They speculated that these compounds 
can extend the depth of respiration for cells deprived of oxygen, such as those found in 
normal tissues and tumors (15, 16). This work was carried out before respiratory pathways 
were fully understood and well before the importance of microbial biofilms in nature and 
disease was widely recognized. In this regard, Barron, Friedheim, and their colleagues were 
both ahead of their time and handicapped by a lack of information. In the interval between 
these pioneering studies and the present work, attention shifted to exploring the roles of 
phenazines as virulence factors (17). Over a decade ago, we revived the “respiratory pigment” 
hypothesis in a biofilm context, speculating that the capacity for extracellular electron transfer 
might provide a physiological benefit for oxidant-limited cells (9, 18). While it has long been 
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appreciated that biofilms are metabolically heterogeneous and that oxygen avail- ability defines 
different metabolic zones (19, 20), to the best of our knowledge, no study has yet demonstrated 
that endogenous electron shuttles such as phenazines increase the habitability zone for biofilm 
cells. Evidence in support of this hypothesis, until now, has been indirect (21). Here, we test the 
hypothesis directly and go beyond it to demonstrate that the intracellular redox state, not 
phenazines per se, correlates with colony morphological development.

2-3 MATERIALS AND METHODS 
2-3-1 Strains and growth conditions. 
The strains used in this study are listed in Table 2-1. For routine liquid cultures, P. aeruginosa 
PA14 was grown in 3 ml lysogeny broth (LB) (22) in 12 by 100-mm tubes at 37°C with shaking at 
250 rpm. Growth conditions for colonies are described below.

2-3-2 Construction of deletion and complementation plasmids. 
Unmarked deletions were generated for the genes napA and narG in PA14 wild-type and ∆phz 
backgrounds.  Deletion plasmids were generated using yeast gap repair cloning. Flanking 
regions (~1 kb in length) for napA and narG were generated using primers listed in Table 2-2. The 
flanking regions and the linearized allelic-replacement vector pMQ30 were assembled by gap 
repair cloning using the yeast strain InvSc1 (23). The resulting deletion plasmid was 
transformed into Escherichia coli BW29427 and mobilized into PA14 using biparental 
conjugation. PA14 single recombinants were selected on LB agar containing 100µg/ml 
gentamicin. Potential napA or narG deletion mutants were generated by selecting for double 
recombinants by identifying strains that grew in the presence of 10% sucrose. Strains with 
properties of double recombination were further analyzed by PCR for the desired deletion. 

For construction of the nap operon complementation plasmid pAPW1, primers were designed 
using the P. aeruginosa PA14 genome sequence to anneal 490 bp upstream of napE and to 
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the last 19 bases of napC, yielding a PCR product including the napEFDABC operon and a 
putative promoter region. The amplified DNA was digested using restriction sites (HindIII and 
NheI) engineered within the primers. It was then ligated into plasmid pMQ72 digested with the 
same restriction enzymes and treated with calf intestinal phosphatase (Sigma). The resulting 
plasmid, pAPW1, contains the napEFDABC operon under the control of its native promoter.

2-3-3 Colony morphology assay. 
Agar plates for colony morphology exper- iments were prepared as follows. A mixture of 1% 
agar (Teknova) and 1% tryptone (Teknova) was autoclaved and cooled to 60°C before 20 f..g/ml 
Coomassie blue (EMD) and 40µg/ml Congo red (EMD) were added. Sixty milliliters of medium 
was poured per 10-cm-square plate (Simport; D210-16) and allowed to dry with closed lids at 
room temperature for 24 h. For colony spotting and developmental studies, precultures were 
inoculated from single streak plate colonies and grown in LB medium for 12 h. Ten microliters of 
the preculture was spotted on plates and incubated for up to 6 days at 23 to 25°C. Colony 
images were taken daily with a digital microscope (Keyence; VHX-1000).

For colony development at different oxygen concentrations (15%, 21%, and 40%), we 
incubated plates in C-Chambers (BioSpherix; C274). Oxygen concentrations were regulated by 
mixing pure nitrogen and oxy- gen (TechAir) using the gas controller ProOx P110 (BioSpherix). 
Each chamber contained an open 10-cm round plate filled with 25 ml of water to keep the 
chambers humid. Humidity was monitored using an iButton Humidity Data Sensor (Maxim) and 
maintained at >90%. For colony growth under anoxic conditions, plates were stored in an 
anaerobic glove box filled with 80% N2, 15% CO2, and 5% H2.

2-3-4 Preparation and imaging of colony thin sections. 
Colonies were covered with 4% paraformaldehyde and allowed to fix for 10 min. The colonies 
were then lifted from the agar by gently shaking the plate and allowed to fix for an additional 10 
min. Following this, the colonies were transferred into a wash basket, and the fixative was 
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removed by washing the colonies three times in phosphate-buffered saline (PBS). Excess PBS 
was removed by washing in 25%, 50%, and 75% Tissue-Tek OCT (Sakura; no. 4583) in PBS 
before the colonies were transferred to disposable embedding molds (Electron Microscopy 
Sciences; no. 70182) and overlaid with Tissue-Tek OCT. After flash freezing in a dry-ice– ethanol 
slurry, the samples were stored at -80°C. The frozen samples were cut into 10-µ.m-thick sections 
using a Leica CM1850 microtome at -16°C. The sections were collected on Thermo Superfrost 
Plus slides (no. 6776214) and stored at -80°C until imaging.

Thin sections were photographed using a Zeiss Axio Imager 2. All images were obtained at 
X10 magnification using a Zeiss EC-Plan Neofluar objective with differential interference 
contrast (DIC) and fluorescence optics. The images were taken at an exposure time of 328 ms, 
false colored, and processed in Photoshop CS4 (Adobe).

2-3-5 Oxygen measurements. 
Oxygen profiles were taken using a miniaturized Clark-type oxygen sensor (Unisense; 10µm tip 
diameter). The electrode was connected to a picoampere amplifier multimeter (Unisense) and 
polarized with -0.8 V. The sensor was calibrated using a two-point calibration system. The 
atmospheric oxygen reading was obtained by placing the electrode in a calibration chamber 
(Unisense) that contained well-aerated deionized water. Complete aeration was achieved by 
constantly bubbling the water with air. The zero reading was obtained by bubbling water in 
the calibration chamber with ultra-high-purity nitrogen gas (TechAir). All calibration readings 
and profile measurements were obtained using SensorTrace pro 2.0 software (Unisense).

2-3-6 NADH/NAD+ assay. 
Extraction and quantification of NADH and NAD+ were carried out according to the methods 
described by San et al. (24) and Bernofsky and Swan (25). For cultures grown in LB, two 1-ml 
samples of culture were placed in two separate microcentrifuge tubes and centrifuged at 16,000 
X g for 1 min. Colonies grown on 1% tryptone and 1% agar plates amended with 40µg/ml Congo 
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red and 20µg/ml Coomassie blue dyes were scraped off the agar plate at the indicated time 
points using sterile razor blades and resuspended in 1 ml of 1% tryptone. The colonies were 
disrupted using a pellet disrupter. For each resuspended colony, two 450 µL samples were 
placed into two separate microcentrifuge tubes. NADH and NAD+ were then extracted from the 
liquid culture- or colony-derived samples, and relative or absolute quantification was carried 
out using an enzyme-cycling assay, as described by Price-Whelan et al. (26)

2-4 RESULTS AND DISCUSSION

In this study, we set out to characterize the relationship between redox metabolism/electron 
acceptor availability and P. aeruginosa biofilm development. This work supports the hypothesis 
that phenazine production and colony rugosity are adaptations that facilitate survival by 
mitigating electron acceptor limitation. In homogeneous liquid cultures of P. aeruginosa, 
phenazines affect gene expression and oxidize the intracellular redox state (26–28). Under 
conditions where no other oxidant is available, phenazine-dependent electron transfer between 
cells and an oxidizing electrode supports survival (21). Given that cells in biofilms experience 
steep gradients in oxygen availability, leading to hypoxia or anoxia at a distance from the 
surface (19, 20), we reasoned that the morphological switch observed in phenazine-deficient 
colonies is related to their limited ability to access oxidants.

To test this hypothesis, we first characterized the depth of oxygen penetration within our colony 
biofilm system. P. aeruginosa phenazine-null (∆phz) biofilms characteristically increase their 
surface area relative to wild-type communities. ∆phz colonies also produce more 
exopolysaccharides than wild-type colonies (7). We therefore asked whether dissolved oxygen 
concentrations differed in the wild-type and ∆phz biofilms when they were grown under 
atmospheric (21%) oxygen on a nutrient-rich complex medium (1% tryptone, 1% agar 
containing 20µg/ml Coomassie blue and 40µg/ml Congo red). Measurements taken with a Clark 
oxygen electrode (10µm tip) revealed steep gradients, with oxygen becoming undetectable 
60µm into the colony when the base area was profiled (Fig. 2-1B). Qualitatively, this is consistent 
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Figure 2-1. P. aeruginosa colony morphotypes and oxygen profiles. (A) Graphical representation of terms used 
to describe features within P. aeruginosa colonies. WT, wild type; ∆phz, phenazine-null mutant. The scale bar 
represents 1 cm, and the images were taken after 3 days of colony development. (B) Oxygen profiles in colony 
biofilms. Oxygen concentrations were measured in P. aeruginosa colonies on day 3 as a function of microelectrode 
depth in the colony. (C) Oxygen depletion (calculated as the initial slope, typically between 0- and 20- µm depth, 
of oxygen profiles over depth in the colony, as depicted in panel B) for the base and a wrinkle (spoke) during 
colony development. Wrinkles appear in ∆phz colonies 1 day earlier than in WT colonies. The error bars represent 
the standard deviations of this measurement in the bases or wrinkles of 5 independent colonies. (D) Oxygen 
depletion slopes from ∆phz colonies (representing data plotted in panel C) shown as a function of wrinkle 
thickness.
with oxygen microelectrode measurements of P. aeruginosa biofilms grown in flow cells showing 
oxygen depletion at depth due to the combined effects of consumption and diffusion limitation 
(20). The extent of oxygen depletion in the base remained constant over 4 days (Fig. 2-1C). 
When we measured oxygen depletion in emerging wrinkles, its slope was lower and decreased 
over time compared to the base. We found that wrinkle thickness correlated with oxygen 
abundance: thinner wrinkles were less oxygen depleted than thicker wrinkles (Fig. 2-1D).

While respiratory versatility is a hallmark of some bacterial species, P. aeruginosa is relatively 
limited in this regard. It can grow by aerobic respiration and denitrification and poorly by 
arginine fermentation (29); therefore, the major energy-generating metabolism contributing to 
growth of colonies on 1% tryptone is aerobic respiration. Moreover, it is generally believed that 
in the organic-rich environment of infections—such as the mucus that collects on the lungs of 
individuals with cystic fibrosis— growth and survival of Pseudomonas is not carbon/electron 
limited but constrained by oxygen availability (30). Microelectrode measurements showed 
oxygen depletion for both wild-type and ∆phz colonies 60µm from the surface (Fig. 2-1B), 
although wild-type colonies were 100µm tall. We asked if cell distributions in the colonies were 
comparable, expecting the cells to be confined to the region within 60µm from the colony 
surface, where oxygen was available. For these experiments, we generated versions of the wild 
type and the ∆phz mutant that constitutively expressed a stable yellow fluorescent protein 
(YFP). Colonies were fixed under oxic conditions with paraformaldehyde and embedded in 
Tissue-Tek OCT, frozen, and sectioned at a thickness of 10 µm (Fig. 2-2A to F). Because YFP 
can fully mature and fluoresce posttranslationally in the presence of oxygen (31, 32), our thin-
section preparation method ensured that YFP could be seen even in regions of the sections that 
were previously anoxic.

In sections taken from ∆phz colonies, cells were found within 60µm from the surface, in the 
oxic zone (Fig. 2-2G). In sections taken from wild-type colonies, however, cells were found 
up to 100µm from the surface (Fig. 2-2G). Some of these cells, therefore, inhabited the 40µm-
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Figure 2-2. Oxygen and phenazine availability modulates colony morphology. (A to F) Oxygen and phenazines 
affect cell layer thickness in P. aeruginosa colonies. Colonies expressing constitutive (PA1/04/03-driven [41]) YFP 
were grown at 15% (hypoxic), 21% (atmospheric), and 40% (hyperoxic) oxygen for 3 days and then embedded in 
Tissue-Tek OCT. The images were taken using fluorescence (YFP) and DIC microscopy. The scale bar represents 
200 µm. (G) Depth at which the YFP signal was detected in the sample. The error bars represent standard 
deviations for the means of measurements for 15 bases or wrinkles from 3 colonies. P values were calculated 
using the one-tailed heteroscedastic Student’s t test comparing YFP signal depth in WT or ∆phz colonies at 
different oxygen concentrations. The least significant differences are shown. (H) Colony morphology. 
Representative images of phz colonies grown at various atmospheric oxygen concentrations over 3 days. The 
scale bar represents 1 cm. (I) Colony wrinkle width (top) and surface coverage (bottom) for ∆plz colonies grown at 
various oxygen concentrations, with nitrogen comprising the atmospheric balance. The error bars represent the 
standard deviations of widths for 15 wrinkles from 3 colonies (top) or of measurements taken from 5 colonies 
(bottom).
thick anoxic zone. Reasoning that phenazines enable this survival by acting as alternate 
electron acceptors in the absence of oxygen, we altered the ambient oxygen concentration 
and predicted that the extent of the oxic zone within ∆phz colonies would determine the cell 
colonization depth (i.e., wider zones of habitation would correspond to higher atmospheric 
oxygen levels). We grew colonies under hyperoxic and hypoxic conditions (40% and 15% 
oxygen, respectively) and ob- served that the depth at which cells could be detected in both 
wild-type and ∆phz colonies correlated with the concentration of oxygen provided (Fig. 2-2A 
to F). Quantification of the cell layer thickness showed that under all conditions the ∆phz mutant 
was sig- nificantly thinner than the wild type, confirming that the presence of phenazines increases 
the habitable zone (Fig. 2-2G). We further probed this correlation using a mutant that overproduces 
the phenazine pyocyanin and found that the habitable zone increased beyond that of the wild type 
(Fig. 2-7).

We next evaluated whether oxygen accessibility affects other aspects of colony morphology by 
quantifying the surface coverage and wrinkle thickness of colonies grown with various 
concentrations of oxygen. As oxygen concentrations increased, the colonies spread less and 
formed fewer wrinkles. In addition, wrinkle thickness increased with increasing oxygen 
concentration (Fig. 2-2H and I). To further probe the link between oxidant availability and colony 
structure, we took advantage of P. aeruginosa’s ability to use nitrate instead of oxygen for 
respiration and redox homeostasis. Two P. aeruginosa nitrate reductase complexes, Nar and 
Nap, might be expected to affect the intracellular redox state under hypoxic conditions. 
While Nar is a cytoplasmic, membrane-associated complex that contributes to the production 
of a proton motive force and ATP generation, the Nap complex is periplasmic and is thought to 
balance the intracellular redox state without directly contributing to the generation of a 
transmembrane electrochemical gradient (33, 34). Both Nap and Nar catalyze the reduction of 
nitrate to nitrite. Three additional enzyme complexes, known as Nir (nitrite reductase), Nor (nitric 
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oxide reductase), and Nos (nitrous oxide reductase), allow P. aeruginosa to perform 
denitrification, the full reduction of nitrate to nitrogen gas (N2)

We grew a ∆.phz colony under atmospheric oxygen on medium amended with 40 mM 
potassium nitrate and found that these conditions rendered the colony smooth (Fig. 2-3A). To 
determine whether this was due to nitrate reduction, we generated mutants lacking the nitrate 
reductase subunits NarG and NapA. The t,.narG mutant formed a smooth colony when grown 
on nitrate, suggesting that nitrate respiration is not required for the nitrate- dependent smooth-
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Figure 2-3. Nap-mediated nitrate reduction supports redox homeostasis for cells in colonies. (A) Nap-
mediated nitrate reduction prevents colony wrinkling. Shown is the effect of medium amendment with 40mM 
potassium nitrate on colony morphology. The images are representative of 3 independent experiments. The scale 
bar represents 1 cm. (B) Colony morphology of denitrification mutants. Specific steps in the canonical 
denitrification pathway catalyzed by Nap, Nir, and Nor contribute to the nitrate-induced smoothness observed for 
wild-type colonies. The images shown are representative of 3 independent experiments. The scale bar represents 
1 cm. (C) PCA rescues the ∆napA phenotype on nitrate; addition of exogenous PCA promotes smoothness in a 
∆napA∆phz mutant. The images are representative of 3 independent experiments. The scale bar represents 1 cm.
colony phenotype. Strikingly, the ∆napA mutant wrinkled when grown on medium amended 
with nitrate (Fig. 2-3A) but reverted to smooth when complemented by the nap operon on a 
plasmid (Fig. 2-8). We then tested whether the downstream enzymes in the denitrification 
pathway were required for Nap-mediated colony smoothness. Mutants deficient in Nir and Nor 
also formed wrinkled colonies on 40 mM nitrate, while the mutant lacking functional Nos 
remained smooth, suggesting that reduction to nitrous oxide is required for NapA-dependent 
nitrate reduction (Fig. 2-3B). Furthermore, these results suggest that P. aeruginosa 
community structure is determined, at least in part, by the intracellular redox state. If both 
phenazine reduction and nitrate reduction contribute to oxidizing the intracellular redox state, 
one would predict that these two activities could complement each other to promote col- ony 
smoothness. Nitrate addition to a ∆phz mutant decreased wrinkling (Fig. 2-3A), and 
phenazine-1-carboxylic acid (PCA) addition to a ∆napA ∆phz mutant (grown in the presence of 
nitrate) also had this effect (Fig. 2-3C).

To further test the hypothesis that community structure and the intracellular redox state are 
linked, we set out to measure and manipulate the NADH-to-NAD+ ratio in colony biofilms under 
different growth conditions. Building on previous results showing that phenazines and nitrate 
decreased NADH/NAD+ ratios in liquid cultures (26), we first asked whether nitrate-dependent 
redox balancing required napA. We extracted NADH and NAD+ from planktonically grown cells 
and measured their levels using an enzyme-based cycling assay (24, 25). We found that the 
∆napA mutant showed a partial but significant defect in nitrate-dependent oxidation of the 
intracellular redox state relative to ∆phz and wild-type P. aeruginosa (Fig. 2-4A). We next 
adapted the NADH/NAD+ extraction and quantification protocol for use with colony samples. 
This method revealed that the NADH/NAD+ ratio of phenazine-null colonies reached a maximum 
that coincided with the induction of wrinkling, while the NADH/NAD+  ratio of wild- type 
colonies remained relatively consistent throughout the time course (Fig. 2-4B). Absolute 
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quantitation of the NADH and NAD+ levels (Fig. 2-9) confirmed that the total NAD(H) pools of 
cells in wild-type and ∆phz colonies were approximately equivalent.

Rugosity appears to be induced when the cytoplasmic reducing potential reaches a threshold 
value, indicating that increased colony surface area is an adaptive response to oxidant limitation 
that promotes rebalancing of the intracellular redox state. To test this idea, we used a mutant 
defective in wrinkle formation. Previously, we observed a correlation between wrinkle formation 
and colony staining with Congo red, suggesting that production of the PEL polysaccharide is 
critical for rugose morphology (7). We therefore obtained ∆pel mutants lacking genes required 
for PEL biosynthesis to test in our colony biofilm assay (35). As expected, colony wrinkle 
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Figure 2-4. (A) NADH/NAD+ ratios for liquid 
cultures grown for 16 h. For 40 mM KNO3 
cultures, potassium nitrate was added to the 
medium at the same time that blue pigmentation 
(pyocyanin production) was apparent in the wild-
type cultures. The error bars represent the 
standard deviations of triplicate cultures. (B) 
(Top) NADH/NAD+ for wild-type and ∆phz 
colonies. The error bars represent the standard 
deviations of measurements from triplicate 
colonies. (Bottom) Representative images of 
∆phz and wild-type colonies at the time points 
for collection. The scale bar represents 0.5 cm. 
The images are representative of 3 independent 
experiments.
formation was abolished when this mutation was made in both wild-type and ∆phz 
backgrounds (Fig. 2-5A). We then measured NADH/NAD+ ratios during colony maturation and 
found that the transient increased ratio that coincided with the onset of wrinkling in the t,.phz 
mutant persisted in the ∆phz ∆pel mutant (Fig. 2-5B). In contrast, the pel deletions had no 
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Figure 2-5. (A) PEL production is required for wrinkle formation. pelB-pelG were deleted in the wild-type and ∆phz 
backgrounds. Colonies were grown for 5 days on 1% tryptone,1%agar supplemented with 40µg/ml Congo red 
and 20µg/ml Coomassie blue. (B) NADH/NAD+ ratios in colony biofilms for ∆phz and ∆phz∆pel mutants. The error 
bars represent the standard deviations of measurements from triplicate colonies. P values were determined using 
the one-tailed heteroscedastic Student’s t test comparing ∆phz and ∆phz∆pel colonies at 42 and 48 h. (C) NADH/
NAD+ ratios in liquid culture (early stationary phase) for wild-type, ∆phz, ∆pel, and ∆phz∆pel colonies grown in 1% 
tryptone to early stationary phase. The error bars represent the standard deviations of measurements from 
biological triplicates.
effect on the NADH/NAD+ ratios of planktonically grown cells (Fig. 2-5C). This supports the 
hypothesis that wrinkling is a strategy for balancing the intracellular redox state of cells within 
a community. These results suggest that colony morphological development is an active 
process in which a critical redox state is sensed, leading to a biological response. We are in 
the process of identifying the circuitry responsible for this phenomenon and the extent to 
which wrinkling is an emergent property. We note that the specific time when the NADH/NAD+ 
ratio peaks can vary from experiment to experiment as a function of slight differences in plate 
thickness, density of the initial inoculum, etc. However, occurrence of the peak just prior to 
colony wrinkling is highly reproducible.

All cells catalyze a repertoire of catabolic and anabolic reactions that must be balanced so that 
the cytoplasm remains a hospitable environment for protein function. In bacterial physiology, 
there has traditionally been a focus on the individual cell level, and redox reactions have been 
identified that appear to serve the sole purpose of modulating the intracellular redox state, i.e., 
they do not contribute directly to energy generation or the production of biomass. We have 
shown that P. aeruginosa can use endogenous phenazines and/or exogenous nitrate to 
balance the intracellular redox state when oxygen is limiting. The observation that mutants 
unable to produce phenazines form structurally more complex communities with increased 
surface area led us to propose that this morphogenetic switch is a response to a reduced 
cytoplasm. Similarly, we have observed that electron acceptor limitation elicits a community-
wide response that maximizes oxygen accessibility—and thereby redox balance—in a bacterial 
system (Fig. 2-6). Furthermore, inhibiting this response disrupts redox balancing (Fig. 2-5B). 
Whether rugosity has a similar effect in other microbial species remains to be investigated. It 
would not be surprising if bacteria with different metabolic properties (e.g., with or without the 
ability to produce electron shuttles) have different mechanisms for growing and surviving in 
multicellular communities. Intriguingly, a recent study of patterning in Bacillus subtilis biofilms 
(36) suggested that localized cell death promotes wrinkle formation. Redox homeostasis may 
also play a role in this system, but to our knowledge, experiments have not yet been performed 
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that enable a direct comparison. Understanding how active processes and passive physical 
effects interweave to achieve multicellular patterning in Pseudomonas is our long-term goal; it 
will be interesting to learn whether the mechanisms that underpin these patterns are 
generalizable. As has been well articulated by others (37), the complex interplay between 




Figure 2-6. P. aeruginosa communities employ various strategies that enable access to electron acceptors. 
From inoculation to day 2, oxygen is detectable throughout the structure. By day 3, wild-type colonies and ∆phz 
colonies grown on nitrate-containing medium exceed the critical height that allows full oxygenation, and the lower 
portion of the colony becomes anoxic. Cells in the anoxic zone can maintain redox homeostasis by reducing 
phenazines or nitrate. In the absence of phenazines or nitrate, redox homeostasis can be mediated by a 
community-wide response: colony wrinkling increases the colony surface area and oxygen accessibility.
In conclusion, as Friedheim recognized nearly a century ago (15), cellular aggregation leads to 
gradient formation due to limited diffusion and consumption of substrates by individual cells 
within a community. Whether they subsist in bacterial colonies or eukaryotic tissues, cells in 
multicellular environments likely em- ploy differing strategies to ensure substrate acquisition 
and survival, depending on the specific microenvironment they inhabit. This concept is well 
recognized in the biofilm field, and numerous reports have discussed the fact that oxygen 
defines metabolic zones in biofilms (19, 20, 38). Here, for the first time, we have 
demonstrated that it is not oxygen per se but rather changes in the intracellular redox state that 
correlate with biofilm morphological development. Mechanisms that aid in redox homeostasis 
at the cellular level have been characterized in diverse organisms. In metazoans, redox-
balancing mechanisms that function at the multicellular level are also well known; for example, 
the development of the vascular system prevents oxygen starvation of the growing embryo 
(39). In multicellular aerobes, cells must cope with limited oxygen availability that leads to the 
formation of aerobic, microaerobic, and anaerobic zones. During processes such as tumor 
angiogenesis, relative oxygen concentrations act as cues that determine adaptive 
morphological features, facilitating oxygen delivery to cells within the macroscopic structure 
(40). Our findings suggest that, like metazoans, bacteria can also respond to electron 
acceptor limitation and balance intracellular redox levels through morphological changes at 
the community level. Morphological adaptation to redox imbalance thus appears to be a 





Figure 2-7. The pyocyanin-overproducer BigBlue forms a thicker cell layer in colony biofilms than wild type. 
BigBlue, wild type and Δphz colonies were grown for 3 days on 1% agar and 1% tryptone (supplemented with 40 
μg/ml Congo Red and 20 μg/ml Coomassie Blue), then fixed and sectioned. Cells were visualized by DAPI staining 





Figure 2-8. Complementation of ΔnapA. Colonies were grown for 3 days on 1% agar, 1% tryptone 
and 40 mM potassium nitrate (supplemented with 40 μg/ml Congo Red and 20 μg/ml Coomassie 
Blue). In contrast to the wrinkled colony phenotype of ΔnapA, cells complemented with the nap operon 
(pAPW1) exhibited a smooth colony morphotype. Scale bar is 1 cm.
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Figure 2-9. Total NAD(H) is comparable between wt and Δphz colonies. Colonies were harvested at indicated 
times and then resuspendend in 1 ml of 1% tryptone buffer before extraction. Concentrations refer to the 
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The phosphodiesterase RmcA (PA0575) mediates the 
Pseudomonas aeruginosa community response to 
oxidant limitation 
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3-1 ABSTRACT 
Diverse bacteria form three-dimensional multicellular structures by producing an extracellular 
matrix scaffold. While the signaling pathways that control this behavior have been extensively 
characterized in several species, the cues and mechanisms that activate these pathways, 
thereby enabling multicellular responses to environmental conditions, are not well understood. 
In colonies of the opportunistic pathogen Pseudomonas aeruginosa PA14, defects in the 
production of electron-shuttling antibiotics called phenazines stimulate matrix production and 
the development of wrinkle features that increase the colony surface area-to-volume ratio. Prior 
to wrinkling, phenazine-null colonies exhibit a transient accumulation of cellular reducing 
power, suggesting that electron acceptor limitation is a signal that triggers the multicellular 
response. PA14 matrix production is stimulated by the intracellular signal bis-(3’,5’)-cyclic-
dimeric-guanosine (c-di-GMP). Here, we describe the molecular and physiological 
characterization of RmcA, a c-di-GMP phosphodiesterase containing 4 Per-Arnt-Sim (PAS) 
domains. Our results suggest that RmcA is activated by oxidized phenazines and/or 
cytoplasmic conditions to degrade c-di-GMP and thereby inhibit matrix production. RmcA thus 
acts as a mechanistic link between environmental redox conditions and the morphogenetic 
output of PA14 communities, playing a role similar to those of PAS-domain-containing 
regulatory proteins found in complex eukaryotes. 
3-2 INTRODUCTION 
Diverse species of microbes form colonies with intricate wrinkle patterns [1]. Detailed studies in 
a handful of organisms have revealed commonalities to this behavior, which requires secretion 
of aggregating proteins and/or polysaccharides and appears to be influenced by the availability 
of electron acceptors for ATP generation [2-7]. This latter property is intriguing due to its 
parallels in complex eukaryotic model systems such as embryos and tumors, where 
mechanisms that control development in response to the environmental or intracellular redox 
state have been described [8,9]. For bacterial species, however, the molecular links between 
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the redox environment or cellular energy metabolism and community morphogenesis remain 
largely uncharacterized. 
The opportunistic pathogen Pseudomonas aeruginosa PA14 forms intricate wrinkle patterns in 
a simple model of colony development amenable to characterization using a variety of 
techniques. We have used this standardized colony morphology assay to show that structure 
formation is influenced by the production of endogenous redox-active antibiotics called 
phenazines. While wild-type (phenazine-producing) PA14 colonies initially exhibit a smooth 
surface and develop concentric ring structures after ~60 hours of incubation in this assay, a 
mutant unable to produce phenazines (∆phz) begins to form a pronounced wrinkle pattern at 
~37 hours that is characterized by a central ring surrounded by radial spokes. Phenazines can 
act as alternate electron acceptors to support ATP generation when O2 is not available [10,11]. 
We have therefore proposed that colony wrinkling and its associated increase in the colony 
surface area-to-volume ratio is an adaptive response that maximizes access to O2 for cells that 
would otherwise experience a redox imbalance due to electron acceptor limitation [12]. 
Measurements of intracellular NAD(H) extracted from colonies support this hypothesis [7].  
PA14 colony wrinkling requires secretion of a polysaccharide called Pel, which is stimulated by 
high levels of the intracellular signal Bis-(3’,5’)-cyclic-dimeric-guanosine (c-di-GMP) [13-15]. A 
suite of enzymes encoded by the PA14 genome contain domains with the potential to 
modulate c-di-GMP levels through diguanylate cyclase (DGC) or phosphodiesterase (PDE) 
activity, and genetic screening has identified a subset of these that qualitatively affect Pel 
production [16]. However, the specific players that mediate the effects of extra- or intracellular 
redox state on Pel production and thus colony development have not yet been defined. Here, 
we describe identification and characterization of PA0575, a compelling candidate mediator of 
redox-driven community morphogenesis. We have named this protein RmcA for redox 
modulator of c-di-GMP. 
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3-3 RESULTS AND DISCUSSION 
To identify sensors that act as mechanistic links between redox conditions and community 
behavior, we amassed a collection of transposon-insertion and deletion mutants representing 
each of the PA14 proteins predicted to produce or degrade c-di-GMP (i.e, those that contain 
“GGDEF”, “EAL”, and/or “HD-GYP” domains) and screened for mutations that influence biofilm 
morphogenesis using our colony morphology assay [7]. Of the 40 mutants tested, we found 8 
with phenotypes that differed from that of wild-type PA14 (Supplmentary Fig 3-1). For brevity, 
we refer to PA14 genes of interest using the ORF numbers of homologous genes in strain 
PAO1. Four mutants, with disruptions in PA0290, PA1107 (roeA), PA3702 (wspR) and PA4332 
(sadC) (roeA: [17], wspR: [18], sadC: [19]), showed delayed wrinkling or smooth phenotypes 
(Fig. 3-1a), suggesting that their corresponding encoded proteins are DGCs. We also found 4 
mutants, with disruptions in PA0575 (rmcA), PA4367 (bifA), PA5017 (dipA/pch) and PA5295 
(bifA: [20], dipA/pch: [21,22]), that displayed early wrinkling or hyperwrinkled phenotypes (Fig. 
3-1a). Though all 4 of the proteins represented by these mutants harbor both GGDEF and EAL 
domains, their associated colony phenotypes suggest that these proteins have PDE activity. 
Quantification of cellular c-di-GMP and CR binding (Supplmentary Fig. 3-3) by colonies 
representing a subset of DGC and PDE mutants produced results that generally correlated with 
colony phenotypes. 
Several of our screen hits have previously been implicated in PA14 colony Pel production 
(roeA: [17]; sadC: [19]; bifA: [20]; wspR, dipA and PA5295: [16]). Although the conditions of our 
colony assay differ from those used in studies by other groups, the phenotypes we observed 
for these mutants were generally consistent with those that have been described previously. An 
exception to this is the enhanced-wrinkling phenotype we observed for ∆PA0575 (rmcA), which 
contradicts the CR-binding defect previously reported for a similar mutant [16]. We engineered 
a complemented version of our ∆PA0575 (rmcA) strain and found that it displayed a wild-type 
colony phenotype (Supplmentary Fig. 3-2), confirming that the ∆PA0575 (rmcA) phenotype we 
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Figure 3-1. GGDEF- and GGDEF+EAL-domain-containing proteins modulate P. aeruginosa PA14 colony 
morphogenesis and are differentially affected by phenazine production. (a) Representative images of PA14 
wild type (WT), ∆phz, and strains containing disruptions in the indicated genes, designated by PAO1 ORF number. 
Colony images are arranged according to the timing of the onset of wrinkling, with the time of inoculation 
represented by the start of the timeline at the left. Cartoons shown next to each colony depict the domain 
organization of each disrupted protein. (b) Pel content, quantified using the Congo red binding assay, in colonies 
grown for 2 days on 1% tryptone, 1% agar medium with no added dyes. Error bars represent SD and n≥3. (c) 
Surface coverage over time for WT and for mutants with early-onset wrinkling. Error bars represent SD and n=3. (d) 
Colony development over time for the indicated strains grown in the colony morphology assay. (e) Timing of the 
onset of wrinkling for the indicated strains. Orange and teal shading represent the shift in the onset brought about 
by the indicated mutations made in the ∆phz and WT parent strains, respectively. (f) Graphical representation of the 
effect of high NADH/NAD+ levels on signaling and morphological output in PA14 colonies. Each scale bar=1 cm.
observe can be attributed to the function of this locus. 
We were struck by the phenotypic similarity between colonies formed by ∆PA0575 (rmcA) and 
∆phz [23]. PA0575 (RmcA) contains 4 PAS (Per-Arnt-Sim) domains (Fig. 3-1d). PAS domains 
function to sense environmental signals such as oxygen, nitrate and redox state [24-26] and 
control regulatory processes in diverse organisms. As we have been interested in identifying 
regulatory proteins with the potential to control Pel production in response to redox cues and 
therefore mediate the switch between ∆phz and wild-type colony morphotypes, PA0575 
(RmcA) caught our attention as one such potential mediator. We propose a model in which 
PA0575 (RmcA) is active in the presence of phenazines and lowers c-di-GMP levels during the 
early stages of colony development in the wild type, thereby inhibiting Pel production and 
delaying colony wrinkling. Conversely, in the absence of phenazine, we propose that RmcA is 
inactive due to high NADH/NAD+. This raises c-di-GMP levels which leads to colony wrinkling 
(Fig. 3-1f). We created combinatorial mutants with deletions in either PA0575 (rmcA) or PA4367 
(bifA) in the ∆phz background and monitored the timing of colony wrinkling for these mutants 
relative to their phenazine-producing counterparts. Deleting PA4367 (bifA) in the ∆phz 
background moved the onset of wrinkling to a much earlier time point (26 h) than that observed 
for the individual ∆PA4367 (bifA) or ∆phz mutants (50 h and 37 h, respectively) (Fig. 3-1e). In 
contrast, deleting PA0575 (rmcA) in the ∆phz background gave rise to a mutant colony with an 
onset of wrinkling at 37 h and therefore had a negligible effect on the timing of wrinkling for the 
∆phz mutant (Fig 3-1e). These results are consistent with a scenario in which the effects of BifA 
and phenazines on colony development act independently to inhibit wrinkling, while the effects 
of PA0575 (RmcA) and phenazines may act via the same pathway. 
We performed additional phenotypic characterization of ∆PA0575 (rmcA) to compare it to ∆phz. 
Colony phenazine production and liquid-culture growth phenotypes for ∆PA0575 (rmcA) did 
not differ from those of the wild type (Supplmentary Fig. 3-4a,b). We assessed the swarming 
capabilities of selected mutants and found that the ∆PA0575 (rmcA) and PA5295::tn mutants 
 83
exhibited swarming motility (similar to ∆phz [27]), while ∆PA4367 (bifA) and ∆PA5017 (dipA) did 
not swarm (Fig. 3-3b). As hyperwrinkling phenotypes tend to be associated with swarming 
defects in mutants that have been described previously [21,28], the ∆phz, ∆PA0575 (rmcA) and 
PA5295::tn mutants stand out as exceptions to this trend [17]. We also compared cellular 
NADH/NAD+ levels from ∆PA0575 (rmcA) colonies to those from ∆phz colonies. Consistent with 
previously published results, ∆phz showed a spike in NADH/NAD+ just prior to wrinkling [7], 
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Figure 3-2. Specific GGDEF-domain proteins contribute to wrinkling upstream or downstream of RcmA-
dependent effects on colony morphogenesis. (a) Representative images of PA14 WT, ∆rcmA, and deletion 
mutants made in the indicated parent backgrounds and grown on colony morphology assay medium for 3 days. 
Scale bar=1 cm. (b) Cartoon depicting the relative effects of RmcA and various GGDEF-domain proteins on c-di-
GMP levels during PA14 colony development.
while ∆PA0575 (rmcA) did not exhibit elevated NADH/NAD+ before wrinkling (Supplmentary Fig. 
3-4c). This suggests that ∆PA0575 (rmcA) hyperwrinkling is attributable not to a redox 
imbalance but rather to the “unnecessary” initiation of an adaptive wrinkling mechanism. 
How does the PDE activity of PA0575 (RmcA) operate within the network of DGCs and PDEs 
that influence cellular c-di-GMP levels and colony development? We generated combinatorial 
mutants to investigate whether PA0575 (RmcA) degrades c-di-GMP produced by the DGCs 
identified in our screen (Fig. 3-1a). Deleting PA1107 (roeA) and PA4332 (sadC) in the ∆PA0575 
(rmcA) background yielded colonies that looked like the single PA1107 (roeA) and PA4332 
(sadC) deletions (Fig. 3-2a). Deleting PA0290 or PA3702 (wspR) however, did not affect the 
∆PA0575 (rmcA) morphology drastically. This suggested that, under the conditions of our 
colony morphology assay, PA1107 (RoeA) and PA4332 (SadC) both lie upstream of PA0575 
(RmcA) and likely produce the c-di-GMP that PA0575 (RmcA) then degrades to exert its 
inhibitory effects on colony structure formation while PA0290 and WspR likely fine tune c-di-
GMP levels under certain conditions. 
We continued our characterization of RmcA by generating a series of strains with mutations 
predicted to alter in vivo function. Strains in which the native rmcA promoter was replaced with 
a constitutive tac promoter, leading to a ~10-fold increase in protein levels, showed smooth 
colony morphology phenotypes. Colonies of the RmcA-overproduction (“RmcA+”) strain 
(Supplmentary Fig. 3-5) also showed a ~2-fold reduction in c-di-GMP levels and CR binding 
compared to wild type (Fig. 3-3c). EAL domains have a canonical E(A/E/V)L motif that is 
required for PDE activity. We mutated the catalytic site of the RmcA EAL domain from EAL to 
AAA and found that this mutant phenocopied the ∆rmcA mutant in the colony morphology 
assay (Supplmentary Fig. 3-6). These results suggest that RmcA acts as a PDE to decrease c-
di-GMP levels, and therefore Pel production, in colonies. 
Next, we mutated the EAL motif in a strain that constitutively expresses RmcA and found that 
colonies formed by this RmcA+AAA strain displayed a distinct phenotype (Fig. 3-3c), with taller 
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Figure 3-3. Characterization of in vivo functions of GGDEF+EAL-domain-containing proteins and in vitro 
function of RmcA. (a) Alignment highlighting the I-site (RxxD motif; in red) and A-site (GGDEF motif; in green) in 
RmcA and corresponding residues in other GGDEF+EAL-domain-containing proteins of interest. (b) Assessment 
of swarming capability for WT and selected mutants with altered colony phenotypes. (c) Relative Pel content, 
quantified using the Congo red binding assay after 2 days of growth, and c-di-GMP content, quantified after 3 
days of growth, for colonies of the WT and indicated mutants. Error bars represent SD, n≥7, and p values were 
calculated using one-tailed heteroscedastic t-tests. Scale bar=1 cm. (d) Ligand binding and in vitro activities of the 
cytosolic portion of RmcA with a C-terminal 9xHis tag. Left-hand panels show cyclic-di-GMP (top left) and GTP 
(bottom left) binding. NC, no competitor. Right-hand panels show in vitro phosphodiesterase (top right) and 
diguanylate cyclase (bottom right) activity.
wrinkles forming the central ring and emanating spokes. RmcA+AAA mutant colonies also 
showed higher c-di-GMP levels and CR binding than those formed by ∆rmcA (Fig. 3-3c). These 
results were suggestive of a DGC activity for RmcA. RmcA has an intact GGDEF motif in the 
active site (A-site) that, when mutated to GGAAF in both wild-type and RmcA+ backgrounds, 
yielded colonies with wrinkling phenotypes similar to those of ∆rmcA (Fig. 3-4a). Colonies 
formed by the strain overexpressing the RmcA GGAAF mutant protein also exhibited c-di-GMP 
levels and CR binding that were similar to those measured for ∆rmcA colonies (i.e., higher than 
those found in wild-type colonies) (Fig. 3-3c). These results suggest that the GGDEF A-site in 
RmcA somehow acts to promote degradation of c-di-GMP and colony smoothness. These 
observations are similar to those reported for the mutational analysis of PA4367 (BifA), a PDE 
that also contains GGDEF and EAL domains; however, the A-site motif in the BifA GGDEF 
domain is degenerate [20]. 
Beyond its role in promoting the activity of the EAL domain, the higher c-di-GMP levels 
displayed by RmcA+AAA relative to ∆rmcA imply that the GGDEF domain also has a DGC 
activity that is only observable in the absence of a functional EAL domain (Fig. 3-3c). We 
investigated this by creating strain “RmcA+GGAAF;AAA,” which constitutively expresses a 
version of RmcA that harbors mutations in both the GGDEF and the EAL domains. Adding the 
RmcA GGAAF mutation to RmcA+AAA decreased c-di-GMP to a level comparable to that 
observed for ∆rmcA (Fig. 3-3c) and produced a colony morphology similar to that of ∆rmcA 
(Fig. 3-3c).  
In the context of the apparent PDE-promoting and DGC activities of the RmcA GGDEF domain, 
it is interesting to note that although all 4 of the hits from our screen with hyperwrinkled 
phenotypes represent proteins harboring both GGDEF and EAL domains, RmcA is the only one 
that contains an intact version of the GG(D/E)EF motif typically required for DGC activity; the 
corresponding sites in PA4367 (BifA), PA5017 (DipA) and PA5295 are degenerate. PA0575 
(RmcA) is also the only one of these 4 represented proteins that contains an intact version of 
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the “I-site”, an RxxD motif that found in some GGDEF domains (Fig. 3-3a). In some DGCs, c-
di-GMP binding to the I-site results in non-competitive allosteric inhibition, and the presence of 
an intact I-site tends to correlate with an intact GGDEF motif and DGC activity [29]. 
We next employed in vitro assays to test the ability of RmcA to bind c-di-GMP and other 
substrates associated with these domains, and to test RmcA for PDE and DGC activity. These 
studies were conducted using a His-tagged, truncated version of RmcA that lacks the domains 
predicted to localize to the periplasm and cytoplasmic membrane. Using a DRaCALA assay 
[30], we observed that the His-tagged cyotosolic truncation of RmcA is able to bind 
radiolabelled GTP and c-di-GMP (Fig. 3-3d), but that binding of c-di-GMP appeared to be 
much stronger than binding of GTP. We further tested the specificity of RmcA GTP and c-di-
GMP binding by competition with other unlabeled substrates. RmcA binding to radiolabeled c-
di-GMP was abolished by unlabeled c-di-GMP. GTP, GDP, and GMP caused modest decreases 
in c-di-GMP binding, while pGpG showed robust competition with c-di-GMP for binding. 
RmcA binding to radiolabeled GTP was abolished by unlabeled GTP and GDP. c-di-GMP, GMP 
and pGpG did not significantly affect GTP binding. The fact that GTP and GDP lead to similarly 
large decreases in the binding of radiolabeled GTP suggests that although RmcA may have 
modest DGC activity in vivo, its binding of GTP is not specific.  
To investigate the in vitro kinetics of RmcA PDE and DGC activity, c-di-GMP or GTP was 
incubated with purified RmcA (His-tagged cytosolic truncation) and spotted on TLC plates. We 
observed a modest conversion of c-di-GMP to pGpG after 60 minutes, but no conversion of 
GTP during this time (Fig. 3-3d). The results of our assays for ligand binding and catalytic 
activities are consistent with RmcA functioning predominantly as a PDE. This is consistent with 
results from our mutational analyses of RmcA’s GGDEF and EAL domains, which suggest that, 
although this protein has both DGC and PDE activity, its PDE activity plays a dominant role in 
determining c-di-GMP levels, Pel production, and morphogenesis of PA14 colonies. 
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Finally, we shifted our attention to RmcA’s PAS domains and tested the hypothesis that one or 
more of these is required for RmcA’s role in colony development. We found that deleting PAS-
B, PAS- C and PAS-D resulted in colonies that phenocopied ∆rmcA suggesting that they 
support RmcA PDE activity. Intriguingly, we found that deleting PAS-A in both the wild-type 
and ∆phz backgrounds yielded colonies that were smoother than those formed by their 
corresponding parent strains (Fig. 3-4a). This prompted us to hypothesize that PAS-A is 
involved in the modest DGC activity exhibited by RmcA in vivo, as the smoother phenotype of 
the PAS-A deletion indicates less Pel production and possibly less c-di-GMP produced. To test 
this, we took advantage of the RmcA+AAA mutant, which exhibited increased c-di-GMP levels 
and CR binding phenotypes that were attributed to DGC activity (Fig. 3-3c). When PAS-A was 
deleted in the RmcA+AAA background, the resulting colony phenocopied that formed by the 
RmcA+GGAAF;AAA mutant (Fig. 3-4b). This suggested that PAS-A might regulate the RmcA 
DGC activity that we observe in RmcA+AAA. 
Sequence alignments using the PAS-D domain of RmcA revealed conserved residues that are 
involved in the binding of an FAD cofactor in other proteins (Fig. 3-4c). Indeed, when we 
expressed and purified a truncated form of RmcA composed of the 4 PAS domains, it exhibited 
a bright yellow color and an absorbance spectrum consistent with FAD binding (Supplementary 
Fig. 3-4e). If PAS-D does bind FAD, the redox state of this cofactor could be affected by that of 
the cytoplasm, providing a mechanism whereby RmcA activity--and therefore c-di-GMP levels, 
Pel production, and colony morphogenesis--could be modulated by redox conditions. 
Confirmation of this and identification of the cofactors associated with the other PAS domains 
of RmcA will likely require structural analysis, but the structural similarity of the pseudomonad 
phenazines to the isoalloxazine heterocycle of the flavin group raises the tantalizing possibility 
that RmcA binds phenazines directly and is influenced by their redox states. In addition to 
RmcA, the PDE PA5017 (DipA) and the DGC PA0290 also contain PAS domains with the 
potential to respond to changes in the redox environment. These various sensors could provide 
diverse avenues by which environmental influences ultimately determine the morphological 
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Figure 3-4. Roles of individual RmcA domains in cofactor binding and regulation of colony morphogenesis. 
(a) Alignment of the RmcA PAS domains with the PAS domain of Azotobacter vinelandii NifL shows that the PAS-D 
domain contains aa tryptophan required for covalent linkage to FAD (highlighted in teal). (b) Mutation of the residue 
implicated in FAD binding by RmcA leads to enhanced colony wrinkling. (c) Purification of a His-tagged RmcA 
truncation containing only the PAS domains yields a preparation that is bright yellow in color, and the UV visible 
spectrum for this preparation shows peaks corresponding to oxidized FAD. (d) Representative colony images for 
mutational analysis of the roles of individual PAS domains in RmcA function in vivo. Colonies were grown for 3 
days. (e) Representative colony images for mutants testing the roles of specific motifs and potential interdomain 
crosstalk in RmcA. Cartoons depict hypothesized interactions between RcmA domains involved in c-di-GMP 
metabolism. Colonies were grown for 3 days. Scale bars each =1 cm.
output of PA14 communities. 
3-4 MATERIALS AND METHODS 
3-4-1 Strains and growth conditions 
Strains used in this study are listed in Table 3-1. Unless otherwise stated, liquid cultures of 
Pseudomonas aeruginosa UCBPP-PA14 were grown in lysogeny broth (LB) (Miller) (Bertani 
2004) at 37˚C, with shaking at 250 rpm. For genetic manipulation, strains were routinely plated 
on LB + 1.5% agar. For selection purposes, gentamicin was added to the medium at 100 µg/
mL and 15 µg/mL for P. aeruginosa and E. coli, respectively. Growth conditions for colony 
biofilms are described below. 
3-4-2 Phenazine quantification 
Ten technical replicates (10 µL each) of overnight pre-cultures were spotted on 10-cm round 
petri dishes containing 40 mL of solidified 1% agar, 1% tryptone medium. Colonies were 
incubated for 3 days at 25 °C and 80-90% humidity, then scraped from the plate. Half of the 
solidified medium containing released phenazines was transferred to 50-mL conical tube 
containing 3 mL of water and nutated overnight in the dark at room temperature to extract 
phenazines. Extract was filtered using 0.22 µm Spin-X filter tubes (Costar) and loaded directly 
onto a Waters Symmetry C18 reverse-phase column (4.6 x 250 mm; 5 mm particle size) in a 
Beckman SystemGold HPLC with a photodiode array detector. Phenazines were separated 
following a previously described protocol (Dietrich 2006). Conversion factors used for PYO, 
PCA and PCN were 8 x 10-6 mM/AU, 9.5 x 10-6 mM/AU and 9.5 x 10-6 mM/AU respectively. 
3-4-3 Colony morphology assay 
Colony morphology assay medium was prepared by autoclaving a mixture of 1% tryptone 
(Teknova) and 1% agar (Teknova). Mixture was cooled to 60˚C and 20 mg/L Coomassie blue 
(EMD) and 40 mg/L Congo red (EMD) dyes were added. Sixty mL of medium was poured into 
10 cm x 10 cm x 1.5 cm square plates (LDP) and allowed to solidify and dry for 16 - 24 hours. 
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Ten µL of overnight pre-cultures were spotted on dried plates and colonies were grown at 25 
°C and 80-90% humidity. Images of colonies were taken daily using a Keyence VHX-1000 
digital microscope. 
3-4-4 Quantification of c-di-GMP from colonies 
Ten µL of overnight pre-cultures were spotted in biological triplicates on colony morphology 
assay agar plates (prepared as described above) and grown for 2.5 days in conditions used for 
the colony morphology assay. Each colony was scraped from the plate, transferred to 1 mL 
PBS, and homogenized using a BeadBug (Benchmark Scientific) for 3 minutes. Homogenized 
colonies were transferred to pre-weighed MicroTubes (Sarstedt) and pelleted by centrifugation 
at 16,873 rcf. The supernatant was removed and cyclic di-GMP was extracted with methanol/
acetonitrile/water (40:40:20) with 0.1 N formic acid at -20°C for 1h. The extract was then 
centrifuged at 14,549 rcf for 5 min at 4°C. Two hundred µL of supernatant was transferred to a 
fresh tube and neutralized with 8 μl of 15% NH4HCO3, dried with a speed vacuum, and 
resuspended in 200 μl 10mM tributylamine +15mM Acetic acid. Samples were quantified at the 
Mass Spectrometry Facility of Michigan State University by electrospray ionization (ESI) 
analysis with Quattro Premier XE LC/MS/MS. The pellet from the extraction step was dried 
using a speed a vacuum and weighed. The final concentration of cyclic di-GMP was 
normalized to cell dry weight. 
3-4-5 Pel polysaccharide quantification 
Congo red binding was used to determine the amount of Pel polysaccharide produced by 
colonies. Ten µL of overnight pre-cultures were spotted in biological triplicates on 1% 
tryptone ,1% agar solidified medium and spots were grown for 2 days at 25˚C. Colonies were 
scraped from the plate into a 1 mL solution of PBS + 40mg/L Congo red dye. The resuspension 
was incubated at 37˚C for 1 hour, then transferred to clear 96-well plate (Grenier bio-one) for 
measurement of absorbance at 490 nm using a plate reader (Biotek Synergy 4). PBS + 40 mg/L 
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Congo red was used as a standard to determine to amount of Congo red bound by the colony 
and removed from the solution. 
3-4-6 Initiation of colony wrinkling 
Ten µL of overnight pre-cultures were spotted on colony morphology assay plates (as 
described above). After growth for 24 hours at room temperature, images of the developing 
colony were taken every 15 minutes over a 4-day period using a customized recording system 
(Logitech HD Webcam C525) under LED illumination. Lighting and image capture were 
synchronized with LabView (National Instruments). 
3-4-7 Swarming assay 
Overnight precultures were washed once in PBS and resuspended at an OD500 of 1.0. Two μL 
of this suspension was spotted at the center of a plate containing 20 mL of swarming assay 
medium (M9 salts medium amended with 0.2% glucose and 0.5% casamino acids, solidified 
with 0.5% agar) that had been dried for 45 minutes in a laminar flow hood. Plates were sealed 
with parafilm and incubated in an inverted position for 16 hours at 37 ̊ C [31]. Plates were 
imaged with a Canon CanoScan 5600F scanner. 
3-4-8 NADH/NAD+ assay 
Extraction of NADH and NAD+ was performed as described previously [7,32] Ten µL of pre-
cultures were spotted in biological triplicates on colony morphology assay agar plates 
(prepared as described above) and grown for the specified time. At the indicated time point, 
the colony was scraped off the plate into 1 mL 1% tryptone using a sterile 1 mL pipette tip and 
homogenized using a pellet disruptor. For each colony, two 450 µL samples were transferred to 
separate MicroTubes (Sarstedt) for NADH and NAD+ extractions. NADH and NAD+ were 
qunatified using an enzyme-cycling assay as described previously [32]. 
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3-4-9 Western blot 
Two mL cultures of strains with and without the N-terminal histidine tag on Rom were grown 
overnight with shaking at 37˚C, then used to seed 1 L cultures. The 1 L cultures were grown 
overnight at 37˚C with shaking. Cells were pelleted by centrifugation at 3,250 rpm for 30 
minutes (Beckman J6-MI) and were resuspended in 50 mL of lysis buffer [50 mM Tris-HCl, pH 
7.5, 0.5 M NaCl, 10% (v/v) glycerol, 1 mM MgCl2, 1 mg/mL lysozyme (Sigma), 13.2 µg/mL 
dnase (Sigma) and 1 complete EDTA-free protease inhibitor tablet (Roche)]. Lysis buffer 
components that were degassed and chilled at 4˚C prior to cell lysis.  
Cells were lysed by four passages through an Avestin Emulsiflex C-3 cell disrupter at an 
operating pressure of 15,000 psi. Cell lysate was centrifuged at 4,500 rpm for 15 minutes 
(Beckman Coulter, SX4750 rotor) at 4˚C to remove cell debris and unlysed cells; the 
supernatant was then ultracentrifuged at 45,000 rpm for 1 hour (Beckman, L8-70M). The pellet 
was rinsed by swirling lysis buffer over pellet twice and then resuspended in 10 mL of 
resuspension buffer [0.5 M NaCl, 50 mM Tris-HCl, pH 7.5, 0.3% (w/v) n-Dodecyl β-D-
maltoside, 1 mM tris(2-carboxyethyl)phosphine (TCEP) and 30% (v/v) glycerol]. The 
resuspended pellet was incubated overnight with slow rotation at 4˚C and then ultracentrifuged 
at 45,000 rpm for 1 hour (Beckman, L8-70M). Protein concentration in supernatant was 
determined using the Bio-Rad protein assay with bovine serum albumin (BSA) as the standard. 
Protein samples were separated on 4 - 12% NuPage Bis-Tris gels (Life Technologies) and 
blotted on to a 0.45 µM-pore size nitrocellulose membrane (GE Water and Process 
Technologies). The membrane were stained using Ponceau S stain (0.1%) (G Biosciences) and 
destained with 0.1 M NaOH according manufacturer’s protocol. The membrane was incubated 
overnight in blocking solution [1X Tris buffered saline with 1% (v/v) Tween-20 (TBST) and 5% 
(w/v) non-fat dry milk powder]. The membrane was then probed with anti-6X His tag (HIS.H8; 
abcam) at a 1:2000 dilution in 50% (v/v) blocking solution (diluted with 1X TBST) for 1 hour at 
room temperature. Blots were washed and probed with goat anti-mouse horseradish 
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peroxidase (HRP)-conjugated secondary antibody (Sigma) and developed using Amersham 
ECL Plus Western Blotting Detection kit (GE Healthcare).  
3-4-10 Construction of deletion, complementation, point mutation, and constitutive 
expression plasmids 
Deletion, complementation, point mutation and constitutive expression plasmids were 
generated using yeast gap repair cloning. The strains generated from these plasmids are listed 
in Table 3-1 and the primers used to construct the plasmids are listed in Table 3.-3 
To construct the deletion and point mutation plasmids, flanking regions ~1 kilobase in length 
for the genes to be deleted and residues to be mutated were amplified using PCR. For point 
mutation plasmids, the intended mutation sequence to be inserted into the genome was added 
at the 5’ end of both flanking regions. To construct the PA14_07500 complementation plasmid, 
PA14_07500 with ~1 kilobase on both sides of the gene was amplified using PCR. A “promoter 
swap” plasmid was used to generate the constitutively expressing PA14_07500 mutant. The 
regions flanking the native PA14_07500 promoter and the constitutive PA1/04/03 promoter were 
amplified using PCR. 
Where applicable, the constitutive PA1/04/03 promoter (constitutively expressing mutant only), 
the flanking regions and the linearized allelic-replacement vector pMQ30 were assembled by 
gap repair cloning using the yeast strain InvSc1 (Invitrogen) (Shanks 2006). The resulting 
plasmid was transformed into Escherichia coli BW29427 and transformed into PA14 using 
biparental conjugation. PA14 single recombinants were selected on LB agar containing 100 µg/
ml gentamicin. Potential complemented strains, deletion and point mutants were generated by 
selecting for double recombinants by identifying strains that grew in the presence of 10% (w/v) 
sucrose. Strains with properties of double recombination were further analyzed by PCR. 
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3-4-11 Construction of His-tag plasmids 
The his-tag plasmid was designed to insert a N-terminal 9x Histidine tag 72 base pairs into 
PA14_07500. Flanking regions ~1 kilobase to this point in the gene were amplified using PCR. 
Each flanking region had a 9x Histidine residue sequence at the 5’ end. The flanking regions 
and the linearized allelic-replacement vector pMQ30 were assembled by gap repair cloning 
using the yeast strain InvSc1 (Invitrogen) (Shanks 2006). The resulting plasmid was transformed 
into Escherichia coli BW29427 and transformed into PA14 using biparental conjugation. PA14 
single recombinants were selected on LB agar containing 100 ︎µg/ml gentamicin. Potential his-
tagged strains were generated by selecting for double recombinants by identifying strains that 
grew in the presence of 10% (w/v) sucrose. Strains with properties of double recombination 
were further analyzed by PCR. 
3-4-12 Liquid-culture growth curves 
Overnight pre-cultures were grown in LB at 37˚C with shaking at 250rpm. Pre-cultures were 
diluted in 1% (w/v) tryptone to a starting OD500 of 0.01 into 96-well plates (Greiner Bio-one). 
Cultures were shaken at “medium” speed and absorbance at 500nm was taken every 30 




Supplementary Figure 3-1. Screen for proteins that modulate c-di-GMP levels during P. aeruginosa PA14 
colony development. Representative images of mutants grown for 4 days in the colony morphology assay. All 
mutants shown contain transposon insertions or in-frame markerless deletions in genes predicted to encode 
GGDEF, EAL, and/or HD-GYP domains. Mutants are arranged according to the domain content of their disrupted 
proteins, then by number of the  PAO1 ORF homologous to that of the disrupted protein. The corresponding PA14 
ORF number for each protein is shown in parentheses.
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Supplementary Figure 3-2. Complementation of ∆rmcA restores the wild-type colony phenotype. 
Representative images of colonies grown for 3 days in the colony morphology assay. Scale bar=1 cm.
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Supplementary Figure 3-3. Quantification of c-di-GMP and Pel production for selected mutants with altered 
colony phenotypes. Left: Relative cyclic-di-GMP (c-dI-GMP) levels in colonies grown for 3 days on colony 
morphology assay medium Right: Pel content, quantified using the Congo red binding assay, in colonies grown for 
2 days on 1% tryptone, 1% agar medium with no added dyes. p values were calculated using one-tailed 
heteroscedastic t-tests. Error bars represent SD and n=3.
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Supplementary Figure 3-4. Characterization of ∆rmcA liquid-culture growth, colony phenazine production, 
and cellular redox state. (a) Growth of shaken liquid cultures of WT, ∆phz, and related mutants in LB at 37°C. 
Error bars represent SD and n=4. (b) Quantification of pyocyanin (PYO), phenazine-1-carboxamide (PCN), and 
phenazine-1-carboxylic acid (PCA) in extracts of medium that supported the growth of PA14 WT and ∆rmcA 
colony biofilms. Colonies were grown on 1% tryptone, 1% agar for 3 days, then removed with a razor blade. 
Aqueous extract prepared from the agar was analyzed by HPLC. Error bars represent SD and n=3. (c) Top, time 
course showing differences in the intracellular redox state for ∆phz and ∆rmcA, two mutants with similar colony 
phenotypes (bottom). Colonies were grown on colony morphology assay medium. Scale bar=1 cm. Error bars 
represent SD, n=3, and p value was calculated using a one-tailed heteroscedastic t-test.White arrows indicate 
initiation of wrinkling ∆rmcA colony at 39 h
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Supplementary Figure 3-5. Phenotypic characterization and expression analysis of RmcA with an N-
terminal 9xHis tag. (a) Cartoon depicting the domain architecture of RmcA and the location of the N-terminal tag. 
(b) Addition of an N-terminal 9xHis tag does not affect in vivo function of RmcA. Colonies were grown on colony 
morphology assay medium for 3 days. Scale bar=1cm. (c) Overproduction of the His-tagged protein was 
confirmed by Western blot using membrane fractions from whole-cell lysates.
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Supplementary Figure 3-6. Mutations in RmcA’s EAL but not GGDEF motifaffect 
colony morphology. Representative images of colonies grown for 3 days on colony 
morphology assay medium. Scale bar=1 cm.




UCBPP-PA14 Clinical isolate 
UCBPP-PA14
Rahme, et al. 1995
PA14 ∆phz PA14 with deletions 
in phzA1-G1 and 
phzA2-G2 operons
Dietrich, et al. 2006
PA14 ∆0575 PA14 with deletion 
in PA14_07500
Dietrich et al. 2008
PA14 ∆0290 PA14 with deletion 
in PA14_03790
This study
PA14 ∆4332 PA14 with deletion 
in PA14_56280
This study
PA14 ∆1107 PA14 with deletions 
in PA14_50060
This study
PA14 ∆3702 PA14 with deletion 
in PA14_16500
This study
PA14 ∆2870 PA14 with deletion 
in PA14_26970
This study
PA14 ∆3825 PA14 with deletion 
in PA14_14530
This study
PA14 ∆2133 PA14 with deletion 
in PA14_36990
This study
PA14 ∆2200 PA14 with deletion 
in PA14_36260
This study
PA14 ∆3258 PA14 with deletion 
in PA14_21870
This study
PA14 ΔbifA PA14 with deletion 
in PA14_56790
This study
PA14 Δ4396 PA14 with deletion 
in PA14_57140
This study
PA14 Δ4781 PA14 with deletion 
in PA14_63210
This study




PA14 Δ1107ΔbifA PA14 with deletions 
in PA14_50060 and 
PA14_56790
This study
PA14 Δ4332ΔbifA PA14 with deletions 
in PA14_56280 and 
PA14_56790
This study
PA14 Δ0575Δ1107 PA14 with deletions 
in PA14_07500 and 
PA14_50060
This study
PA14 Δ0575Δ4332 PA14 with deletions 




UQ950 E. coli DH5 λ(pir) 






endA1 spoT thi-1 
hsdR17 deoR λ pir+
D. Lies, Caltech
BW29427 Donor strain for 
conjugation. 
thrB1004 pro thi 















Table 3-2. Plasmids used in this study. 
Plasmids Description Source
pMQ30 7.5 kb mobilizable 
vector oriT, sacB, 
GmR
Shanks et al. 2006
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PA0169/PA14_02110 transposon insertion check
PA0169 in-check 1 GACCACGCGCTGCTCAAG 
PA0169 in-check 2 AGGATTGCAGCTTCCCCTTC 
PA0338/PA14_04420 transposon insertion check
PA0338 in-check 1 CAAGGTGAAGTGGCTGCTG 
PA0338 in-check 2 CTCTCCAGCGTGTTCATCG 
PA3343/PA14_20820 transposon insertion check
PA3343 in-check 1 GAGGAGCGTTTCGGCAAG 
PA3343 in-check 2 GGGAAGATGCCGTAGTGC 
PA3177/PA14_23130 transposon insertion check
PA3177 in-check 1 GCGACTTCGTTACTGTCTACAA
PA3177 in-check 2 GGTTCATCAACGCCTTCAGT
PA1851/PA14_40570 transposon insertion check
PA1851 in-check 1 GCTCCGCCTACTCCGATC 
PA1851 in-check 2 AGTTGGCCCACGGATCTTG 
PA1120/PA14_49890 transposon insertion check
PA1120 in-check 1 CATCCGGTCCTGTCCATCA 
PA1120 in-check 2 GAGACGGTCGAGATTGTTGC 
PA0847/PA14_53310 transposon insertion check
PA0847 in-check 1 GCTGGAAGGCATCGACGAT 
PA0847 in-check 2 CAGCAGGTTGAGGGTCAGG 
PA4396/PA14_57140 transposon insertion check
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PA4396 in-check 1 GGCGATCCAGTTCCTTGATG 
PA4396 in-check 2 CTGGCCGTCTTCCACCAG 
PA4843/PA14_64050 transposon insertion check
PA4843 in-check 1 CATAAGCATGCCGTAGTCCG 
PA4843 in-check 2 CTGGTCGAGCAACTGGAAC 
PA4929/PA14_65090 transposon insertion check
PA4929 in-check 1 TACTCATAGGCAGGAAGGGC 
PA4929 in-check 2 TCTCGATGGACATGCTGGC 
PA5487/PA14_72420 transposon insertion check
PA5487 in-check 1 GAGGAACACGGCGATGTTG 
PA5487 in-check 2 AATCTCGACCACATCCTGCT 
PA0285/PA14_03720 transposon insertion check
PA0285 in-check 1 CTCATGGGTCTCTGCTCCTG 
PA0285 in-check 2 TCGAGAAAACCGTTGAACCAC 
PA3311/PA14_21190 transposon insertion check
PA3311 in-check 1 GTTACGAGCCGGTCAAGTG 
PA3311 in-check 2 CCACCCATTGAAGCAACTCC 
PA2567/PA14_31330 transposon insertion check
PA2567 in-check 1 CAGCCTCGTCGTGGTCTG 
PA2567 in-check 2 TACGTCCTACTTCCAGACGC 
PA2072/PA14_37690 transposon insertion check
PA2072 in-check 1 AAACTCCAGGTCGTAGCAGA 
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PA2072 in-check 2 GTCCGCTATGCCGAGGTAC 
PA1727/PA14_42220 transposon insertion check
PA1727 in-check 1 CAAAGCGCTGTACAAAAGGC 
PA1727 in-check 2 AGAAGCCCCAGTACACACAG 
PA1433/PA14_45930 transposon insertion check
PA1433 in-check 1 CGACCTGTTGCCGGTGTA 
PA1433 in-check 2 CCTTGCGCATCGAACTCAAT 
PA1181/PA14_49160 transposon insertion check
PA1181 in-check 1 TTCCAGCAACTCAAGGACCA 
PA1181 in-check 2 ATCATCGAGAGCTACGACGG 
PA0861/PA14_53140 transposon insertion check
PA0861 in-check 1 TGGCAGTCGACGATCAGTT 
PA0861 in-check 2 AAACGCTGTCTGTTCCGC 
PA4367/PA14_56790 transposon insertion check
PA4367 in-check 1 CAACTGGGACTTCGTAGCGA 
PA4367 in-check 2 CGAATGGAACCGGGTGCG 
PA4601/PA14_60870 transposon insertion check
PA4601 in-check 1 CAGTTGCAATGGGTGGACAG 
PA4601 in-check 2 CCGAACTGATGCCGAAGAG 
PA4959/PA14_65540 transposon insertion check
PA4959 in-check 1 GCAGAGCAGCCACTACCT 
PA4959 in-check 2 AACGAGTTGCAGATCGTCGA 
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PA5295/PA14_69900 transposon insertion check
PA5295 in-check 1 CCTGGCCTTCGAGTGGAA 
PA5295 in-check 2 GCGTATTCTAACAGGCTGGC 
PA5442/PA14_71850 transposon insertion check
PA5442 in-check 1 AATCGGGATAGCAGGAGTCG 
PA5442 in-check 2 GGGAGAGGTCGTCGTTCATC 
PA3947/PA14_12810 transposon insertion check
PA3947 in-check 1 CGAGATCGCCGTCCAGAATA 
PA3947 in-check 2 GACGGATGCGCTTCGATG 
PA14_59790 transposon insertion check
PA14_59790 in-check 1 AACAGCAATACGGTCAGCAC 
PA14_59790 in-check 2 CTACGGCGCCAAGGGTTC 
PA4108/PA14_10820 transposon insertion check
PA4108 in-check 1 CCATTTCTGCTGCGCTCTTC 
PA4108 in-check 2 GTCGGCGGAGGGATTTGTAT 
PA2572/PA14_30830 transposon insertion check
PA2572 in-check 1 AAATTTCCCAGACCATCCGC 
PA2572 in-check 2 CTCATCGATCACCAGCAAGC 
PA0290/PA14_03790 transposon insertion check
PA0290 in-check 1 ATCGCTACCCTGGTCTTCAG
PA0290 in-check 2 GTGTGCATGGGTGTACTCGT
PA3702/PA14_16500 transposon insertion check
PA3702 in-check 1 CGCGGTGCAGATCCTTTC 
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PA3702 in-check 2 AATGGTCTGGGTGCGCTC 
PA2870/PA14_26970 transposon insertion check
PA2870 in-check 1 AGCTCGCTGACCTGGACC 
PA2870 in-check 2 CAGCCCATCCTCGCCTATC 
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CHAPTER 4 
Summary of Work and Future Directions 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4-1 SUMMARY OF WORK 
Most bacterial species show a tendency to form biofilms, communities of cells surrounded by 
self-produced matrices [1]. Biofilms, particularly those grown as colonies on agar-solidified 
media, often exhibit complex morphologies that are tuned by environmental conditions. In turn, 
community architecture influences the formation of internal microenvironments with unique 
conditions that influence bacterial physiology. Understanding biofilm-specific physiology is 
critical to efforts to promote or inhibit biofilm growth in clinical, industrial, and agricultural 
contexts. However, rigorous characterization of biofilm-specific metabolism and regulatory 
mechanisms has been hindered somewhat by technical challenges associated with popular 
laboratory biofilm models, as many of these are not amenable to high-throughput screening or 
metabolite analysis.  
The work presented in this thesis leverages a simple, standardized model of colony biofilm 
development to investigate the relationship between electron acceptor availability and colony 
morphogenesis, and mechanisms underpinning the community response to redox conditions, 
in the opportunistic pathogen Pseudomonas aeruginosa PA14. This colony morphology assay 
can be used for high-throughput genetic screening and the generation of replicate samples for 
the investigation of the effects of environmental perturbations, profiling of chemical 
microecology, and metabolite analysis. I adapted protocols for the extraction and measurement 
of cellular metabolites and signals to enable quantitative descriptions of morphotypic 
responses, a significant technical advance over the status quo established for biofilm studies 
to date. 
This work was initiated at a time when the importance of redox conditions in determining 
bacterial community behavior was garnering renewed attention in the field of microbiology. The 
colony morphology assay had revealed a dramatic effect for the production of phenazines, 
redox-active antibiotics that balance the intracellular redox state and support survival of anoxic 
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PA14 liquid cultures. Colonies of a PA14 mutant unable to make phenazines (∆phz) show earlier 
and enhanced formation of wrinkle structures. This led to the hypothesis that wrinkle formation 
is an adaptive response that increases the surface area-to-volume ratio of the biofilm, and 
therefore increases access to oxygen for cells residing in the densely populated community 
(Chapter 1). 
I began my thesis by characterizing relationships between redox conditions, utilization of 
electron acceptors for cellular redox balancing, changes in intracellular redox state, and colony 
morphogenesis in PA14 (Chapter 2). Colony oxygen profiling and thin sectioning paired with 
fluorescence microscopy showed that cells in wild-type colonies were distributed across the z-
axis, including anoxic regions. ∆phz colonies were thinner than wild-type colonies and did not 
contain cells in anoxic zones, supporting a model in which phenazines support survival in 
anoxic subzones. NADH/NAD+ measurements of samples obtained at time points over the 
course of development showed that ∆phz colonies exhibit spike in cellular reducing power just 
prior to the onset of wrinkling, corroborating the notion that colony wrinkle formation is an 
adaptive response to electron acceptor limitation. In further support of this, increased oxygen 
availability and the presence of an alternative electron acceptor, nitrate, decreased the extent 
of, or altogether abolished, wrinkling. Phenotypic analysis of mutants representing enzymes 
involved in P. aeruginosa nitrate metabolism indicated that nitrate reduction in PA14 colonies 
proceeds via a novel pathway that starts with a periplasmic nitrate reductase, which consumes 
reducing power but does not contribute to the proton motive force, and continues through the 
well-studied steps of P. aeruginosa denitrification. A modeling approach examining the effects 
of biofilm structure on the availabililty of a single oxidant (oxygen) or dual oxidants (oxygen and 
phenazines) for cellular redox balancing further supported the model that wild-type and ∆phz 
colonies assume structures that are optimal for cellular growth (Appendix B). Examination of 
the effects of phenazines on the morphogenesis of colony biofilms formed by the fungus 
Candida albicans revealed parallels in this system (Appendix C). 
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The transient elevation in NADH/NAD+ exhibited by ∆phz colonies immediately before wrinkling 
prompts speculation that redox imbalance is the signal that triggers the community response. 
Therefore, for the next major phase of my thesis research, I identified and characterized 
sensor/regulators that serve as mechanistic links between redox conditions and PA14 biofilm 
morphogenesis (Chapter 3) As regulatory cascades controlling the stages of PA14 biofilm 
development have been studied in detail, I conducted a screen for potential redox-sensing 
proteins that could function in this context. PA14 colony wrinkling requires the excretion of a 
matrix polysaccharide called Pel, the production of which is stimulated by the bacterial 
secondary messenger cyclic di-GMP (c-di-GMP). We screened mutants representing proteins 
with the potential to modulate cellular levels of c-di-GMP for altered colony morphogenesis 
and identified the protein encoded by PA14 ORF 07500, which we named RmcA for redox 
modulator of cyclic-di-GMP. RmcA is a membrane bound protein with a periplasmic solute 
binding domain and four tandem PAS domains, a GGDEF domain and an EAL domain in the 
cytoplasm. Functional GGDEF and EAL have diguanylate cylclase (DGC) activity, which 
synthesizes c-di-GMP, and phosphodiesterase (PDE) activity, which hydrolyzes c-di-GMP, 
respectively [2]. PAS domains have been found in all domains of life and are involved in sensing 
environmental signals such as redox [3]. Colonies of the ∆rmcA mutant phenocopy ∆phz and 
detailed characterization of RmcA suggested that it posseses both DGC and PDE activity, but 
that PDE activity is dominant in vivo. Mutational analyses also provided clues regarding 
interdomain crosstalk in RmcA and suggested that one of the PAS domains binds FAD. We 
propose a model where RmcA PDE activity is inhibited by reducing intracellular conditions via 
redox sensitivity conferred by one or more of the PAS domains. This inhibition of RmcA PDE 
activity causes a buildup of c-di-GMP which leads to increased Pel production and colony 
wrinkling. 
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4-2 FUTURE DIRECTION 
The findings presented in this thesis provide a foundation for understanding the molecular 
mechanisms underpinning redox-driven regulation of PA14 colony biofilm morphogenesis. 
They also raise several questions about the PA14 community response to environmental redox 
state, qualitative differences in community architecture, and the molecular mechanisms of 
redox sensing relevant for colony morphogenesis. 
The colony morphology screen identified 8 proteins with the potential to modulate c-di-GMP 
levels that are required for wild-type colony development. Subsequent work focused on RmcA, 
which is a strong candidate sensor of intracellular redox state because it harbors 4 PAS 
domains and because the ∆rmcA mutant phenocopies the ∆phz mutant. However, two other 
proteins identified in the screen, the PDE DipA and the DGC PA0290, both contain PAS 
domains and therefore also have the potential to influence biofilm development in response to 
redox cues. Furthermore, whether specific electron donors (e.g., carbon sources) or acceptors 
(e.g., phenazines or nitrate) control the activities of individual DGCs and PDEs that operate 
within the PA14 c-di-GMP-dependent regulatory network remains to be investigated. In this 
context, it is interesting to note that, while preliminary observations suggest that one of the 
PAS domains of RmcA binds FAD, ligands or sensory motifs that influence the structures of the 
other RmcA PAS domains and potentially the activity of RmcA remain to be identified. 
Structural and additional mutational and biochemical analyses may ultimately reveal the 
molecular details that allow RmcA to control PA14 colony morphogenesis in a redox-depedent 
manner. 
A further intriguing aspect of mutants with altered morphologies identified in the colony screen 
is that those with hyperwrinkled phenotypes showed qualitative differences in pattern 
formation. While the ∆rmcA mutant forms a spreading colony similar to that formed by ∆phz, 
the ∆dipA, ∆bifA, and ∆PA5295 mutants form constrained colonies. The onset of wrinkling also 
varied between mutants. What is the biological significance of the different types of wrinkling 
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and the onset of wrinkling? A large colony morphology screen of mutants spanning the entire P. 
aeruginosa PA14 genome may provide clues as to what metabolic or signaling pathways 
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Appendix A. The Carbon Monoxide Releasing Molecule CORM-2 Attenuates 
Pseudomonas aeruginosa Biofilm Formation 
This appendix is adapted from a manuscript that was published in PLoS ONE– Murray, Okegbe 
et al 2012. Here we show that that the carbon monoxide-releasing molecule CORM-2, prevents 
P. aeruginosa biofilm maturation and kills bacteria within an established biofilm. I contributed 
the experiments comparing the efficacy of CORM-2 against two P. aeruginosa strains PA14 and 
PAO1 in liquid culture and biofilms as well as under anaerobic conditions (Figures A-10 and 
A-11). 
ABSTRACT 
Chronic infections resulting from biofilm formation are difficult to eradicate with current 
antimicrobial agents and consequently new therapies are needed. This work demonstrates that 
the carbon monoxide-releasing molecule CORM-2, previously shown to kill planktonic bacteria, 
also attenuates surface-associated growth of the Gram-negative pathogen Pseudomonas 
aeruginosa by both preventing biofilm maturation and killing bacteria within the established 
biofilm. CORM-2 treatment has an additive effect when combined with tobramycin, a drug 
commonly used to treat P. aeruginosa lung infections. CORM-2 inhibited biofilm formation and 
planktonic growth of the majority of clinical P. aeruginosa isolates tested, for both mucoid and 
non-mucoid strains. While CORM-2 treatment increased the production of reactive oxygen 
species by P. aeruginosa biofilms, this increase did not correlate with bacterial death. These 
data demonstrate that CO-RMs possess potential novel therapeutic properties against a 
subset of P. aeruginosa biofilm related infections.

INTRODUCTION 
Organized bacterial communities or biofilms are formed on both biotic and abiotic surfaces 
during infections by a wide variety of Gram-positive and Gram-negative pathogens [1]. The 
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bacteria are protected from both the immune system and antimicrobials by an extracellular 
matrix leading to prolonged colonization of the host [2]. Therefore, new approaches to biofilm 
eradication and the treatment of chronic biofilm-associated infections are needed. P. 
aeruginosa is an opportunistic Gram-negative pathogen that has served as a model organism 
to study the dynamics of biofilm assembly and maintenance [3]. Since P. aeruginosa causes 
chronic infection in patients with underlying lung disease such as cystic fibrosis (CF), therapies 
that disrupt or prevent P. aeruginosa biofilm formation are of critical clinical interest [4,5].

Carbon monoxide (CO) is a product of heme oxygenase activity that serves as an anti-
inflammatory signaling molecule in mammalian cells [6,7] by binding, among others, divalent 
metals of heme-containing proteins such as guanylate cyclase, mitochondrial cytocrome c 
oxidase and NADPH oxidase [8,9,10]. CO selectively inhibits the expression of pro-
inflammatory cytokines, increasing the anti-inflammatory cytokine IL-10 [11,12,13] and 
reducing neutrophil migration in septic lungs by suppressing transendothelial migration [14]. 
CO inhalation has been reported to exert an anti-inflammatory effect in patients with chronic 
obstructive pulmonary disease [15]. Exogenous administration of low concentrations of CO 
(10–500 ppm) by inhalation is currently in a phase I clinical trial to evaluate its potential to 
reduce acute airway inflammation (NCT00094406).

Due to concerns about delivering gaseous CO, which cannot be precisely controlled and could 
be toxic to tissue with prolonged exposure, chemical carriers of this gas known as CO-
releasing molecules (CO-RMs) have been developed [6,16]. These carbonyl complexes contain 
a transition metal bound to CO that is released once in solution. Recent studies in bacteria, 
including P. aeruginosa, Staphylococcus aureus, and Escherichia coli, show that CO liberated 
from CO-RMs binds primarily to the heme moieties of proteins in the electron transport chain 
resulting in decreased oxygen consumption and rapid cell death [17,18,19]. Exposure of E. coli 
to CO-RMs also increases intracellular reactive oxygen species (ROS) resulting in bacterial 
DNA damage and death [20]. Thus, in addition to their anti-inflammatory properties, CO-RMs 
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potentially represent a novel class of antimicrobials. While the water-soluble CORM-3 efficiently 
kills planktonic P. aeruginosa at concentrations as low as 1 µM [18], the effect of CO-RMs on 
biofilms, where bacterial metabolism and respiration is likely to be altered, is poorly 
understood. Biofilm formation by E. coli is enhanced after exposure to CO-RMs but whether 
this is also true for other bacteria is unknown and has implications for developing these drugs 
as antimicrobials [21]. The purpose of this study was to evaluate the effects of CORM-2, a 
ruthenium-containing CORM soluble in dimethyl sulfoxide (DMSO), on P. aeruginosa biofilm 
formation and surface colonization. Our study demonstrates that CORM-2 attenuates P. 
aeruginosa formation at concentrations that are not toxic for mammalian cells, and that the 




CORM-2 kills P. aeruginosa PAO1 during planktonic growth and biofilm formation. 
Recent studies have shown that CORM-2, CORM-3 and, to a lesser extent, CORM-371 have 
previously been shown to kill planktonic P. aeruginosa [18,22]. All these CO-RMs contain a 
transition metal, either ruthenium (CORM-2 and CORM-3) or manganese (CORM-371). Our 
data confirm that CORM-2, but not its inactive counterpart iCORM, kills planktonic PAO1 in M9 
medium supplemented with glucose. The effect was dose-dependent with a minimal inhibitory 
concentration of 10 µM (Fig. A-1). The vehicle alone (DMSO) did not affect growth of PAO1 
(data not shown). Colony counts of viable bacteria determined that this killing was rapid with a 
three-log drop in recovered bacteria at 20 min and no viable bacteria recovered after 30 min 
(data not shown).

We next assessed whether CORM-2 can impact surface associated P. aeruginosa. Crystal 
violet (CV) staining of PAO1 biofilms formed in plastic wells demonstrated that a 6 h exposure 
to CORM-2 decreased CV biofilm staining with exposure to concentrations ≥25 µM of CORM-2 
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showing a statistically significant effect (ANOVA p<0.001) (Fig. A-2A). Post-test Dunnett’s 
analysis demonstrated that CV staining levels for all samples treated with ≥25 µM CORM-2 
were different from the control but not different from each other. The effect of CORM-2 on 
biofilm formation compared with vehicle was observed as early as 60 min after treatment and 
was statistically significant at 4 h (p<0.007, paired t-test) (Fig. A-2B). We next performed colony 
counts from sonicated biofilms +/- 100 µM iCORM or 100 µM CORM-2 to determine if bacterial 
cell death contributed to changes in CV of the biofilm. The data demonstrate that there is a 
statistically significant two-log drop in the number of viable bacteria recovered from the 
CORM-2 treated biofilm when compared with the initial viable cell counts and 100 µM iCORM 
(Fig. A-2C) (ANOVA<0.001, Dunnett’s post-test analysis). Cell death is observed as early as 30 
min after drug treatment and persists up to 6 h.

CORM-2 prevents maturation of PAO1 biofilms. 
We next examined the dynamics of biofilm formation after addition of CORM-2, iCORM or 
tobramycin, a known antibiotic used for P. aeruginosa therapy. PAO1-YFP bacteria were 
incubated in glass bottom dishes for 16 h, then gently washed. Fresh medium with iCORM, 
DMSO, CORM-2 (50 µM) or tobramycin (100 µg/ml) was added to surface attached bacteria. 
Fluorescence microscopy was used to image the biofilm at a single location over time. We 
observed that PAO1 biofilms do not continue to mature in the presence of CORM-2 compared 
with biofilms formed in absence of the drug (compare Fig.s A-3A–D and A-3I–L). CORM-2 is as 
effective as tobramycin (100 µg/ml) in preventing bacterial growth, thus maturation of PAO1 
biofilms (compare Figs. A-3I–L to M–P).

No effect on biofilm maturation was observed in the presence of the iCORM vehicle control 
(Fig. A-3E–H) or DMSO (data not shown). These data suggest that the release of CO mediated 
by CORM-2 prevents further biofilm development, similar to the growth inhibition observed 
during planktonic growth.

CORM-2 attenuates PAO1 microcolony formation on human bronchial epithelial cells. 
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We observed that CORM-2 prevents the development of mature biofilms on plastic and glass. 
We next decided to examine the effect of CORM-2 on bacterial colonization of human 
bronchial epithelial cells. PAO1-GFP bacteria attached to 16HBE14o- cells were treated with 50 
µM of CORM-2 or DMSO and microcolony formation was followed for 6 h with time-lapse 
microscopy. The addition of 50 µM CORM-2 inhibited bacterial growth resulting in reduced 
microcolony formation and less damage to the epithelial cells when compared with DMSO 
addition (Fig. A-4A–H ) or iCORM (data not shown). Epithelial cell integrity was continuously 
assessed by differential interference contrast.

Previous work has shown that CO-RM molecules are not toxic to mammalian cells [16,23] or 
when used intravenously in animal models [7]. We tested whether CORM-2 has a cytotoxic 
effect on airway epithelial cells. 16HBE14o- cells were treated with 50 µM, 100 µM and 200 µM 
of CORM-2 for 6 h or 12 h. Control cells were treated with vehicle alone (DMSO). CORM-2 was 
not associated with any cell toxicity at the doses tested either after 6 h or 12 h exposure (Fig. 
A-5A, B). These data reveal that at bactericidal concentrations (50 µM – 200 µM) CORM-2 is 
effective in disrupting P. aeruginosa surface colonization of biotic surfaces at doses that are not 
toxic for human bronchial epithelial cells.

CORM-2- and tobramycin-mediated antimicrobial activities are additive. 
Given the difficulty in treating bacterial biofilms, we next sought to determine if CORM-2 would 
work as an adjuvant therapeutic agent with currently available antimicrobials. Tobramycin is an 
aminoglycoside antibiotic commonly given by nebulizer to patients with chronic pulmonary P. 
aeruginosa infection. One hundred µM CORM-2 is as effective as 1 mg/mL tobramycin at 
decreasing biofilm biomass as measured by CV staining (Fig. A-6A). The addition of CORM-2 
(100 µM) and tobramycin (1 mg/ml) in combination for 6 h resulted in decreased CV staining of 
PAO1 biofilms compared with either no drug or either drug alone with no recovery of viable 
bacteria (Fig. A-6A) (p<0.05 ANOVA, Dunnett’s post-test analysis). To determine whether there 
was a difference in the recovery of viable bacteria comparing single and combination 
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treatments, we lowered the dose of tobramycin to 100 µg/ml. Exposure to 100 µg/ml 
tobramycin resulted in a one-log drop in bacterial viability by 60 min, while exposure to 
CORM-2 led to a two-log drop at 60 min (Fig. A-6B). Exposure to both drugs resulted in an 
additive effect with a four-log drop in recovered viable bacteria at 60 min (Fig. A-6B), as 
assessed by colony forming units assay. Bacterial recoveries from all treatments except the 30-
minute tobramycin group were significantly different than the number of bacteria recovered at 
t0 (ANOVA<0.001, Dunnett’s post-test analysis).

Antioxidants protect PAO1 biofilms from CORM-2 inhibition. 
Previous work on planktonic P. aeruginosa demonstrated that multiple reducing agents (NAC, 
L-cysteine, and reduced glutathione) prevent P. aeruginosa killing by CO-RMs [18]. Our initial 
studies of planktonic P. aeruginosa and CORM-2 with NAC or L-cysteine confirmed this 
protection (data not shown). We next added NAC or L-cysteine in combination with CORM-2 
during biofilm formation in M9 medium to determine whether the treated biofilms were 
protected against CORM-2 induced cell death. Indeed, CV staining of PAO1 biofilms formed in 
96-well plates exposed to either NAC or L-cysteine in the presence of CORM-2 was similar to 
untreated biofilm formation (Fig. A-6A). CORM-2 treatment alone showed a significant 
decrease in CV staining compared with controls (no drug or DMSO) (Fig. A-7A) (p<0.01 
ANOVA, Dunnett’s post-test analysis).

Published reports have suggested multiple mechanisms of the bactericidal action of CO-RMs 
including ROS-mediated activity for CORM-2 [18,20,21]. ROS production by PAO1 biofilms 
increased after CORM-2 exposure >10 µM as assessed by DCF fluorescence intensity 
compared with untreated biofilms (Fig. A-7B, ANOVA p<0.001, Dunnett’s post test analysis). 
Interestingly, while the addition of NAC to PAO1 biofilms prevented ROS production, the 
addition of L-cysteine only reduced ROS production to levels seen when 25 µM CORM-2 alone 
is added (Fig. A-7B). At this concentration, CORM-2 was sufficient to reduce CV staining (Fig. 
A-2A). L-cysteine with 100 µM CORM-2 resulted in no statistical significant decrease in biofilm 
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formation compared with control samples despite similar levels of ROS production (Fig. A-7A) 
(N.S. by ANOVA). Therefore, our data support the previous observations that ROS production is 
not the major mechanism by which CORM-2 disrupts P. aeruginosa growth in M9 medium with 
glucose and an alternative mechanism such as binding of CO to P. aeruginosa respiratory chain 
is more likely [22].

Rich medium protects against CORM-2-dependent PAO1 death. 
We next examined biofilm formation in rich medium, where an increase in biofilm formation has 
been observed for E. coli after CORM-2 addition [21]. In contrast to E. coli, PAO1 biofilm 
formation in LB does not change significantly after addition of CORM-2 (Fig. A-8A). Planktonic 
PAO1 grown in shaking LB were also protected from CORM-2-dependent cell death (Fig. 
A-8B). ROS production by PAO1 biofilms grown in LB was slightly increased after exposure to 
100 µM CORM-2 but not to the same extent as biofilms grown in minimal media (data not 
shown). The nutritional conditions and composition of the growth medium are therefore 
critically important in determining the activity of CORM-2 during both liquid and surface 
associated growth and this likely has implications [20] for in vivo efficacy.

CORM-2 has differential effects on biofilm formation and planktonic growth of clinical 
isolates and PA14. 
CORM-2 prevents PAO1 planktonic growth and biofilm maturation. Given the genetic and 
phenotypic diversity of P. aeruginosa [24] we next tested the effect of CORM-2 on liquid growth 
and the biofilm formation of a number of previously characterized clinical isolates from 
respiratory specimens of non- CF patients [25]. Two of twelve respiratory isolates grew poorly 
in liquid M9 minimal medium (isolates #5 and #8) (Fig. A-9A, left panel). Of the remaining ten, 
growth of all strains was inhibited by the presence of 100 µM CORM-2 (Fig. A-9, right panel). 
Ten of the twelve (83%) strains grown overnight in plastic wells displayed statistically 
significant reduced CV staining of the biofilm after 6 h incubation with 100 µM CORM-2 
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compared with no treatment (Fig. A-9B) (p<0.05, paired t-tests). Three isolates (#3, #4, #10) 
formed poor biofilms both in the absence of CORM-2 and when CORM-2 was added. For 
these three isolates, the CV staining of the CORM-2 treated biofilms was similar to the un-
inoculated blank. Two strains unaffected by CORM-2 (#1, #8) formed robust biofilms compared 
with PAO1 during standing growth in M9 with glucose (Fig. A-9B). These data suggest that 
while the majority of respiratory isolates are susceptible to CORM-2 treatment, isolates with 
robust biofilm formation are less likely to be affected by CORM-2 treatment. Interestingly, 
isolate #8 had poor planktonic growth but robust biofilm formation in M9 with glucose. These 
data highlight the role of biofilm formation in the process of P. aeruginosa strain adaptation to 
unfavorable metabolic conditions.

The above strains were from patients without CF and more likely represent environmental 
strains and not strains from patients with chronic infection. Chronic pulmonary P. aeruginosa 
infection often results in the selection of alginate producing mucoid strains [26]. We next 
examined whether CORM-2 alters the biofilm formation of isolates recovered from CF patients. 
We included both mucoid and non-mucoid clinical isolates from CF patients along with 
PDO351(mucA:aac+;alg+), a mucoid strain that is otherwise isogenic to PAO1 [27] (Fig. A-9C). 
Similar to the results for the non-CF P. aeruginosa isolates we found that CORM-2 reduced 
biofilm formation in some strains but not all (Fig. A-9C) (p<0.012, paired t-test). The efficacy of 
CORM-2 did not correlate with the mucoid status of the isolate; for example, CORM-2 had the 
same effects on mucoid PDO351 compared with non-mucoid wild type PAO1 while the biofilm 
formation of other mucoid clinical strains were unaffected by the addition of CORM-2 (Fig. 
A-9C). Given that biofilms may form under anaerobic conditions during chronic pulmonary 
infection, we assayed anaerobic planktonic growth in M9 glucose or LB medium using 40 mM 
potassium nitrate as an electron acceptor. Addition of 100 µM CORM-2 inhibited growth of 
PAO1 in M9 medium but not LB (as observed for aerobic conditions), demonstrating CORM-2 
activity at different oxygen tensions (Fig. A-11).
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Given the heterogeneity of the effects of CORM-2 on clinical isolates we next tested the effect 
of CORM-2 on another commonly used laboratory strain, PA14 (Fig. A-10). Similarly to clinical 
isolates #5 and #8, PA14 displayed poor planktonic growth in M9 glucose medium when 
compared with PAO1 (data not shown). PA14 was relatively resistant to CORM-2 and to 
prevent planktonic PA14 growth 200 µM CORM-2 was required; iCORM did not have any effect 
on PA14 growth at any concentration (Fig. A-10A). Interestingly, while planktonic PA14 growth 
was poor in M9, PA14 formed strong biofilms after overnight growth in M9 similarly to what 
observed for PAO1 (Fig. A-10B). Thus, PA14 displays adaptation to unfavorable metabolic 
conditions as also observed for clinical isolates #5 and #8. PA14 biofilms were insensitive to 
low doses of CORM-2 (10 – 200 µM) (as also observed for clinical isolated #8), and required 
much higher doses of CORM-2 (400–600 µM) to inhibit biofilm formation compared with PAO1 
(Fig. A-10C). These data suggest that intrinsic differences in P. aeruginosa strains affect their 
susceptibility to CORM-2. Since we observed different growth rates between PAO1 and PA14 
stains in minimal M9 medium supplemented with glucose, we hypothesized that the 
susceptibility to CORM-2 is related to the strain-related capability of using different carbon 
sources for energy. Our finding that CORM-2 becomes ineffective when either PAO1 or PA14 is 
grown in rich LB media (Fig. A-8) also supports this hypothesis.

DISCUSSION 
In patients with CF, there is a chronic hyper-inflammatory state within the infected lung that fails 
to eradicate colonization with pathogens such as S. aureus and P. aeruginosa leading to clinical 
symptoms and frequent hospitalizations [5]. Chronic colonization is initiated with surface 
attachment followed by microcolony formation, the precursors to the mature, antibiotic-
resistant biofilm [4,5]. Since mature biofilms are difficult to eradicate, an alternative approach to 
therapy is to generate novel antimicrobial agents to prevent these early stages of biofilm 
formation enhancing the efficacy of the immune response. CO is an appealing therapeutic 
agent because it has the potential to reduce both host pulmonary inflammation and bacterial 
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viability [15]. CO-RMs were developed to improve and maximize the effects of CO delivery to 
tissues and CORM-2, used in this study, can efficiently release controlled amount of CO with 
the same cytoprotective activities that are described by exogenous administration of CO gas 
without any cytotoxic effect on mammalian cells [16]. 

We demonstrate that, in addition to killing planktonic P. aeruginosa, CORM-2 also prevents 
microcolony formation on human bronchial epithelial cells while maintaining the integrity of the 
epithelium (Fig. A-4). Importantly, CORM-2 concentrations required for P. aeruginosa killing 
were not toxic to human airway epithelial cells even after a 12 hours exposure (Fig. A-5). We 
cannot exclude that CORM-2 prevented epithelial cells disruption not only by impairing 
bactericidal growth, but also by enhancing the antimicrobial activity of mammalian cells. This is 
an area of active investigation.

CORM-2 also attenuates P. aeruginosa biofilm formation on abiotic surfaces confirming the 
antimicrobial effect beyond that previously shown for planktonic bacteria [17,18] (Fig. A-2). 
Together, these data suggest CORM-2 can inhibit biofilm formation regardless of the surface 
used for bacterial attachment. Despite the genetic and phenotypic diversity of P. aeruginosa, 
the majority of clinical isolates from non-CF patients tested had decreased biofilm formation 
after exposure to CORM-2 (Fig. A-7). Importantly, pulmonary infections in CF patients are 
usually initiated by environmental P. aeruginosa strains that often cause other types of human 
infection. The two clinical isolates resistant to CORM-2 formed robust biofilms rapidly when 
compared with the other isolates, suggesting that the earlier CORM-2 is applied the more 
effective it is likely to be. CORM-2 also attenuated the biofilm formation of a subset of isolates 
from CF patients, including both non-mucoid and mucoid strains. While mucoid and non-
mucoid strains have multiple phenotypic and genetic differences, mucoidy did not predict 
failure of CORM-2 treatment [28]. Interestingly, the commonly used laboratory strain PA14 
showed increased resistance to CORM-2 exposure. We hypothesize this is due to its slow 
growth rate in the presence of glucose and its ability to adapt to unfavorable metabolic 
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conditions. Additional studies are required to determine whether metabolic differences 
between PA14 and PAO1 are responsible for their different susceptibility to CORM-2 treatment.

The combination of CORM-2 with tobramycin, an antibiotic currently used in therapy for P. 
aeruginosa pulmonary infection in CF patients, was more effective at killing bacteria and 
reducing biomass than either drug alone (Fig. 6). To our knowledge this is the first example of 
an added benefit when combining CORM-2 with another antimicrobial agent suggesting 
CORM-2may have a role as an adjunct therapy with currently available antimicrobials. This may 
be particularly helpful during chronic infections where subpopulations of antibiotic resistant 
bacteria persist after treatment.

Exposure of E. coli to CORM-2 results in increased ROS production, DNA damage and 
intracellular iron levels of iron [20], suggesting that ROS generation is the primary mechanism 
of cell death [20]. ROS production does not appear to be the mechanism of CORM-2 
dependent PAO1 cell death in liquid growth [22]. Interestingly, while ROS production is 
increased from P. aeruginosa biofilms after CORM-2 exposure, the addition of L-cysteine only 
partially inhibits ROS production but completely protects P. aeruginosa biofilm formation from 
the effects of CORM-2 (Fig. A-7). This suggests that ROS do not cause cell death in CORM-2 
treated biofilms. The mechanism of protection provided by reducing agents to P. aeruginosa 
observed by us and others remains unknown [20]. Microarray analysis of E. coli exposed to 
CO-RMs also demonstrate a global effect with transcriptional changes in a wide variety of 
metabolic pathways and transcriptional regulators, including those involved in carbohydrate 
production, energy metabolism, and stress response [19,21]. Whether any of the above 
transcriptional changes occur in P. aeruginosa and contribute to CORM-dependent cell death 
is unclear.

Exposure to CO-RMs has been shown to result in CO binding to components of the respiratory 
chain in both E. coli and P. aeruginosa [18,19]. The P. aeruginosa respiratory chain is complex 
and involves a large number of respiratory oxidases [29]. At least two cytochrome oxidases 
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interact with CORM-3 as assayed via dual wave spectrophotometry [18]. Exposure of 
planktonic cultures to CORM-3 results in a temporal decrease in oxygen consumption 
consistent with the hypothesis that interference of CO with the respiratory chain kills P. 
aeruginosa [18]. CORM-2 inhibits E.coli, Camplyobacter jejuni and P. aeruginosa PAO1 also 
under anaerobic conditions [19,30], suggesting that oxygen is not required as the terminal 
electron acceptor for CORM-2 activity.

In LB-rich medium P. aeruginosa planktonic growth and biofilm formation are unaffected by 
CORM-2. This is in contrast to E. coli where CO-RMs increase both oxidative stress and biofilm 
formation [21]. The reason CORM-2 is not effective during growth in rich medium is unknown. 
One hypothesis currently being tested is that the active energy pathways used by P. aeruginosa 
determine its susceptibility to CORM-2 and are dependent on the nutritional environment and 
bacterial growth rate. Given the genetic and phenotypic variability of P. aeruginosa, these 
observations are of particular importance since intrinsic differences in metabolism amongst P. 
aeruginosa strains may limit the effectiveness of therapies that target energy production.

In conclusion, this report demonstrates that, in addition to infections that likely involve 
planktonic bacteria such as bacteremia, CO-RMs are a potential therapeutic option for P. 
aeruginosa surface-associated infections with a biofilm component such as pulmonary and 
perhaps burn infections [18]. Since CORM-2 demonstrated activity against mucoid strains and 
under anaerobic conditions it has the potential to have an effect on chronic P. aeruginosa 
pulmonary infections as observed in patients with long-standing lung disease such as CF. 
However, as several clinical isolates and PA14 were resistant to CORM-2 dependent killing, this 
compound will not work for all infections and the emergence of resistant strains is possible. We 
hypothesize that the nutrients available and the energy pathways used by P. aeruginosa in the 
host during infection will be critical in determine the potential for CO-RMs as in vivo 
therapeutics. This is an important area for additional studies.
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Importantly, a single dose of CORM-2 achieved significant bacterial killing for most isolates. If 
CORM-2 were dosed more frequently, we hypothesize it will result in additional bacterial death 
within the biofilm. Current efforts are underway to improve CORM-2-dependent biofilm 
disruption and better understand the mechanisms of both CORM-2 action within P. aeruginosa 
and CORM-2 resistance in non-susceptible strains or in different metabolic conditions.

METHODS 
Drugs. CORM-2, which contains a ruthenium metal surrounded by six carbonyl (CO) groups, 
was dissolved in DMSO (stock solution 10 mM) (Sigma-Aldrich, St Louis MO). As a negative 
control for CORM-2, an inactive compound, here referred to as iCORM, was used (stock 
solution 10 mM). This compound [Ru(DMSO)4Cl2) consists of a ruthenium metal where the CO 
groups have been replaced by DMSO [11]. Both drugs were diluted to final concentrations of 
10–600 µM, depending on the experiment. Stocks were prepared fresh for each experiment. 
Tobramycin (stock solution 100 mg/ml) (MP Biomedicals, Solon OH) was used at final 
concentrations ranging from 100 µg to 1 mg/ml, depending on the experiment. N-acetyl 
cysteine (NAC) was added at a final concentration of 1 mM and L-cysteine was used at 100 µM 
[18].

Strains and Growth Conditions. PAO1 is the reference laboratory strain used in all 
experiments except where described. In some experiments, the mucoid PDO351(mucA:aac
+;alg+) strain, derived from PAO1, was used [27]. The effect of CORM-2 on clinical isolates was 
determined using previously characterized P. aeruginosa respiratory isolates from patients 
without CF [25] and isolates from patients with CF. M9 salts growth medium was supplemented 
with 0.4% glucose. Vogel Bonner Medium (VBM) agar plates selective for P. aeruginosa were 
made as described [25]. The expression of the yellow fluorescent protein (YFP) from the 
plasmid pMQ72 in PAO1 was induced by supplementing the media with arabinose (0.02%) 
[31]. PAO1 expressing green fluorescent protein (GFP) from the high copy plasmid pUCPSK 
was grown overnight in the presence of carbenicillin (200 µg/ml). The PAO1-GFP bacteria were 
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washed and resuspended in M9 medium without carbenicillin prior to incubation with 
respiratory epithelial cells. For growth experiments, overnight cultures of PAO1 were diluted 
into fresh medium to an optical density (OD) at 600 nm of 0.05, the CORM-2, iCORM, or DMSO 
added, and the OD followed over time. At specified intervals, aliquots were removed from the 
cultures, diluted to VBM agar plates, and incubated overnight at 37˚C to determine the number 
of viable bacteria. In some growth experiments, another laboratory strain, PA14, was used. 
PA14 was also diluted to an OD (600 nm) of 0.05 from overnight cultures grown aerobically at 
37˚C in Luria-Bertani broth (EMD) or M9 salts growth medium was supplemented with 0.4% 
glucose. The CORM-2, iCORM or DMSO treatment was added and the OD at 600 nm was 
followed over time using a Biotek Synergy 4 spectrophotometer.

The effect of CORM-2 on PAO1 growth in anaerobic conditions was also tested. Luria-Bertani 
broth (EMD) and M9 medium with 0.4% glucose as the carbon source both supplemented with 
40 mM KNO3 were autoclaved and moved into a Coy anaerobic chamber (80% / 15% / 5% N2 
/ CO2 / H2 atmosphere) 16 hours before inoculation. Pre-cultures were grown aerobically 
overnight and moved into the anaerobic chamber for use as inocula. Anaerobic media were 
dispensed 5 mL per 18X150 mm anaerobic Balch tube (Bellco) and inoculated to a final OD 
(600 nm) of 0.05. Cultures were stoppered and crimp-sealed in the chamber, then incubated at 
37˚C with shaking at 250 rpm. OD at 600 nm was followed using a Thermo Spectronic 20D+ 
spectrophotometer.

Ethics Statement. Clinical P. aeruginosa isolates were taken from de-identified frozen stocks 
conserved at 280uC as part of a previous study approved by the Human Investigations 
Committee at Yale. These bacteria were recovered from pediatric and adult patients 
hospitalized at Yale-New Haven Hospital and identified by the clinical microbiology laboratory, 




Static biofilm formation and analysis. PAO1 static biofilms were formed in either 24-well plastic 
dishes (Corning, Lowell MA) or 96-well plastic dishes (Grenier bio-one, Germany). PA14 static 
biofilms were formed in 96-well plastic dishes (Grenier bio-one, Germany); the bacteria were 
inoculated from an overnight shaking culture to an OD (600 nm) of 0.05 and then incubated as 
a static (non-shaking) culture from 18 to 24 hours at 37˚C [32]. Under these conditions, a 
biofilm forms around the edge of the miniscus against the wall of the well. CORM-2, iCORM, 
DMSO, and/or tobramycin were added directly without removing planktonic cells after biofilm 
formation. In a different set of experiments, the planktonic cells were removed and the 
remaining biofilm was gently washed before adding fresh medium with CORM-2 or controls 
(DMSO or iCORM). At selected times, the biofilm was washed in water, stained with 0.05% 
crystal violet (CV) and absorption at 595 nm was recorded [32]. For a single experiment, the 
drug additions were tested in triplicate and all experiments were repeated at least three times.

To recover viable bacteria from mature biofilms, the planktonic culture was removed after 
overnight growth, the biofilms were gently washed, and fresh medium with drug was added for 
30 min to 6 hours. Following this incubation, the biofilms were washed 4 times with fresh 
medium, then sonicated to release bacteria [32]. The medium containing the released bacteria 
was serially diluted and plated on VBM agar. In all experiments, 3 wells on each plate were 
initially washed and sonicated to determine the viable cell counts at time point t0.

Analysis of biofilm formation in real time. For real-time imaging of the effects of CORM-2 on 
biofilm formation, PAO1-YFP was grown overnight in glass bottom polylysine coated dishes 
(MatTek, Ashland MA) [33] and then placed in a VivaView incubator fluorescent microscopy 
system (Olympus, Center Valley PA), and equilibrated at 37˚C. CORM-2 (50 µM), iCORM (50 
µM), tobramycin (100 µg/ml) or DMSO was added and images were collected every 15 minutes 




Microcolony formation on respiratory epithelial cells. The static bacteria/bronchial epithelial 
cell co-culture system was established as described [33]. 16HBE14o- bronchial epithelial cells 
(a kind gift of Dr. Dieter Gruenert) were maintained in Minimum Essential Medium 
supplemented with 10% fetal bovine serum, L-glutamine and penicillin/streptomycin. For time-
lapse microscopy experiments, 1X106 cells were plated in collagen/fibronectin coated glass 
bottom 3 cm dishes (MatTek, Ashland MA) and cultured for 5–7 days, allowing for tight junction 
formation. Subsequently the epithelial cells were inoculated with P. aeruginosa-GFP at a ratio of 
1:3 in media without antibiotics. After 40 minutes in culture, unattached planktonic P. 
aeruginosa were removed by rinsing and replaced with fresh M9 medium supplemented with 
glucose, L-glutamine and 0.04% L-arginine. CORM-2 (50 µM), iCORM (50 µM) or DMSO was 
added and images were collected by time-lapse microscopy (VivaView, Olympus) every 10 
minutes for 6 hours (objective 20X). The epithelium integrity was assessed by differential 
interference contrast and remained intact for 7–8 hours of culture in the absence of bacteria. 
The images from three fields for each sample were collected and analyzed with VivaView 
software.

Cell Viability Assay. 16HBE14o- bronchial epithelial cells were seeded in 96-wells plate (5X104 
cells/well). After 5 days of culture in Minimum Essential Medium supplemented with 10% fetal 
bovine serum, Lglutamine and penicillin/streptomycin, cells were treated with different doses of 
CORM-2 (50 µM, 100 µM and 200 µM) or with vehicle alone (DMSO) for 6 hours or 12 hours. 
The cell viability was then assessed using the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide) colorimetric assay, which measures cellular metabolic activity. As 
control for cell death, 16HBE14o- cells were treated with saponin for 10 minutes before 
proceeding with the MTT staining. The MTT staining and the colorimetric detection (Cell 




Measurement of ROS production in bacteria. To determine ROS production, static biofilms 
were grown in 96-well plastic dishes (Corning, Lowell MA) as described above [32]. Biofilms 
were washed gently and CORM-2 (25 µM or 100 µM) or DMSO in the absence or presence of 
NAC (1 mM) or L-cysteine (100 µM) were added to the biofilm for 2 hours at 37˚C. Biofilms were 
then washed in Phosphate Buffered Saline (PBS) and loaded with 10 µM 5-(and-6)-
chloromethyl-29,79-dichlorodihydrofluorescein diacetate, acetyl ester (CMH2DCFDA; 
Molecular Probes) for 30 min at 37˚C. This was followed by two washes in PBS. In the 
presence of intracellular ROS and esterases, CM-H2DCFDA is oxidized and deacetylated 
yielding the fluorescent molecule 29,79-dichlorodihydrofluorescein diacetate (DCF). 
Fluorescence intensity was assessed using a fluorescence plate reader (arbitrary units).

Statistical analysis. Data was compiled in Excel and transferred to Minitab for statistical 
analysis. For data derived from biofilm analysis using the CV method, for analysis of ROS 
production and for the analysis of cell viability statistical comparison of paired means was done 
with a paired t-test. When required, multiple comparisons of means were done using a one-
way ANOVA. Post-test analysis determining confidence intervals for individual means was 





Figure A-1. CORM-2 kills planktonic P. aeruginosa. The control molecule iCORM has no effect on 
PAO1 growth in liquid M9 medium with glucose (left panel), while CORM-2 doses >5 µM prevent growth 
of PAO1 (right panel). doi:10.1371/journal.pone.0035499.g001
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Figure A-2. CORM-2 attenuates P. aeruginosa biofilm formation. A) Crystal violet (CV) biomass 
staining decreases after CORM-2 exposure in a dose-dependent manner. Each condition was done in 
triplicate. B) CV staining of PAO1 biofilms treated with 100 µM CORM-2 demonstrates decreased 
staining of the biofilm after 2–6 hours of CORM-2 exposure compared with DMSO vehicle where the 
biofilm increases overtime. C) Colony counts of PAO1 released from the iCORM (100 µM) and CORM-2 
(100 µM) treated biofilms demonstrate that there is a sustainable 2-log drop in bacterial viability. doi:
10.1371/journal.pone.0035499.g002
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Figure A-3. CORM-2 attenuates PAO1 biofilm formation. YFP-P. aeruginosa were grown for 16 hours 
in a glass bottom dish and then visualized at selected locations for 12 additional hours using VivaView. 
A–D: control (CTR = no addition) biofilm formation; E-H: biofilm formation in presence of iCORM (50 
µM); I–L: biofilm formation in presence of CORM2. The CORM-2 (50 µM) treated biofilm remains 
unchanged compared with the control biofilms that continue to mature; M–P: biofilm formation in 
presence of tobramycin. T indicates time; h indicates hours. Scale bars = 50 µm. doi:10.1371/
journal.pone.0035499.g003
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Figure A-4. CORM-2 attenuates P. aeruginosa colonization of respiratory epithelium. Time-lapse 
microscopy of bronchial epithelial cells cocultured with PAO1 (1:3 ratio) show that the addition of 50 µM 
of CORM-2 reduced microcolony formation. The time (hours) when the images were acquired is 
indicated at the bottom of each panel. Scale bars = 50 µm.doi:10.1371/journal.pone.0035499.g004
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Figure A-5. CORM-2 does not affect airway epithelial cell viability. The MTT viability assay shows 
that 50–200 µM of CORM2 is not toxic to airway epithelial cells after 6 hours (A) or 12 hours (B) 
treatment. As a control for cell death, 16HBE14o- cells were treated with saponin for 10 minutes before 
proceeding with the MTT staining. CORM-2 viability is expressed as percentage of non-treated control 
cells (DMSO). doi:10.1371/journal.pone.0035499.g005
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Figure A-6. CORM-2 and tobramycin have additive effects on PAO1 biofilm formation. A) CORM-2 
(100 µM) is as effective as tobramycin (1 mg/ml) in decreasing the biomass of the bacterial biofilm after 
6 hours treatment, as measured by CV staining and the combination is better than either alone. B) The 
combination of CORM-2 (100 µM) and tobramycin (Tobr.) results in increased PAO1 killing within the 
biofilm than either drug alone. doi:10.1371/journal.pone.0035499.g006
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Figure A-7. Anti-oxidants protect P. aeruginosa biofilms from CORM-2 inhibition. A) The addition 
of NAC (1 mM) or L-cysteine (100 µM) to CORM-2 (100 µM) treated P. aeruginosa biofilms (6 hours) 
restores CV staining to levels comparable to untreated biofilms. B) Treatment with CORM-2 (25 µM and 
100 µM) induces bacterial ROS formation; NAC (1 mM) prevents ROS production while the addition of 
L-cysteine (100 µM) did alter only partially ROS levels. doi:10.1371/journal.pone.0035499.g007
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Figure A-8. Rich medium protects P. aeruginosa biofilms against CORM-2. A) Biofilm formation by 
P. aeruginosa treated with CORM-2 (100 µM) for 6 hours is similar to untreated controls when grown in 
LB. B) The addition of CORM-2 (100 µM) to P. aeruginosa growing in liquid LB medium does not result 
in cell death. doi:10.1371/journal.pone.0035499.g008
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Figure A-9. The effect of CORM-2 on growth and biofilm formation of clinical, respiratory P. 
aeruginosa isolates. A) The addition of 100 µM CORM-2 to M9 liquid medium with glucose (left) 
prevents the growth of all clinical isolates compared with addition of DMSO alone (right). B) 6 hours 
exposure to 100 µM CORM-2 reduces the CV staining of 10/12 biofilms formed by respiratory isolates 
after overnight growth in plastic wells. C) 100 µM CORM-2 reduces the CV staining of 3 out of 4 biofilms 
formed by respiratory isolates from CF patients independently of the mucoid or non-mucoid after 
overnight growth in plastic wells. A similar effect was observed in mucoid-PAO1 laboratory strain 
PDO351 (mucA:aac+;alg+). doi:10.1371/journal.pone.0035499.g009
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Figure A-10. High doses of CORM-2 are required to reduce growth and biofilm formation of 
PA14. A) CORM-2 doses .100 µM (right panel) but not iCORM (left panel) prevents PA14 growth in 
liquid M9 medium with glucose. B) As measured by CV staining, PA14 biofilms are resistant to the low 
doses of CORM2 treatment (10–200 µM) that reduce PAO1 biofilm formation. C) Higher doses of 
CORM-2 (400 µM and 600 µM) decreases CV staining of both PA14 and PAO1 biofilm formation. Each 
condition was tested in triplicate. doi:10.1371/journal.pone.0035499.g010
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Figure A-11. CORM-2 inhibits anaerobic growth of PAO1 in M9 glucose medium. PAO1 was grown 
anaerobically in M9 glucose or LB medium in the presence of 40 mM nitrate. Addition of CORM-2 
(100μM) inhibited planktonic growth of PAO1 in M9 but not in LB.
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Appendix B Morphological optimization for access to dual oxidants in biofilms 
This appendix is adapted from a manuscript that was published in PNAS– Kempes, Okegbe et 
al 2014. Here we develop and apply a mathematical model, which incorporates empirical 
values, to show that the tall “ridges” produced by Pseudomonas aeruginosa colony biofilms 
maximize community growth via enhanced access to oxygen. I contributed all the experimental 
data that was used to develop the model. 
ABSTRACT 
A major theme driving research in biology is the relationship between form and function. In 
particular, a longstanding goal has been to understand how the evolution of multicellularity 
conferred fitness advantages. Here we show that biofilms of the bacterium Pseudomonas 
aeruginosa produce structures that maximize cellular reproduction. Specifically, we develop a 
mathematical model of resource availability and metabolic response within colony features. 
This analysis accurately predicts the measured distribution of two types of electron acceptors: 
oxygen, which is available from the atmosphere, and phenazines, redox-active antibiotics 
produced by the bacterium. Using this model, we demonstrate that the geometry of colony 
structures is optimal with respect to growth efficiency. Because our model is based on 
resource dynamics, we also can anticipate shifts in feature geometry based on changes to the 
availability of electron acceptors, including variations in the external availability of oxygen and 
genetic manipulation that renders the cells incapable of phenazine production.

INTRODUCTION 
A desire to understand the relationship between form and function motivates many lines of 
inquiry in biology, including the study of multicellular morphologies and the evolution of these 
features. Cells grow and survive in populations in many types of natural systems. These 
multicellular populations include bacterial biofilms, such as Pseudomonas aeruginosa 
microcolonies in the lungs of cystic fibrosis patients (1) and cyanobacterial colonies and mats 
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in marshes, lakes, and oceans (2, 3), and complex eukaryotic macroorganisms, such as plants 
and animals. In many of these contexts, enhanced survival arises from advantages associated 
with multicellularity at multiple scales. Recent work demonstrated that simple cooperation 
within aqueous microbial biofilms allows groups of genetically similar cells to form tall 
mushroom-like structures that reach beyond local depletion zones into areas of fresh resources 
(4–12). Other work has shown that basic colonial growth (e.g., that of budding yeast) and the 
evolution of complex multicellular life are accompanied by enhanced growth efficiency and 
several energetic advantages (13–15).

The specific organization of and relationship between cells living within a population are 
important characteristics that determine whether organisms benefit from the multicellular 
lifestyle. For example, in mammals the metabolic rate of individual cells is regulated by the size 
of the whole organism, an effect that confers greater efficiency (15). Cells have dramatically 
elevated metabolic rates when living as individuals in culture compared with when they survive 
and grow as members of a multicellular organism (15). This regulation is considered a natural 
consequence of resource supply within hierarchical vascular networks (15–17) and highlights 
the importance of morphology and structure in dictating cellular physiology for multicellular 
systems. Variations in gross morphology also may provide information about how different 
species are adapted to their environments. For example, differences in leaf venation patterns 
among diverse species of plants are fundamentally related to tradeoffs associated with carbon 
assimilation and transpiration rates, water supply rates, and overall mass investment (18). This 
variation in venation network structure is affected by and may influence the mechanisms and 
efficiency with which resources are supplied to individual cells. Gradients of resources, 
particularly oxygen, are similarly important in modulating the development of embryos, lungs, 
hearts, and tumors (19–24).
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Thus, one of the dominant effects of multicellularity is to alter the environment experienced by 
the individual cell. This raises questions such as (i) how are morphology, metabolism, and 
environmental conditions interconnected and (ii) how do these relationships govern the 
fundamental benefits and tradeoffs of multicellularity? Understanding these connections may 
help us understand the general trajectory by which simple and complex multicellular life 
evolved and allow us to better identify and quantify morphologically complex structures that 
may represent paleobiological populations (25).

Bacteria form structurally diverse biofilms in different environments and are well-suited for the 
study of relationships among the morphology, metabolism, and chemical heterogeneity of 
multicellular populations (26). Most laboratory studies addressing biofilm development are 
performed in flow-cell systems, in which bacteria are grown on a glass slide and exposed to a 
continuous flow of a liquid growth medium. In the regime of biofilms submersed in liquid, 
representative Gram-negative bacteria, including P. aeruginosa, form mushroom-like structures 
in response to external nutrient gradients (4–12). We grow P. aeruginosa biofilms on agar-
solidified growth media in a controlled atmosphere. A standard protocol, the colony 
morphology assay, is used to generate these biofilms (27). Ten microliters of a cell suspension 
is pipetted onto an agar plate, and the development of the colony at room temperature and 
constant humidity is monitored over several days. In this model system, we can modify the 
environmental and biological conditions and examine the resulting shifts in structure and 
chemistry. Colony biofilms that form under these conditions exhibit spatial patterning (Fig. 
B-1A) and environmental sensitivity and constitute an ideal model system for exploring 
morphology as a metabolic adaptation (28). 

Although numerous processes, including extracellular matrix production, osmotic pressure 
gradients, cellular motility, and spatially heterogeneous cellular death (e.g., refs. 4, 9, 12, 29, 
30), have been shown to be involved in the production of biofilm patterning, it is not yet fully 
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understood why or how feature formation has evolved, especially in the context of air-exposed 
biofilms. We have reported that redox-active signaling molecules called phenazines have 
dramatic effects on population behavior. Whereas wild-type colonies remain smooth for the 
first 2 days of growth, phenazine-null mutant (Δphz) colonies undergo a major morphotypic 
transformation (31). At day 2, Δphz colonies begin to spread over the surface of the agar plate. 
Two types of wrinkle structures form: those within the area of the original droplet, which appear 
to be more “disorganized,” at the colony center and those that radiate from the center toward 
the colony edge (referred to here as “ridges”). Both types of features are vertical structures 
(Fig. B-1). Wild-type colonies also form wrinkles in the center, but only after 3 days of growth, 
and a mutant that overproduces phenazines remains smooth when monitored for 6 days. 
These strains therefore demonstrate an inverse correlation between increased colony surface 
area and phenazine production (31). 

More recently, we showed that P. aeruginosa colony wrinkling is a strategy to increase oxygen 
accessibility (28). We have proposed that phenazines attenuate this mechanism because they 
act as electron acceptors for cells in anoxic regions of the biofilm and shuttle electrons to the 
well-aerated regions, allowing cells to balance their internal redox state (28, 32, 33). We 
proposed that a reduced cellular redox status triggers a morphological change at the 
population level. Consistent with this model, adding nitrate (an alternate electron acceptor) to 
the agar, or increasing atmospheric oxygen concentrations (to 40%) prevents spreading of the 
Δphz colony and discourages wrinkle formation. Decreasing external oxygen availability (to 
15%) increases wrinkle formation as well as spreading of the colony (28). Oxygen profiling of 
the colonies indicates that the Δphz mutant is well oxygenated within wrinkles, suggesting that 
its morphotype is an adaptation for enhanced oxygen uptake (28). It is noteworthy that wrinkles 
reach a final, static width while continuing to grow taller. The wrinkle width achieved is 
correlated with the concentration of oxygen provided in the atmosphere. Additionally, 
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eliminating the ability to wrinkle (by deleting the genes for extracellular matrix production) has 
been shown to lead to a redox imbalance, as indicated by an elevated NADH/NAD+ ratio (28).

The sensitivity of colony morphogenesis to oxygen, nitrate, and phenazines suggests a 
significant role for oxidative capacity in modulating morphology. Here we develop a simple 
mathematical model, rooted in established physical laws and physiology, that demonstrates 
and confirms this significance. Combining this model with experimental verification enables us 
to make predictions and interpretations that would be infeasible using modeling or 
experimentation alone. The model incorporates the response of growth rate to oxygen 
availability and accurately predicts the measured oxygen distribution within colony features. 
Because it is based on resource dynamics, it also anticipates shifts in feature geometry based 
on external oxygen availability. Finally, quantitative experiments verify our methodology. We 
demonstrate that biofilms produce features with geometries optimal for the growth efficiency of 
the entire colony and sensitive to the redox environment, as determined by factors such as 
oxygen availability and phenazine production. 

MODELING BIOFILM METABOLISM AND OXYGEN DYNAMICS 
Several key features of the colony biofilm system inform our understanding of the processes 
governing morphology and form the foundation for our modeling framework. (i) Wrinkling in the 
colony system is a basic feature of the wild type that occurs late in development as a response 
to electron acceptor limitation (28). (ii) Overall colony wrinkling, as well as the geometry of 
individual features (width of wrinkles), can be modified easily by altering the redox conditions 
(e.g., increasing oxygen availability or knocking out the ability to produce phenazines) (see ref. 
28 for P. aeruginosa and ref. 34 for similar results in Bacillus subtilis). (iii) Colony wrinkles reach 
a constant width early in development but continue to grow taller at a nearly linear rate. Taking 
these last two observations together, we assume that electron acceptor rather than nutrient 
supply is the primary limitation faced during colony development and is responsible for feature 
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geometry. If nutrient supply from the agar below a feature were controlling width, we would 
expect to see a decrease in the overall growth of a feature as the constant width is reached. 
We would not expect to observe the linear increase in ridge height; this would only increase 
nutrient limitation as chemicals are forced to diffuse over a narrow and increasingly long 
distance.

To study the basic dynamics of resources and geometric feature formation, we first empirically 
characterize and model colonies of the phenazine-deficient mutant (Δphz) in a context in which 
oxygen is the only available terminal electron acceptor. We later expand experiments and the 
model to consider wild-type colonies, which have the sole addition of redox-active phenazines 
produced by the cells.

We base our mathematical model on the simplest hypothesis for feature regulation: the 
dynamic feedback between metabolism, resource availability, and physical diffusion (e.g., refs. 
6, 8, 35–43). We use the Pirt model, which interprets the linear relationship between population 
metabolism and growth rate as a metabolic partitioning between growth and maintenance (44) 
and is consistent with the physiology of a broad range of bacterial and eukaryotic species (see, 
e.g., refs. 13, 45 for a review). It is combined with the Monod model, which parameterizes 
population growth rate as a saturating function of the external concentration of a limiting 
resource (46). This combination of parameterizations has been used widely (e.g., refs. 6, 35, 41, 
43) and here provides an equation for the oxygen consumption as a function of available 
oxygen:

	 	 	 	 	 	 	 	 [1]

where Q is a consumption rate per unit mass of a limiting resource that provides energy and/or 
structural material to the population of cells (mol resources · s-1·g cells-1), μ is the specific 
growth rate (s-1), Y is a yield coefficient (g cells · mol resource-1), P is a maintenance term (mol 
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resource · s-1·g cells-1), μmax is the maximum growth rate approached as the substrate 
concentration is taken to infinity, and ks is the half-saturation constant.

Depletion of oxygen within the biofilm creates a gradient with the atmosphere and drives a 
diffusive flux of oxygen into the colony. The time-dependent spatial concentration of oxygen 
may be described by

	 	 	 	 [2]

where a is the density of cells in the colony (g cells · m-3). Similar models have been used 




where the temporal and spatial scales, respectively, have been normalized by the factors 

Oxygen concentrations have been divided by ks, and the nondimensional maintenance term is 
g = YP/μmax. For steady-state solutions, the model relies only on the concentration of oxygen at 
the colony surface, which is determined by the atmospheric mixing ratio and pressure, and the 
two parameters xfac and ks. We determined the value for both parameters by first compiling 
published measurements and then constructing the mean of every combination within this 
compilation. Here we use the Pirt–Monod diffusion model framework to interpret the 
community benefit of specific geometrical features of the colony and to interpret mechanisms 
underlying the architectural optimization within biofilms. We also model the dynamics and 
benefits associated with multiple oxidative resources and show that biogenic redox-active 




Observations of Internal Oxygen Distribution. To investigate how these mechanisms 
regulate morphology, we study a single feature of a P. aeruginosa colony biofilm, i.e., the ridge 
(Fig. B-1), and its surrounding geometry. We take oxygen profiles of the colony “base” (Fig. 
B-1B), where biofilm geometry is simplest, and we use these profiles to examine our literature-
based parameter estimates and calibrate our model. First, we measure oxygen availability with 
increasing depth (Fig. B-2). There is some variation in the decay rate and the depth at which 
oxygen no longer can be detected (Figs. B-4 and B-5). Most of this observed variation may be 
accounted for by rescaling the depth axis by a simple factor, after which the profiles share a 
similar shape. This normalization highlights common overall biological activity and variation in 
the physiological parameter values. We fit the observed variation in vertical 1D profiles by 
varying xfac and solving for the steady-state oxygen concentration in our model for an isolated 
base geometry while keeping ks fixed. Fig. B-2A shows that steady-state solutions of our model 
in the base capture the range of observed oxygen profiles. The variation in profiles also allows 
us to calibrate the range of xfac to be bounded by 7.3 X 104 and 1.6 X 105 with a mean value of 
9.1 X 104. This range compares well to our estimate from the literature of 7.7 X 104 μm. Given 
our definition of xfac the observed variation could be due to differences in physiological 
parameters, such as maximum growth rate or substrate yield, or to differences in the physical 
parameters, such as density, wetness, and overall oxygen diffusivity of the colony. 
Experimentally, we find that oxygen availability decreases with increasing depth into the colony. 
However, this effect is much more dramatic in the base than in the ridge. This likely is the result 
of increased surface area for a reduced cellular mass. To interpret this phenomenon, we use 
the calibrated model to simulate the steady-state distribution of oxygen availability within a 
ridge and the surrounding base, and we do this for various geometries of the ridge (Fig. B-6A). 
Our model also captures the general decay rate and shape of these ridge profiles (Fig. B-2B). 
These profiles were created using the mean value of the parameter calibration and the general 
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variation in ridge width because it is experimentally challenging to measure the width and 
oxygen profile simultaneously. Our ability to anticipate the general shape and variation of 
oxygen profiles within the ridge gives us confidence in our calibration and the model’s 
predictive capacity. It should be noted that once these calibrations have been made, all other 
results in this paper follow directly as predictions.

The Impact of Colony and Feature Geometry. The increased depth of oxygen penetration in 
the ridge region (Fig. B-2B) illustrates the importance of geometry in enhancing oxygen 
availability within the colony. The question then becomes how changes in this geometry affect 
oxygen availability within the colony. To explore this, we simulate the simplest geometric 
variation by preserving the overall shape of the ridge but varying the width of the ridge for a 
fixed height. Fig. B-6A shows the distribution of oxygen within ridges of different widths. From 
the internal oxygen distribution and Monod equation, we can calculate the local growth rate 
and we find that ridges generally have an enhanced growth rate relative to flatter regions of the 
colony (Fig. B-6B). This is because tall, thin features increase the total surface area for a 
relatively small amount of biomass, which enhances the oxygen flux per total consumption, 
resulting in increased oxygen penetration. However, we also see in Fig. B6 that as ridges grow 
wider, the effect of enhanced growth is diminished and the layer of growing cells within the 
ridge region becomes similar in thickness to that of the base regions. This effect implies a 
tradeoff for population metabolism: Although thin structures are entirely oxygenated, allowing 
cells to grow quickly, their relatively small size limits the number of cells they contain. Thick 
features house many more cells, but the region of enhanced oxygen penetration and growth is 
smaller. This tradeoff may be summarized using the total reproductive rate, R, of the colony, 
where the derivative of R with respect to mass describes how much added growth the colony 
will experience given an investment in additional mass. This derivative gives the growth 
efficiency of the colony in that it represents the return on mass investment in terms of total 
reproductive capacity. We calculate R for an ensemble of simulated features at a fixed height 
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but with different widths, and find that R reaches a maximum for ridges with a specific width. 
This represents the optimal width for efficient cell proliferation within the colony and also 
corresponds to the width at which all cells within a feature can at least meet their minimum 
metabolic maintenance requirements. More importantly, the optimal width found in our model 
accurately predicts the observed average width of colony features along with the observed 
variation in widths for colonies growing on an agar plate exposed to 21%external oxygen (Fig. 
B-3). This prediction is made by solving for the optimal width using the minimum, maximum, 
and average parameter values from our calibration to base profiles. Similarly, for simulations of 
the base, we find that R approaches a constant value when the height of the base reaches the 
maximum depth to which oxygen can penetrate. Thus, any additional base height does not 
produce additional growth for the colony. Experimentally, we find that the average base 
thickness corresponds to the average depth at which oxygen no longer is detectable. The 
observed colony features are such that if features grow wider (or taller in the case of the base) 
than this optimal size, the colony has invested a large amount of mass that will not grow 
quickly. If the features are smaller than this optimum, the colony has invested a small amount 
of mass, but there will be less overall growth as a consequence. We suggest that natural 
selection has favored cellular behavior that gives rise to features with emergent geometries that 
maximally benefit the population, as was proposed previously in similar contexts (e.g., ref. 26). 
It should be noted that we observe that during early colony growth, the ridges maintain a 
constant width while height continues to increase. This implies that nutrients are not limiting, 
and it then is surprising that in the outermost layer of cells, growth is arrested despite the 
abundance of oxygen and capacity for further growth. This raises the possibility that cellular 
growth within the ridges is regulated to optimize the growth efficiency of the population.

Morphological Response to Oxygen Availability. We have shown evidence of oxygen control 
driving the optimization of colony form. Feature geometry is important because of the impact it 
has on the availability of oxygen within the colony. Given this interconnection between 
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geometry and oxygen, we would expect that changes in the external availability of oxygen 
would result in shifts in colony form. To test this hypothesis, we exposed colonies to elevated 
concentrations of external oxygen (40% compared with the standard 21%). To quantify these 
shifts, we again calibrate the parameters of our model. We do not have the appropriate 
experimental setup to measure oxygen profiles in colonies grown in our hyperoxia chambers. 
As an alternative, we use colony base heights as proxies for oxygen penetration distances 
(base heights correspond to the depth at which oxygen is depleted). These measurements are 
sufficient for calibrating xfac to the 40% external oxygen conditions. The observed widths in 
40% external oxygen are wider than in 21%. Running our simulations with 40% external 
oxygen, and the calibrated range of parameter values, we again successfully predict the mean, 
upper bound, and lower bound on observed ridge widths (Fig. B-3). Through our model, we 
interpret the wider ridge width as the result of deeper oxygen penetration, which extends the 
width at which a diminishing return on mass investment occurs. We also predict, in good 
agreement with data, that in 15% external oxygen, ridge width will be reduced (Fig. B-7).

Morphological Response to Other Oxidants. Our observations and modeling thus far have 
concerned a P. aeruginosa Δphz mutant, which cannot produce phenazines. We can predict 
the significant effects of oxygen availability on feature development and the optimal ridge width 
in this scenario, in which oxygen is the only electron acceptor the bacteria can use to balance 
the intracellular redox state. However, it is important to test whether our conceptual framework 
may be used to determine the effects that phenazines, as endogenously produced oxidants, 
have on feature geometry (28). To address this challenge, we examine aspects of the wild-type 
colony in which we have developed a model that accounts for the dual use of oxygen and 
phenazines as electron acceptors. We have developed a mathematical model in which we 
allow both oxygen and phenazines to diffuse and be reduced within the colony. In this model, 
oxygen is consumed directly by cells and also is used for reoxidizing phenazines, and cells 
reduce both substrates to support their metabolic rate.
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This model accurately predicts the decay of oxygen with increasing depth into the base region 
of the colony. Near the surface, this decay rate is observed to be nearly identical to that of the 
Δphz colonies. However, deep in wild-type colonies, cells cease to consume oxygen, which in 
the context of our model, may be interpreted as the point at which phenazines are used as 
alternate electron acceptors. Experimentally, cells expressing YFP from a constitutive promoter 
(suggesting metabolic activity) have been observed at a depth of 100 μm in wild-type colonies 
compared with a depth of only 60 μm in Δphz mutant colonies (28).

It appears that the presence of phenazines allows an oxidative potential to extend deeper into 
the colony. In our model, we see that this is the consequence of phenazines being oxidized in 
the surface layer and diffusing into the deep layers, where they are consumed when oxygen 
reaches a low enough level.

Using this model, we again can evaluate the effect of ridge width on colony growth and predict 
optimal ridge width when phenazines are present. Our predictions agree well with observations 
for the wild type growing in 21% oxygen (Fig. B-3C). The observed and predicted features are 
significantly wider than the Δphz ridges grown under the same conditions. The wild type is 
effectively a Δphz mutant with phenazines added, and the effect of phenazine addition is 
qualitatively the same as that of increasing oxygen availability for the Δphz mutant. This 
highlights that the availability of oxidative resources strongly controls feature geometry and that 
these effects can be modeled predictably, provided that the redox chemistry and physiology of 
the colony are well defined.

DISCUSSION 
The study of biofilms has diverse applications. For example, biofilms may act as model 
ecological systems to investigate the nature of cooperative and competitive behavior and 
dynamics (e.g., refs. 4, 12). To understand biofilm physiology in a variety of contexts, it is 
critical to define the connections between population structure and access to resources. We 
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have developed a mathematical model of substrate availability and cellular metabolism within 
colonies. The predicted oxygen distribution and its effects on colony morphology have been 
verified empirically using a standard biofilm assay. We have shown that standard physiological 
characterizations of biofilms may be combined with an analysis of community growth as a 
function of geometry to predict optimal biofilm morphology. Furthermore, we have illustrated 
that these optima are influenced greatly by external redox conditions and the ability of biofilms 
to produce redox-active molecules.

One of the major findings of this paper is that the shapes of biofilms may allow optimal 
interaction with the environment for resource availability and therefore optimal total growth and 
return on mass investment. The ridges of P. aeruginosa colonies maintain fairly uniform width 
even as they grow taller. Previous studies showed that steady-state biofilm feature shape 
results from external resource limitation and occurs when the environment no longer can 
supply substrates for further growth (e.g., refs. 4, 5, 7, 12, 47). In contrast to the model systems 
used for these studies, our colony biofilm is exposed to the open atmosphere, in which 
external resource gradients effectively are nonexistent. Thus, cells in the outermost layer of a 
colony are not resource limited, and they have the capacity for further growth, as evidenced by 
the oxygen profiles and the observation that they grow taller. The ridges have the capacity for 
horizontal growth, and the simplest passive model of the dynamics driven solely by growth rate 
would predict increasing ridge width over time. Therefore, unknown mechanisms must 
maintain the constant ridge width that apparently is advantageous to the overall colony.

Although wrinkling is a common response of the biofilm system, we have seen that ridge 
geometry is affected by both environmental (external oxygen availability) and physiological (the 
inability of the Δphz mutant to produce phenazines) alterations. Furthermore, it has been 
observed that no wrinkling occurs in a mutant unable to produce the Pel polysaccharide [a 
critical component of matrix structure (27, 28)], and our experience with a wide variety of single 
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gene knockouts indicates that many physiological changes alter the details of spatial 
patterning and wrinkle formation. This suggests that wrinkling is the result of many 
physiological processes, as already highlighted by the variety of single mechanisms shown to 
be related to pattern formation in biofilms (4, 12, 29). Given the complexity of cellular 
physiology and response, there are countless systems of cellular behaviors, interactions, and 
feedbacks that conceivably might evolve to produce diverse biofilm structures. Many of these 
structures would not be optimal for the average reproductive success of cells within the colony. 
This suggests that the specific set of mechanisms in our biofilm system may have been 
selected to produce emergent patterns that we observe to be optimally beneficial to the colony. 
Studies recently indicated that biofilm structures are underpinned by diverse cell behaviors, 
including chemotaxis, extracellular matrix production, chemical signaling, and selective cellular 
death as an induction for mechanical buckling in thin films (4, 12, 29). Whether disruptions in 
these mechanisms produce suboptimal biofilm structures remains to be investigated. In 
addition, features may serve multiple roles in different contexts or species, implying a variety of 
selective pressures. For example, a recent study reported that the channels that form within 
wrinkles in B. subtilis biofilms facilitate liquid movement through the structure (48).

In considering the possibility that biofilm patterning has been selected for as a stable adaptive 
trait, it is important to recognize the tradeoffs faced by individual cells, including the potential 
for “cheaters” to disrupt patterning and the associated benefits to the population. For 
example, phenazines are a community resource produced at a cost. Once excreted, these 
compounds may be taken up and participate in repeated redox cycling by both phenazine-
producing and nonproducing cells (32). In the biofilm context, strategies may be used to avoid 
the likely benefit experienced by cheaters that catalyze redox cycling without contributing to 
the phenazine pool. Recent work has shown that extracellular matrix formation is a strategy 
that allows only cooperating cells to gain the benefit of the tall structures built by the 
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community, so long as the cooperators exist in high enough local abundance and matrix 
properties (production rate and density) fall within a predictable range (4, 12).

Characterization of the relationships among metabolism, chemical gradients, and 
morphogenesis of bacterial biofilms provides information relevant to diverse fields. Bacterial 
biofilms may exhibit complex spatial patterning at scales comparable to those of putative 
microbial fossils (25, 47). Our biofilm system has allowed us to test the effects of different 
atmospheric oxygen concentrations directly and to demonstrate that the width of features 
changes predictably. These findings may provide a basis for verifying microbial fossils and 
using them as reporters of the ancient environment. For example, in aquatic environments, the 
diffusive boundary layer for oxygen that forms around the biofilm is what influences feature 
geometry (4–12) in contrast to the open-atmosphere biofilms studied here, in which the 
important oxidative gradients occur inside the biofilm. These differences provide avenues for 
interpreting which environments are capable of producing an observed morphology.

Biofilm development is a critical component of bacterial colonization of and persistence within 
human and other eukaryotic hosts. It contributes to the establishment and maintenance of 
various types of P. aeruginosa infections. Here we find that biofilms produce optimal structures 
to enhance growth and that the success of the colony depends on the ability to build these 
structures effectively. As we learn more about the complex set of cellular behaviors responsible 
for the emergent regulation of these features, we become better equipped to take new 
approaches toward controlling biofilms in clinical and industrial settings. 

METHODS  
Bacterial Strains and Growth Conditions. Wild-type P. aeruginosa PA14 and a mutant (Δphz) 
deficient in phenazine production were used in this study (49). Bacterial cultures were grown 
routinely at 37 °C in lysogeny broth, shaking at 250 rpm overnight. For all oxygen profiling 
experiments, colony biofilms were grown on 1% tryptone (Teknova)/1% agar (Teknova) plates 
 169
amended with 20 μg/mL Coomassie blue (EMD) and 40 μg/mL Congo red (EMD). Colony 
biofilms were grown at room temperature (22–25 °C) and at high humidity (>90%). Sixty 
milliliters of the medium was poured per 10-cm2 plate (D210-16; Simport) and allowed to dry 
with closed lids at room temperature for 24 h. Ten microliters of the overnight culture was 
spotted on these agar plates, and colony biofilms were grown for 6 d. Colonies were grown 
under hypoxic (15% oxygen) or hyperoxic conditions (40% oxygen) as described earlier (28). 
Briefly, we incubated agar plates in C-Chambers (C274; BioSpherix). Oxygen concentrations 
were regulated by mixing pure nitrogen and oxygen (Tech Air), using the gas controller ProOx 
P110 (BioSpherix).

Colony Geometry Measurements. Width and height of ridges within colony biofilms were 
measured with a digital microscope (Keyence VHX-1000).

Oxygen Depth Profiles. Oxygen profiling was done using a miniaturized Clarktype oxygen 
sensor (Unisense; 10-μm tip diameter) on a motorized micromanipulator (Unisense) for depth 
control. The electrode was connected to a picoampere amplifier multimeter (Unisense) and 
polarized at −800 mV. The sensor was calibrated using a two-point calibration system at 
atmospheric oxygen and zero oxygen. The atmospheric oxygen reading was obtained by 
placing the electrode in a calibration chamber (Unisense) containing well-aerated deionized 
water. Complete aeration was achieved by constantly bubbling the water with air. The zero 
reading was obtained by bubbling water in the calibration chamber with ultra–high-purity 
nitrogen gas (Tech Air). All calibration readings and profile measurements were obtained using 





Figure B-1. Horizontal (A) and vertical (B) structures of P. aeruginosa colony biofilms. The colony 
was grown air-exposed on 1% tryptone, 1% agar for 5 d. The scale bar represents 0.5 cm. (C) The 
simulated concentration of oxygen within a ridge.
 172
Figure B-2. Oxygen profiles of 4-d-old colony biofilms for (A) the base region and (B) the ridge. 
Measured values are given by points, and simulations are represented by the solid curves. We took 
measurements for 37 base profiles and 27 ridge profiles over 5 d of growth, and the data in A and B 
represent the variation within the observed profiles. Arrows indicate the top of the biofilm surface. Data 
from ref. 28
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Figure B-3. The average width of colony ridges as a function of time for Δphz (A–C) and wild-type (D) 
colonies. (A and B) Histograms for all ridge width measurements at 21% and 40% oxygen. (A–D) The 
solid red (21% oxygen) and blue (40% oxygen) lines represent our predictions for optimal ridge width, 
and the dashed lines represent our predictions for the bounds of variation in ridge width.
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Figure B-4. All the measured oxygen profiles for the base region (A) and wrinkles (B) of Δphz colonies 
grown in 21% external oxygen. Note that the wide range of wrinkle profile decay rates, as well as the 
occasional increase in oxygen with increasing depth, is a result of the thin geometry of the wrinkle and 
the resulting experimental challenge of keeping the oxygen probe centered in the wrinkle as it moves 
deeper into the colony. Data from ref. 28
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Figure B-5. All the measured oxygen profiles for the base region of wild-type colonies grown in 40% 
oxygen. Data from ref. 28.
 176
Figure B-6. The modeled internal availability of oxygen (A) along with the spatial distribution of growth 
rate (B) within a biofilm for features of different sizes.
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Figure B-7. The average width (points) of Δphz colony wrinkles grown in 15% external oxygen as a 
function of time. The solid line represents our predictions for optimal wrinkle width, and the dashed 
lines are our predictions for the bounds of variation in wrinkle width. The data were published 
previously in ref. 28.
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Appendix C. Control of Candida albicans Metabolism and Biofilm Formation by 
Pseudomonas aeruginosa phenazines 
This appendix is adapted from a manuscript that was published in mBio– Morales, Grahl, 
Okegbe et al 2013. Here we show that phenazines produced by Pseudomonas aeruginosa 
modulate C. albicans metabolism and, through these metabolic effects, impact cellular 
morphology, cell-cell interactions, and biofilm formation. I contributed the experiments 
measuring oxygen profiles in C. albicans biofilms (Figure C-6). 
ABSTRACT 
Candida albicans has developmental programs that govern transitions between yeast and 
filamentous morphologies and between unattached and biofilm lifestyles. Here, we report that 
filamentation, intercellular adherence, and biofilm development were inhibited during 
interactions between Candida albicans and Pseudomonas aeruginosa through the action of P. 
aeruginosa-produced phenazines. While phenazines are toxic to C. albicans at millimolar 
concentrations, we found that lower concentrations of any of three different phenazines 
(pyocyanin, phenazine methosulfate, and phenazine-1-carboxylate) allowed growth but 
affected the development of C. albicans wrinkled colony biofilms and inhibited the fungal 
yeast-to-filament transition. Phenazines impaired C. albicans growth on nonfermentable carbon 
sources and led to increased production of fermentation products (ethanol, glycerol, and 
acetate) in glucose-containing medium, leading us to propose that phenazines specifically 
inhibited respiration. Methylene blue, another inhibitor of respiration, also prevented the 
formation of structured colony biofilms. The inhibition of filamentation and colony wrinkling was 
not solely due to lowered extracellular pH induced by fermentation. Compared to smooth, 
unstructured colonies, wrinkled colony biofilms had higher oxygen concentrations within the 
colony, and wrinkled regions of these colonies had higher levels of respiration. Together, our 
data suggest that the structure of the fungal biofilm promotes access to oxygen and enhances 
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respiratory metabolism and that the perturbation of respiration by bacterial molecules such as 
phenazines or compounds with similar activities disrupts these pathways. These findings may 
suggest new ways to limit fungal biofilms in the context of disease.

INTRODUCTION 
Candida albicans, a commensal resident of mucosal surfaces, can overgrow under favorable 
conditions, leading to a wide range of diseases, referred to as candidiasis (1). C. albicans 
infections often involve more than one cellular morphology; yeast, pseudohyphal, and hyphal 
growth forms have all been associated with virulence (2). It has been proposed that filaments 
are responsible for tissue penetration, whereas yeasts play an important role in early 
dissemination and in less invasive disease infections (3). C. albicans infections are also 
associated with its formation of biofilms, which are dense single-species and mixed-species 
populations adhering to one another through the action of surface adhesins and extracellular 
polymers. Biofilms on implanted medical devices can serve as a source for infection, and 
dense C. albicans populations within the host may have properties in common with biofilms, 
such as high levels of drug resistance and resistance to host immune defenses (4, 5). 
Importantly, biofilm formation involves filamentation and adhesin-mediated aggregation of cells 
(6,7).

Many environmental cues impact fungal morphology and biofilm formation. Many conditions, 
such as hypoxia, elevated extracellular pH, N-acetylglucosamine (GlcNAc), amino acids, low 
concentrations of glucose, body temperature, and elevated CO2 have been associated with C. 
albicans filamentation (8, 9). There have been a number of studies that also indicate that 
metabolic status can influence the decision to form hyphae (10–16). There are still many 
questions regarding how the fungus integrates these different signals and whether there are 
important links between known inducers of hyphal growth, biofilm formation, and metabolism.

C. albicans and bacteria can coexist within the host (17–19), where the nature of the 
interspecies interactions can determine the fate of the microbial populations (20) and thus 
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probably the outcome of polymicrobial diseases. C. albicans and Pseudomonas aeruginosa, 
two species commonly found together in mixed species, biofilm-related infections (21), interact 
in many different ways through physical association, killing by secreted factors and signaling 
events that modulate virulence properties (22–29). P. aeruginosa adheres to and forms biofilms 
on C. albicans filaments (23) and ultimately causes the death of the fungal hypha. A P. 
aeruginosa quorum-sensing molecule also induces a transition to yeast growth, and yeasts are 
more resistant to killing by P. aeruginosa (23). Redox-active phenazines produced by P. 
aeruginosa play a key role in controlling C. albicans when the two species are in close proximity 
(24, 29). We reported that C. albicans growth was antagonized by two P. aeruginosa 
phenazines, pyocyanin (PYO) and its biosynthetic precursor 5-methylphenazinium-1-
carboxylate (5MPCA), as well as by a synthetic methylphenazinium analog phenazine 
methosulfate (PMS), which we have shown to be a surrogate for studying 5MPCA’s antifungal 
activity (24, 29). Phenazines play important roles in bacterial interactions with fungi in which 
high concentrations of phenazines inhibit fungal growth (30).

Here, we demonstrate a new role for bacterial phenazines as modulators of C. albicans 
metabolism and community behavior. In the presence of phenazine-producing P. aeruginosa or 
low concentrations of purified phenazines, the fungus grew but no longer developed wrinkled 
colonies or robust biofilms on plastic surfaces. Phenazines markedly inhibited the yeast-to-
filament transition. Consistent with published data indicating that phenazines can impact 
mitochondrial activity (31, 32), their presence led to increased production of fermentation 
products and decreased respiratory activity at concentrations that are found in clinical samples 
(33). Methylene blue (MB), which can also interact with the electron transport chain (ETC) (34, 
35), inhibited the development of wrinkled C. albicans colony biofilms. These studies also 
revealed a link between wrinkles in colony biofilms and respiratory activity, and this finding was 
supported by the detection of higher oxygen concentrations in wrinkled colonies than in 
smooth and flat colonies comprised of yeast. Together, our data revealed a previously 
 184
unidentified role for phenazines as modulators of C. albicans metabolism and, through these 
effects, on cellular morphology, colony development, and biofilm formation on solid surfaces. 
Moreover, this work also provides new insights into the links between metabolism, 
morphogenesis, and community behaviors such as biofilm formation in C. albicans, and this 
may represent an emerging theme among the microbes.

RESULTS 
P. aeruginosa phenazines repress C. albicans biofilm formation and hyphal growth. When 
wild-type (WT) P. aeruginosa strain PA14 and WT C. albicans strain SC5314 were grown 
adjacent to one another, a striking change in C. albicans colony morphology occurred, with a 
smooth zone in the region adjacent to the bacterial colony and wrinkling in regions of the 
fungal streak that were more distant from the bacterial colony (Fig. C-1A). In contrast, C. 
albicans cocultured with a phenazine-deficient (∆phz) P. aeruginosa strain wrinkled robustly up 
to the edge of the bacterial colony, suggesting that the soluble excreted phenazines played a 
role in this effect on C. albicans colony morphology (Fig. C-1A).

To determine if phenazines were directly responsible for the change in C. albicans colony 
morphology, we spot inoculated C. albicans onto medium with and without purified 
phenazines. Control cultures without phenazines formed wrinkled colony structures, while 
colonies grown in the presence of low concentrations of any of three phenazines, PYO, PMS, 
or PCA, were smooth, flat, and undifferentiated (Fig. C-1B). The effects of different 
concentrations of PMS and PYO were tested, and complete repression of colony wrinkling was 
apparent at concentrations as low as 5µM for PMS and 10µM for PYO, indicating that the 
concentrations required to inhibit wrinkled colony development were ~100-fold below those 
shown previously to be toxic to C. albicans (24, 29, 36).

C. albicans hyphal growth has been associated with both wrinkled colony morphology and 
biofilm formation on plastic surfaces (5, 37). We found that wrinkled colonies, formed upon 
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growth on medium with GlcNAc at 37°C, exhibited some biofilm-associated characteristics, 
including cells in hyphal, pseudohyphal, and yeast morphologies that remained associated with 
one another even upon suspension in liquid (Fig. C-1B). In contrast, smooth colonies formed in 
the presence of phenazines were comprised almost exclusively of yeast that dispersed easily 
upon transfer to liquid (Fig. C-1B). In addition to the change in cellular morphology, phenazines 
repressed expression of HWP1, a gene that is strongly correlated with hyphal growth and 
involved in biofilm formation (38, 39), as shown using a strain harboring a lacZ transcriptional 
reporter fused to the HWP1 promoter. A strain expressing an actin transcriptional reporter 
(ACT1::lacZ) did not show differences between colonies grown in the presence or absence of 
phenazines. Colonies grown at 30°C without GlcNAc (noninducing conditions) were smooth 
and contained only yeast (Fig. C-1B); no phenotypic changes in colony morphology were 
observed upon inclusion of phenazines in the agar medium under these conditions. The total 
numbers of CFUs in smooth colonies formed in the presence of either PMS or PYO were 
slightly but significantly (P < 0.05) lower than those in control colonies (Fig. C-1C).

Inhibition of extracellular alkalinization by phenazines prevents C. albicans filamentation 
and wrinkling. Previous studies demonstrated links between C. albicans morphological 
transitions and extracellular pH, with yeast growth dominating under acidic conditions and 
filamentation promoted at neutral pH (40). Seminal studies by Vylkova and colleagues (41) 
showed that C. albicans amino acid catabolism can raise the extracellular pH in environments 
that are initially acidic. Since our culture medium was rich in amino acids and had an initial pH 
of 5.0, we determined the role of alkalinization in the induction of filamentation and wrinkled 
colony morphology. As expected, alkalinization of the medium was evident only in the presence 
of amino acids, while medium containing only glucose as a carbon source remained acidic (Fig. 
C-2A). The addition of GlcNAc and incubation at 37°C (conditions that induce filamentation) 
promoted colony wrinkling on medium with amino acids that had increased pH (Fig. C-2A; 
control). However, GlcNAc and 37°C were not sufficient to support wrinkled colony formation in 
the absence of amino acids (Fig. C-2A). Concentrations of phenazines that inhibited colony 
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wrinkling also had striking effects on the pH changes in the medium. While the medium 
surrounding control colonies became red by 48 h, indicating a pH greater near 7, the medium 
surrounding PMS- and PYO-grown colonies remained acidic (Fig. C-2A). The addition of PMS 
or PYO did not change the pH of uninoculated media. These differences in extracellular pH led 
us to hypothesize that phenazines were impacting C. albicans metabolism.

Phenazine-induced fermentation correlates with C. albicans acidification of the 
extracellular milieu. In liquid culture conditions, as observed on agar (Fig. C-1C), PMS caused 
a small decrease in growth rate and final yield (Fig. C-2B), and the pH in the extracellular 
medium of cultures grown with PMS was lower (Fig. C-2C). Extracellular pH can increase upon 
ammonia release (41, 42), and acidic products can lower the pH. We first evaluated the effects 
of phenazines on ammonia release using an acid trap methodology (41). In control colonies, 
138 ± 19 ppm NH3 was detected in comparison to 290 ± 56 ppm NH3 for colonies grown with 
PYO and 270 ± 69 ppm NH3 for colonies grown with PMS. Thus, neither PMS nor PYO caused 
a decrease in ammonia release from colonies, suggesting that differences in amino acid 
catabolism were likely not the cause of the lower pH values in cultures with PMS or PYO.

To determine whether phenazines altered the production of acidic C. albicans products, we 
grew the fungus on filters floating on liquid medium with or without phenazines at 37°C (Fig. 
C-3A) and analyzed the culture supernatants. As on agar, the pH of the supernatants 
decreased in the presence of phenazines, as visualized by bromocresol green addition (Fig. 
C-3A, top). High-performance liquid chromatography (HPLC) analyses of the supernatants 
found 8- and 17-fold-higher levels of acetic acid produced per unit of optical density at 600 nm 
in the presence of PMS and PYO, respectively, at 24 h (Fig. C-3B) despite the fact that slightly 
less glucose was consumed compared to control cultures. Other fermentation products, such 
as ethanol, were also found at higher relative levels upon phenazine exposure. There was 5.5- 
and 3.4-fold more ethanol (mg/ml/OD600) in cultures grown with PMS and PYO, respectively, 
than in 24-h supernatants from untreated cultures of C. albicans colonies (Fig. C-3B). HPLC 
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analyses of C. albicans supernatants in planktonic cultures at 8 h also showed higher levels of 
ethanol as well as glycerol, another C. albicans fermentation product, in PMS-containing 
cultures than in controls. Together, these data suggest a shift toward fermentation in the 
presence of phenazines.

Phenazines inhibit C. albicans growth on nonfermentable carbon sources. C. albicans can 
either ferment or respire glucose, whereas other substrates, like amino acids, alcohols, or 
organic acids, can be used only for energy generation via respiration (43). In light of the finding 
that phenazines increased production of C. albicans fermentation products (Fig. C-3B), we 
tested the hypothesis that phenazines inhibited respiration by assessing their effects on growth 
on non-fermentable carbon sources. Indeed, while growth on glucose was only slightly slower 
in the presence of PMS (Fig. C-4A), this phenazine caused a marked decrease in both growth 
rates and yield in cultures grown on amino acids (Fig. C-4B).

Phenazine-mediated C. albicans colony morphology changes are not due solely to altered 
extracellular pH. Phenazines repressed biofilm behaviors both on agar and in liquid medium 
with glucose (Fig. C-1) and caused acidification of the medium (Fig. C-2A and C). Because of 
the known role of extracellular pH in C. albicans morphological regulation (40, 41), we tested 
whether acidification of the extracellular milieu was required for phenazine-mediated inhibition 
of C. albicans filamentous growth and colony development. The fungus was spot inoculated on 
medium containing glucose and amino acids that was buffered at either pH 5 or pH 7 (Fig. 
C-5A). As previously described (44), a stable acidic extracellular milieu (pH 5.0) completely 
inhibited C. albicans filamentation and wrinkled colony formation (Fig. C-5A). Colonies formed 
on medium that was buffered at pH 7.0 were wrinkled in the absence of PMS or PYO. 
Interestingly, PYO and PMS still repressed filamentation and colony wrinkling on this buffered 
medium (Fig. C-5A). Therefore, our results demonstrate that while phenazine-mediated 
decreases in pH were sufficient to repress hyphal growth, this change in extracellular pH was 
not required to prevent inhibition of wrinkled colony morphology formation and filamentation.
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Phenazines alter C. albicans respiratory activity. Our data led us to propose that phenazines 
altered C. albicans respiratory activity. To assess whether perturbation of respiratory activity 
was sufficient to repress colony biofilm development, we determined if methylene blue (MB), 
another well-known electron acceptor capable of altering mitochondrial activity and with 
structural similarity to phenazines (34, 35), also repressed colony wrinkling. Similar to the 
effects of PMS, PCA, and PYO (Fig. C-1B), micromolar concentrations of MB also caused C. 
albicans formation of smooth colonies on unbuffered medium (Fig. C-5B). Unlike phenazines, 
which promoted extracellular acidification (Fig. C-2A and C and C-3A), cultures with MB 
alkalinized the medium when it was at an initial pH of 5 and did not acidify the extracellular 
milieu when the initial pH was adjusted to 7 (Fig. C-5B). These data highlight that compounds 
that impact respiration can inhibit colony wrinkling and that extracellular pH changes were not 
required for the repression of hyphal growth and the development of wrinkled, structured 
colonies.

We next used TTC, a dye indicative of mitochondrial activity, in order to test the idea that 
phenazines could impair respiration directly. Reduction of TTC by the electron transport chain 
(ETC) leads to the formation of a red product that accumulates within cells (45). Colony biofilms 
formed without phenazines exhibited a high level of TTC reduction as evidenced by the strong 
red pigmentation (Fig. C-6A and B). However, PMS- or PYO-grown colonies showed decreased 
TTC conversion in this assay and, thus, were much less metabolically active (Fig. C-6A). To 
complement these studies, we used an electrode probe to measure the oxygen gradients as a 
function of depth from the top of the colony as an indicator of oxygen utilization within the 
colony interior. Under noninducing conditions, smooth colonies grown with PMS or PYO 
demonstrated higher concentrations of oxygen than control colonies when measured at 
comparable depths from the surface (Fig. C-6A). These data are consistent with oxygen 
utilization being repressed by phenazines. Together, these findings indicate that phenazines 
cause a disruption of the normal respiratory patterns in C. albicans cells.
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The wrinkles of C. albicans colonies have elevated oxygen concentrations and exhibit a 
high respiratory metabolism. When TTC was added to C. albicans wrinkled colonies formed 
in inducing conditions in the absence of phenazines, stronger red pigmentation was observed 
than in colonies grown under noninducing conditions (Fig. C-6A and B), suggesting that 
wrinkled colony biofilms exhibited a more active respiratory metabolism than colonies with a 
smooth morphology. Consistent with this observation, phenazine-treated colonies grown under 
inducing conditions also showed decreased TTC-derived coloration than untreated wrinkled 
controls (data not shown). Strikingly, while there was even, red pigmentation from TTC 
conversion in smooth colonies (Fig. C-6A), wrinkled colonies had higher levels of pigmentation 
in the wrinkled areas (higher regions of the colony). The “valleys” appeared to have less 
respiratory activity (Fig. C-6B, inset). Based on these observations and in light of our previous 
results demonstrating that C. albicans wrinkled colony formation was repressed by phenazines 
and MB (Fig. C-1B and C-5B), we proposed that wrinkling was linked to respiration. To 
determine whether the topology of the wrinkles promoted access to oxygen within dense 
colonies, we used an electrode to quantify the oxygen concentration within the wrinkles of 
colonies grown under inducing conditions compared to non-inducing conditions at similar 
distances from the colony edge. Wrinkled colony areas had shallow oxygen gradients, and 
moderately high oxygen remained detectable throughout the structure (Fig. C-6B). In sharp 
contrast, the gradients for smooth yeast colonies formed in non inducing conditions were 
much steeper and showed significantly lower oxygen concentrations at all levels within the 
colony. Thus, our results suggest a model in which wrinkling promotes aerobic respiration as 
part of fungal colony biofilm development. 

DISCUSSION 
Our work reveals a new role for P. aeruginosa phenazines as modulators of C. albicans 
metabolism and biofilm development. We found that low, nonlethal concentrations of bacterial 
phenazines inhibited fungal morphogenesis and prevented the development of wrinkled colony 
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biofilms, and subsequent analyses indicated that these effects were due to alteration of C. 
albicans respiratory activity. Several lines of evidence indicated that phenazines inhibited 
normal fungal respiratory activity: (i) fermentation products were at higher concentrations in the 
presence of phenazines (Fig. C-3B), (ii) growth on non-fermentable carbon sources was 
severely impaired with only slight growth inhibition on glucose (Fig. C-4B), (iii) metabolic activity 
was lower in the presence of phenazines (Fig. C-6A), and (iv) oxygen concentrations were 
higher in yeast colonies grown with phenazines than in yeast colonies grown in their absence 
(Fig. C-6A). The increased secretion of acetic acid (Fig. C-3B) (46) in the presence of 
phenazines likely reduced the extracellular pH (Fig. C-2A and C); low pH was not the only 
mechanism responsible for the phenazine-mediated effects since buffering the medium at pH 7 
did not ameliorate the effects of phenazines (Fig. C-5A). Importantly, MB, another compound 
that alters the cellular respiratory activity (34, 35), also repressed hyphal growth and colony 
biofilm formation but did not lead to a pH change, suggesting that a different spectrum of 
fermentation products may have been produced (Fig. C-5B). The different effects of MB and 
phenazines with respect to altering the extracellular pH may be explained by their respective 
redox properties (47), which could lead to different interactions with the ETC, or due to 
differences in other targets within the cell. Our data suggest that decreased ability to transfer 
electrons to oxygen led to decreased colony wrinkling and filamentation, and this model is 
supported by the fact that C. albicans wrinkled colony formation was inhibited (Fig. C-7) and 
biofilm formation on plastic in liquid medium does not occur in anoxic environments despite 
the fact that cells form hyphae (48, 49) (Fig. C-7).

Our observations that colony wrinkling was repressed under conditions that limit respiration 
suggest that these structures may allow cells to increase their access to oxygen in dense 
populations. Several findings support this model. First, while the absence of oxygen inhibited 
wrinkled colony formation (Fig. C-7), hypoxic conditions strongly promote colony wrinkling (10). 
Second, we found that wrinkled regions had higher rates of respiration than non-wrinkled 
regions of the colony (Fig. C-6B) and that wrinkled colonies had more respiratory activity than 
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colonies that lacked wrinkling (Fig. C-6). Lastly, mutants locked in a highly respiratory state, 
such as strains lacking Ace2 and Tye2, have increased colony wrinkling (10) and filamentation 
within biofilms (50). We speculate that the C. albicans wrinkled phenotype is related to biofilm 
phenotypes on submerged, plastic surfaces, as both structures involve spatially distributed 
filamemntation and cells that adhere tightly to one another. In multiple bacterial species, the 
study of colony wrinkling has led to the discovery of genes crucial for biofilm formation on solid 
surfaces (51–53).

Links between biofilm formation and oxygen availability may emerge as a common theme in 
diverse microbial species, including both fungi and bacteria. For example, wrinkled P. 
aeruginosa colonies have increased oxygen concentrations within the colony compared to 
smooth counterparts, and it has been hypothesized that biofilm structure enables access to 
oxygen by increasing surface area (54). In P. aeruginosa, endogenously produced phenazines 
serve as alternate electron acceptors, thereby facilitating P. aeruginosa survival in low-oxygen 
conditions (55, 56). Phenazines, likely in part through modulation of intracellular redox, led to 
decreased surface-to-volume ratios in both flow cell and colony biofilms (57, 58) in a manner 
that is reminiscent to what we observed with C. albicans. In addition, C. albicans biofilm 
development may also be influenced by ethanol, a metabolite that has been shown to inhibit 
submerged biofilm formation in this fungus (59).

Previous studies have also shown links between C. albicans respiratory metabolism and 
cellular and colony morphology. For instance, C. albicans strains that lack the mitochondrial 
NADH dehydrogenase were unable to filament (13), and other ETC inhibitors such as rotenone 
(13) and thenoyl trifluoro acetone (16) repressed C. albicans filamentation. However, it is 
important to note that antimycin A, another respiratory chain inhibitor, promoted filamentation 
(10), suggesting that the inhibition of filamentation in response to altered ETC activity is likely 
due to more than decreased energy generation, such as a response to a specific metabolic 
signal (10). Biochemical studies that have examined the interactions between phenazines and 
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respiratory electron transport systems in eukaryotic and bacterial cells have found that these 
compounds and related molecules can either inhibit or stimulate the flux of electrons through 
the ETC (31, 60, 61). Future work will determine what signal, such as ratios of intracellular 
electron carriers, the state of the ETC components, intracellular pH, or ATP levels, is sensed by 
the cell and which regulators respond to these important intracellular signals. Furthermore, 
additional studies will be required to explain the differences in respiration seen in the “folds” of 
wrinkled colonies compared to smooth regions. Possible explanations include regulated 
differences in metabolism or differences in cell density due to morphology or matrix 
production. While phenazines are likely too toxic for use as therapeutic agents, our findings 
with MB may have implications for antifungal therapy. MB is nontoxic in mammals and has 
been used as an antimalarial drug, a neurotoxin antidote, and a potentiating factor in 
photodynamic therapy (34, 35). Thus, there is potential for this or similar compounds to be 
used to inhibit C. albicans biofilm infections in vivo.

This work highlights that phenazines have different biological effects at different 
concentrations. Kerr and colleagues (27, 36) and our laboratory (24, 29) have demonstrated the 
anti-Candida properties of P. aeruginosa phenazines at high concentrations (> 500 µM). Here, 
we show that respiration is inhibited at concentrations that are 25- to 200-fold lower than those 
required to stop growth (29, 36) (Fig. C-1B). In the lungs of cystic fibrosis (CF) patients, where 
P. aeruginosa and C. albicans are often found together (21, 62), PYO and PCA were found to 
be between 5 and 80 µM (33). We show here that these concentrations repressed C. albicans 
filamentation and biofilm development but did not kill the fungus. A 1989 study by Bhargava et 
al. (63) that assessed fungal morphology in the CF lung suggests that this fungus exists as 
yeast in CF airways. Our findings also suggest the possibility that by releasing phenazines, P. 
aeruginosa causes C. albicans to secrete more fermentation products that are readily used by 
P. aeruginosa to enhance its own growth and survival.
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MATERIALS AND METHODS 
Strains, media, and culture conditions. See Table C-1 for strain descriptions. C. albicans and 
P. aeruginosa were inoculated from overnight cultures onto yeast nitrogen base synthetic 
medium (YNB salts with ammonium sulfate that was supplemented with 10 mM glucose [Glu], 
0.2% [wt/vol] amino acids from yeast synthetic dropout medium supplement without 
tryptophan [AA] both Glu and AA, or succinate [10 mM]). Where stated, 40mMMOPS 
(morpholinepropanesulfonic acid; pH 7) or 100 mM citrate buffer (pH 5) was added. Non-
inducing conditions that promoted growth as yeast and the formation of smooth colonies were 
defined as Glu or Glu-AA and incubation at 30°C. In inducing conditions that cause colony 
wrinkling and filamentation, 5 mM GlcNAc was added and cultures were incubated at 37°C. 
When indicated, media were supplemented with phenazines or methylene blue as described in 
the supplemental information. To monitor pH, bromocresol purple (0.01% [vol/vol]) was added 
to the agar medium. C. albicans-P. aeruginosa cocultures were performed on yeast extract-
peptone-dextrose (YPD) agar.

Analysis of extracellular pH and ammonia production. C. albicans strains from stationary 
phase cultures with an adjusted absorbance (OD600) of 8.0 in 5 ml of YPD were spot inoculated 
(10 µl) onto agar media. Extracellular alkalinization was qualitatively evaluated by adding 0.01 
% of the pH indicator bromocresol purple in ethanol (Sigma) to the medium. To measure 
fermentation products from colony biofilms, C. albicans colonies grown in the liquid assay were 
cultured onto a 0.2 µm membrane (Millipore) that was floating on 600 µl of Glu+AA liquid 
medium with or without 5 µM PMS and 20 µM PYO in 24-well plates. 5 µl of a C. albicans was 
inoculated, and colonies were grown for 24 hours at 37oC. Acidification of the extracellular 
milieu was assessed by adding 0.01 % of the pH indicator bromocresol green (Sigma) in 




To quantify the production of volatile ammonia by phenazine treated and untreated colonies, a 
previously described and slightly modified acid trap technique was used (41, 67). Briefly, 
individual colonies were grown under inducing conditions in 96-well plates with 150 µl of YNB 
Glu+AA agar alone or with 5 µM PMS or 20 PYO µM. Acid traps, with 100 µl of 10 % (w/v) citric 
acid per well of a 96-well plate, were situated directly on each well of inverted 96-well plates 
with growing colonies. After 24 hours at 37˚C, the ammonia concentrations within the citric acid 
solution were determined. The solution was diluted 10-fold, and 20 µl was added to 80 µl of 
Nessler’s reagent (Fisher). Samples were incubated at room temperature for 30 min prior to 
measurement of the absorbance at OD400. Ammonia concentrations (ppm) were determined 
using an NH4Cl standard curve (3-50 ppm). 

To determine production of fermentation products, 500 µl of culture media were collected and 
centrifuged (10 min at 13,200 rpm) to pellet cells. Supernatants (450 µl) were filtered by using a 
HPLC Spin-X centrifuge tube filter (Costar) and then stored at -80oC until analysis. Filtered 
samples were acidified with 10% (w/w) H2SO4 and subsequently analyzed by HPLC with an 
Aminex-87H column (Bio-Rad Laboratories, Hercules, CA) operated at 60oC with 0.01 % (v/v) 
H2SO4 mobile phase using dual detection of refractive index and ultra violet (λ =210nm). Peak 
heights were measured and identified by comparison of retention times with authentic 
standards and their concentrations determined by the external standard method. 

Respiratory activity analyses and oxygen tension analyses. To analyze the respiratory 
activity of colonies, we employed a TTC overlay technique (64) in which 2 ml of the TTC-agar 
solution was applied to 48-h-old spot-inoculated colonies. This method that was originally 
described by Lenhard in 1956 (70) has been broadly used to determine the ETC activity of 
microbial populations. Colorless 2,3,5 triphenyltetrazolium chloride (TTC) is able to pass 
through the plasma membrane and reach the mitochondria, where it is converted into reddish 
1,3,5-triphenylformazan (TTF) by reducing equivalents and where the colored products then 
remain immobilized (64, 45). To assess metabolic activity in colonies, 2 ml of the TTC-agar 
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solution (55˚C) was overlaid onto 55 mm plates containing spot-inoculated colonies grown as 
described in previous sections. Red color development was observed 24 hours after the 
addition of TTC at room temperature. The TTC-overlay agar solution consisted of 0.067 M 
potassium phosphate buffer at pH 7.0 and 0.1% TTC. Oxygen tensions within the colonies 
were measured at room temperature using an automated micro Clark-type oxygen sensor 





Figure C-1. Effects of phenazines on C. albicans colony development and cellular morphology. (A) 
C. albicans SC5314 colony morphology when near P. aeruginosa WT or the ∆phz strain. (B) Top, C. 
albicans colonies grown on Glu-AA-GlcNAc at 37°C (inducing conditions) or 30°C in the absence of 
GlcNAc (non-inducing conditions) for 48h in the absence or presence of 5 µM PMS or 20 µM PYO; 
bottom, microscopic view of cells from colonies, captured using differential interference contrast (DIC) 
microscopy. (C) Viable cell counts from C. albicans colonies exposed to phenazines. CFUs from colonies 
grown on Glu-AA at 30°C without or with 5 µM PMS or 20 µM PYO for 48h (*, P < 0.05; n = 4).
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Figure C-2. Phenazines modulate C. albicans extracellular alkalinization and morphogenesis. (A) 
Fungal colonies grown on GluAA or Glu alone under filament-inducing and non-inducing conditions 
without or with 5 µM of PMS and 20 µM PYO for 48h; pH was monitored using bromocresol purple. 
The images were obtained by using a stereoscope (7.5X). (B and C) Growth (B) and pH (C) in liquid 
 199
Figure C-3. Phenazines promote glucose fermentation. (A) Top, extracellular changes in pH were 
visualized by addition of bromocresol green; bottom, C. albicans colonies grown for 24h at 37°C on 
polycarbonate filters suspended on Glu-AA liquid medium in the presence or absence of 20 µM PYO 
and 5µM PMS without bromocresol green. (B) Quantification of acetic acid (black bars) and ethanol 
(white bars) in supernatants of colonies grown on filters (n = 3; *, P < 0.05).
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Figure C-4. Phenazines alter C. albicans growth in fermentable and non-fermentable carbon 
sources. Growth curves of liquid cultures on media containing only glucose (A) or amino acids (B) in 
the presence (triangles) or absence (open circles) of 5 M PMS at 37°C. The optical density (OD600) of 
each culture was monitored every hour.
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Figure C-5. Phenazine-modulated inhibition of C. albicans wrinkled colony morphology is not 
solely due to decreased extracellular pH. (A and B) C. albicans colonies grown on Glu-AA-GlcNAc 
with the pH adjusted to 7.0 or 5.0 prior to inoculation. A total of 5 µMof PMS, PYO, or methylene blue 
(MB) was added to the medium when specified, and the pH indicator bromocresol purple, which yields 
a red-purple color under alkaline conditions and a yellow-orange color under acidic conditions, was 
included. In panel A, the medium was buffered with 40 mM MOPS (pH 7) or 100 mM citrate (pH 5) as 
indicated. Colonies were incubated for 48h at 37°C.
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Figure C-6. Effects of phenazines on respiratory metabolism and oxygen consumption. (A) C. 
albicans colonies grown in Glu-AA medium alone or with 5 µM PMS or 20 µM PYO under non-inducing 
conditions. The respiratory activity of colonies was assessed using TTC, and images were captured 
using a stereoscope at 10X (top). Internal oxygen measurements in similarly grown colonies were made 
from the top to the bottom of control colonies (black), with PMS (light gray) or PYO (dark gray). (B) 
Oxygen gradients in colonies grown under noninducing (smooth) and inducing conditions (wrinkled) 
were measured at room temperature. The respiratory activity in wrinkled colonies was greater in 
wrinkles (gray arrow) than in valleys (black arrow) (inset).
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Figure C-7. C. albicans wrinkled colony development varies with oxygen availability and carbon 
source. Pictures of drop-inoculated fungal colonies grown in modified Glu-AA with 5  mM GlcNAc 
medium (with 20  µM oleic and 80  µM nicotinic acid) supplemented with 10 or 100  mM of Glu, 
incubated under anoxic conditions for 48 h at 37°C. For reference, a colony growth on YNB Glu-AA 
with 5 mM GlcNAc and 10 mM glucose at 48h is shown.
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Appendix D. Efforts to crystallize RmcA and PA0290 
This appendix summarizes efforts to crystallize RmcA and PA0290 for the purposes of solving 
their structures. This work was done in collaboration with Drs. Farhad Forouhar, John Hunt, and 
Liang Tong. Victor Wong and Dr. Chi Wang also provided advice and technical assistance. 
INTRODUCTION 
Chapter 3 described roles for two PAS-domain-containing proteins in the modulation of c-di-
GMP levels and colony morphology in PA14: the phosphodiesterase RmcA and the diguanylate 
cyclase PA0290. Genetic analysis and biochemical characterization suggested that RmcA is 
inactive or repressed, while PA0290 is induced or activated, under reducing conditions. These 
effects lead to increased c-di-GMP levels, which promote colony wrinkling as an adaptation to 
the redox imbalance. I sought to purify, crystallize, and solve the structures of these proteins to 
gain mechanistic insights into the links between PA14 redox sensing and modulation of c-di-
GMP levels, including the identities of co-factors or ligands that bind to the RmcA and PA0290 
PAS domains and how signals are propagated from sensory PAS domains to c-di-GMP output 
domains within these proteins. The experiments and data that follow show approaches 
employed and progress made in these efforts (See Fig. D-1 for overview of work flow).

MATERIALS AND METHODS 
Materials. Plasmid pET28b was a generous gift from Momchil Kolev (NESG and Hunt lab, 
Columbia University). Escherichia coli C43 (DE3), which was used for protein expression, was a 
gift from Dr. Andreas Hartel (Shepard Lab, Columbia University). Unless otherwise stated, all 
enzymes were purchased from Thermo Scientific. Isopropyl-D-1-thiogalactopyranoside (IPTG) 
was purchased from VWR. Terrific Broth growth medium (11.8 g/L tryptone, 23.6 g/L yeast 
extract, 0.4% (v/v) glycerol, 9.4 g/L K2HPO4, 2.2 g/L KH2PO4) was used for all expression 
experiments. Lysis buffer, used to resuspend cells prior to sonication, contained 0.1% NP40 
(Sigma), 500 mM NaCl, 50 mM Tris-Cl pH 7.5, 10mM imidazole, 2 tablets complete protease 
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inhibitor (Roche), 10% glycerol, and 10mM 2-mercaptoethanol (BME). For Ni-NTA gravity flow 
column purification, wash and elution buffers contained 500 mM NaCl, 50 mM Tris-Cl pH 7.5,, 
10% glycerol, and 10 mM BME. Wash and elution buffers also contained 30 mM and 300 mM 
Imidazole, respectively, unless otherwise stated.

Cloning and purification of full-length and/or truncated RmcA and PA0290. Sequences for 
full-length and/or truncated versions of RmcA and PA0290 constructs were amplified from 
PA14 genomic DNA using primers listed in Table D-1. They were ligated into the pET28b vector 
using restriction sites NcoI and XhoI for PA0290 constructs and NdeI and HindIII for RmcA 
constructs. Table D-2 contains a list of engineered constructs.

To improve solubility of expressed proteins, I inserted an MBP (maltose-binding protein)-tag 
derived from a pMAL vector (New England Biolabs) downstream of the N-terminal 
hexahistidine (6xHis) tag in pET28b using BamHI and NdeI restriction sites, generating MBP-
pET28b. A thrombin-cleavage site preceding MBP and a Factor Xa cleavage site downstream 
of MBP allow removal of the MBP and 6xHis-tags from the recombinant protein (Fig. D-2). 

Protein expression and purification. Expression was carried out in E. coli C43 (DE3). Cultures 
were grown at 37˚C with shaking at 250 rpm in Terrific Broth medium with 35 µg/mL kanamycin 
to OD600 = 0.5. Expression was induced by the addition of 0.5 mM IPTG and cells were 
incubated for an additional 16-18 h at 16˚C with continued shaking at 250 rpm. Cells were 
harvested by spinning at 2700 g for 30 min and resuspended in 3x pellet volume of lysis buffer. 
Lysozyme was added at 25µg/mL to aid cell lysis. Cells were sonicated and lysate was 
centrifuged at 24,500 g for 60 min (RC5C, SA-600 rotor, Sorvall Instruments). Clarified lysate 
was applied to a gravity-flow column containing charged Ni-NTA resin and eluted with 300 mM 
Imidazole. Eluted protein was further purified using a Superdex 200 prep grade gel filtration 
column (GE Healthcare, Catalog # 151-1901) on an AKTA FPLC (GE Healthcare, Piscataway, 
NJ) equilibrated with 10 mM Tris, pH 7.5, 100 mM NaCl unless otherwise stated. Gel filtration 
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was done at 4˚C at a flow rate of 0.4mL/min. Protein purity of collected fractions was checked 
by SDS-PAGE.

Crystallization Screening. Pure protein fractions were pooled and concentrated using Amicon 
ultrafiltration cartridges (Millipore, Billerica, MA). Protein samples were concentrated to at least 
8 mg/mL and stored at -80˚C after being flash-frozen in liquid nitrogen. A 460-µL aliquot was 
saved and flash frozen before being sent to Hauptman Woodward Medical Research Institute 
(Buffalo, NY) for high throughput crystal screening in 1536 conditions.

RESULTS AND DISCUSSION 
The cytosolic portion of RmcA is soluble when expressed from pET28b or MBP-pET28b. 
All RmcA constructs described in this appendix are truncations that contain only the cytosolic 
portion (PAS, GGDEF  and EAL domains) of the protein (see Fig. 3-1a, Chapter 3 for RmcA 
domain architecture) This truncation has 922 residues and is ~106kDa. RmcA was expressed 
according to methods listed above. Small scale solubility testing for the cytosolic portion of 
RmcA in both vectors (with or without the MBP fusion) was performed using 6mL cultures. For 
these small scale tests, preparation of lysate and protein purification was conducted as 
described above, except that centrifugation for collection of cells and clarified lysate was 
carried out at 4000 g and 16,000 g respectively. RmcA-pET28b and RmcA-MBP-pET28b were 
both expressed and soluble at 16˚C although RmcA-MBP-pET28b was more soluble (Fig. D-3). 
Nevertheless, for the in vitro assays discussed in Chapter 3 and crystallization studies, I 
proceeded with RmcA-pET28b to avoid any complications that could arise from the MBP tag.

Large scale protein expression and purification for the cytoplasmic porrtion of RmcA was 
carried out using two liters of culture and as described in the methods, except that 60 mM 
imidazole was used to obtain a cleaner elution when using the gravity flow column containing 




Gel filtration traces showed three major peaks (Fig. D-4). Fractions 41, 51 and 67 were 
associated with peaks 1, 2 and 3 respectively. Given the size of RmcA (~106 kDa), we 
expected RmcA to elute in relatively late fractions, and SDS-PAGE analysis of the collected 
fractions showed that RmcA was only associated with the third peak (Fig. D-5). These fractions 
were concentrated to 1.2 mg/mL as described in methods using a 50kDa cutoff ultrafiltration 
cartridge (cat #UFC9050) before submission for crystal screening.

The construct for expression of full-length PA0290 yielded a soluble product. PA0290 is a 
323-amino-acid protein with an N-terminal PAS domain followed by a GGDEF domain (Fig. 
3-1a, Chapter 3). I designed 5 constructs for the expression of full-length PA0290 and various 
PA0290 truncations, which are listed in Table D-2. I tested the solubility of the constructs on a 
small scale using the method described for the RmcA constructs. Of the 5 protein products 
tested, only the full-length version was soluble (Fig. D-6) and this construct was used for 
subsequent large-scale expression and purification as described in the methods.

Gel filtration trace reveals a dominant dimeric state of PA0290. Following Ni-NTA column 
purification, the PA0290 elution was further purified using a gel filtration column as described in 
the Methods section above. In repeated purifications we observed peaks consistent with both 
dimeric and monomeric states for PA0290 (Fig. D-7). Interestingly, SDS-PAGE analysis of the 
collected fractions corresponding to these peaks both showed dominant bands at 36 kDa and 
72 kDa, which match up with expected sizes of a PA0290 monomer and dimer respectively 
(Fig. D-8). The dimeric and monomeric fractions were concentrated as described in methods to 
51 mg/mL and 42 mg/mL,respectively using a 10 kDa cutoff ultrafiltration cartridge (cat 
#UFC9010). Only the concentrated dimeric fractions were submitted for crystal screening.

Crystal screening yielded two hits for the cytoplasmic portion of RmcA and four hits for 
full-length PA0290. Protein samples were sent for crystal screening as described in the 
Methods section. The conditions that gave crystal hits for the cytoplasmic portion of RmcA and 
full-length PA0290 are shown in, and described in the legends of, Figs. D-9 and D-10, 
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respectively. These conditions were identified using UV and Second Harmonic Generation 
(SHG) imaging methods. The cytoplasmic portion of RmcA showed crystallization by UV 
imaging but not SHG imaging, while full-length PA0290 showed crystallization by both UV and 
SHG (Figs. D-9 and D-10). This difference could be attributed to the fact that the protein 
concentration of the cytoplasmic portion of RmcA used for the crystal screen was significantly 
lower than that used for full-length PA0290. As the next step, an additive screening method is 
being used to optimize the conditions that gave crystal hits in order to improve the size and 




Figure D-1. Overview of work flow.
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Figure D-2. Plasmid Map of MBP-pET28b. MBP from the pMAL 





Figure D-3. Small scale solubility test for the cytoplasmic portion of RmcA. 
Lanes 1 and 4: total lysate; Lanes 2 and 5: supernatant (soluble) fraction; Lanes 3 
and 6: pellet (insoluble) fraction for the cytoplasmic portion of RmcA expressed 
from pET28b (~106kDa; Lanes 1-3) and MBP-pET28b (~149kDa; Lanes 4-6).
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Figure D-4. Gel filtration of the cytoplasmic fraction of RmcA yields 3 
peaks. Peak 1, 2 and 3 correspond to fractions 41, 51, and 67, respectively. Y-
axis represents UV absorption (arbitary units) and X-axis represents fractions 
and elution volume (mL)
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Figure D-5. Fractions 61-71 (peak 3) from gel filtration contain the 
cytoplasmic portion of RmcA. Fractions 41 and 51 under peaks 1 and 2 







Figure D-6. Small scale solubility test for 
products from PA0290 constructs. Lanes 
1,4,7,10,13: total lysate; Lanes 2,5,8,11,14: 
supernatant (soluble) fraction; Lanes 
3,6,9,12,15: pellet (insoluble) fraction for 
products from PA0290 constructs in pET28b. 
Full-length PA0290: ~36kDa (Lanes 1-3); 
PA 0 2 9 0 PA S d o m a i n t r u n c a t i o n s : 
PA0290_1-147 (Lanes 4-6); PA0290_10-147 




Figure D-7. Gel filtration of full-length PA0290 yields 2 peaks. X-axis 





Figure D-8. Fractions from gel filtration of full-length PA0290 corresponding to peaks 
representing dimeric and monomeric states. Individual fractions 11-13 corresponding to the 
dominant dimeric peak from Figure D-7 show a ~72kDa band on SDS-PAGE. This band is also 
present in fractions 14-16, corresponding to the monomeric peak, but at a lower intensity. The 





Figure D-9. Crystal screening hits for the cytoplasmic portion of RmcA. Color, UV and SHG 
images (left to right) for the following conditions: (A)"HR Index Screen HT F2”: 0.2M Trimethylamine n-
oxide dihydrate; 0.1M Tris pH: 8.5; 20%(w/v) PEG MME 2000. (B) "HR Index Screen HT H8”: 0.10M 







Figure D-10. Crystal screening hits for full-length PA0290. Color, UV and SHG images (left to right) 
for the following conditions: (A)”(1 :1) Silver Bullet A3 (HR2-096) + 30% PEG3350 pH 6.8”; Silver Bullet 
A3; 0.05M HEPES pH: 6.8; 15% (w/v) PEG 3350. (B)”(1 :1) Silver Bullet A11 (HR2-096) + 30% 
PEG3350 pH 6.8”; Silver Bullet A11; 0.05M HEPES pH: 6.8; 15% (w/v) PEG 3350. (C) "HR PEG/Ion 
HT-011”; 0.2M potassium citrate-tri basic-monohydrate pH: 8.3; 20%(w/v) PEG 3350. (D) "HR PEG/Ion 
HT-G11”; 2%(v/v) Tacsimate, pH 8.0; 0.1 M Tris pH: 8.5; 16%(w/v) PEG 3350.
Table D-1 Primers used in this study.
Primer name primer# Sequence (5’ to 3’)
0290 fwd(NcoI) 1053 ATATATccatggACGACCTACCCGGCATT





MBP-pET28b fwd NdeI 1787 GGGAATTCcatATGAAAATCGAAGAAGGTAAA
MBP-pET28b rev BamHI 1788 ATATATATggatccTGAAATCCTTCCCTCGATCCC
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Table D-2 Constructs used in this study.
Construct Strain# Description
pET28b-PA0290full LD1902, LD1930
full-length PA0290 cloned into pET28b vector and 
transformed into E. coli Dh5𝜶 (LD1902) and E. coli 
C43 (LD1930)
pET28b-PA0290_1-147 LD1903, LD1939
PA0290 PAS domain truncation with residues 1 to 
147 cloned into pET28b vector and transformed into 
E. coli Dh5𝜶 (LD1903) and E. coli C43 (LD1939)
pET28b-PA0290_10-147 LD1904
PA0290 PAS domain truncation with residues 10 to 
147 cloned into pET28b vector and transformed into 
E. coli Dh5𝜶 (LD1904)
pET28b-PA0290_32-147 LD1905, LD1940
PA0290 PAS domain truncation with residues 32 to 
147 cloned into pET28b vector and transformed into 
E. coli Dh5𝜶 (LD1905) and E. coli C43 (LD1940)
pET28b-PA0290_42-147 LD1906, LD1941
PA0290 PAS domain truncation with residues 42 to 
147 cloned into pET28b vector and transformed into 
E. coli Dh5𝜶 (LD1906) and E. coli C43 (LD1941)
MBP-pET28b LD2531 MBP inserted  into pET28b protein expression vector
RmcA-pET28b LD2532, LD2552
RmcA PAS+GGDEF+EAL domains cloned into 
pET28b vector and transformed into E. coli Dh5𝜶 
(LD2532) and E. coli C43 (LD2552). Insert was 
derived from pMAL construct in LD1690 using NdeI 
and HindIII sites
RmcA-MBP-pET28b LD2533, LD2553
RmcA PAS+GGDEF+EAL domains cloned into MBP-
pET28b vector and and transformed into E. coli Dh5𝜶 
(LD2533) and E. coli C43 (LD2553). Insert was 
derived from pMAL construct in LD1690 using BamHI 
and HindIII sites
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Appendix E. Candida albicans Ethanol Stimulates Pseudomonas aeruginosa WspR-
Controlled Biofilm Formation as Part of a Cyclic Relationship Involving Phenazines 
This appendix is adapted from a manuscript that was published in PLOS Pathogens– Chen, 
Dolben, Okegbe et al 2014. Here we show that ethanol, such as that produced by C. albicans, 
causes increased levels of c-di-GMP in P. aeruginosa which promotes biofilm formation. This 
response is mediated through the WspR signaling cascade. I contributed the phenazine 
quantification and analyses in Figure E-9. 
ABSTRACT 
In chronic infections, pathogens are often in the presence of other microbial species. For 
example, Pseudomonas aeruginosa is a common and detrimental lung pathogen in individuals 
with cystic fibrosis (CF) and co-infections with Candida albicans are common. Here, we show 
that P. aeruginosa biofilm formation and phenazine production were strongly influenced by 
ethanol produced by the fungus C. albicans. Ethanol stimulated phenotypes that are indicative 
of increased levels of cyclic di-GMP (c-di-GMP), and levels of c-di-GMP were 2-fold higher in 
the presence of ethanol. Through a genetic screen, we found that the diguanylate cyclase 
WspR was required for ethanol stimulation of c-di-GMP. Multiple lines of evidence indicate that 
ethanol stimulates WspR signaling through its cognate sensor WspA, and promotes WspR-
dependent activation of Pel exopolysaccharide production, which contributes to biofilm 
maturation. We also found that ethanol stimulation of WspR promoted P. aeruginosa 
colonization of CF airway epithelial cells. P. aeruginosa production of phenazines occurs both in 
the CF lung and in culture, and phenazines enhance ethanol production by C. albicans. Using a 
C. albicans adh1/adh1 mutant with decreased ethanol production, we found that fungal ethanol 
strongly altered the spectrum of P. aeruginosa phenazines in favor of those that are most 
effective against fungi. Thus, a feedback cycle comprised of ethanol and phenazines drives this 
polymicrobial interaction, and these relationships may provide insight into why co-infection 
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Pseudomonas aeruginosa is an opportunistic pathogen capable of causing severe nosocomial 
infections and infections in immunocompromised patients. P. aeruginosa is a common 
pathogen of individuals with cystic fibrosis (CF), a genetic disease that is caused by a mutation 
in the gene coding for the CFTR ion transporter and strongly associated with chronic, 
recalcitrant lung infections. Altered CFTR function leads to a fluid imbalance that results in 
thick, sticky mucus in the lungs that is difficult to clear, thus creating a hospitable environment 
for microbial growth, biofilm formation, and persistence. While P. aeruginosa is a common 
microbe in the CF lung, it is rarely the only microbe present [1–5]. Co-infections of P. 
aeruginosa with other bacterial and fungal species are common, and there is a need to 
understand how these complex multi-species infections impact disease course and treatability. 
For example, the presence of the fungus Candida albicans correlates with more frequent 
exacerbations and a more rapid loss of lung function in CF patients [6,7]. Additional studies are 
needed to determine if the presence of the fungus contributes to more severe disease.

Published reports strongly suggest that in the CF lung, P. aeruginosa forms biofilms [8], 
described as hearty aggregations of cells in a sessile group lifestyle that includes extracellular 
matrix comprised of proteins, membrane vesicles, DNA, and exopolysaccharides. A biofilm 
existence provides many advantages to P. aeruginosa including increased antibiotic tolerance 
[9,10]. As with many Gram-negative species, P. aeruginosa biofilm formation is positively 
regulated by the secondary signaling molecule cyclic-di-GMP (c-di-GMP) [11]. C-di-GMP is 
formed from two molecules of GTP by diguanylate cyclases (DGCs) and its levels inversely 
correlate to motility. High levels of c-di-GMP promote biofilm formation in a number of ways 
including via increased matrix production and decreased flagellar motility [12–14].
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P. aeruginosa also produces a class of redox-active virulence factors called phenazines. In CF 
sputum, the phenazines pyocyanin (PYO) and phenazine-1-carboxylate (PCA) are found in 
micromolar (5–80 mM) concentrations, and their levels are inversely correlated with lung 
function [15]. Phenazines play a role in the relationships between P. aeruginosa and eukaryotic 
cells. Several studies have shown how phenazines can negatively affect mammalian physiology 
[16,17]. In addition, phenazines impact different fungi, including C. albicans. At high 
concentrations, phenazines are toxic to C. albicans, and lower concentrations of phenazines 
reduce fungal respiration and impair growth as hyphae [18]. Phenazines figure prominently in 
shaping the chemical ecology within mixed-species communities. For example, when exposed 
to low concentrations of phenazines, C. albicans increases the production of fermentation 
products such as ethanol by 3 to 5 fold [18]. Furthermore, P. aeruginosa-C. albicans co-
cultures form red derivatives of 5-methyl-phenazine-1-carboxylic acid (5MPCA) that 
accumulate within fungal cells [19].

In the present study, we show that ethanol produced by C. albicans stimulated P. aeruginosa 
biofilm formation and altered phenazine production. Ethanol caused a decrease in surface 
motility in both strains PA14 and PAO1 concomitant with a stimulation in levels of c-di-GMP, a 
second messenger nucleotide that promotes biofilm formation. Through a genetic screen, we 
found that the diguanylate cyclase WspR, a response regulator of the Wsp chemosensory 
system, was required for this response. Elements upstream and downstream of WspR 
signaling were required for the ethanol response. Ethanol no longer stimulated biofilm 
formation in a mutant lacking WspA, the membrane-localized sensor methyl-accepting 
chemotaxis protein (MCP) that is involved in the activation of WspR [20]. In addition, an intact 
Pel exopolysaccharide biosynthesis pathway, known to be stimulated by c-di-GMP derived 
from the Wsp pathway [21,22], was also required for ethanol stimulation of biofilm formation. 
The effects were observed on both abiotic surfaces and a cell culture model for P. aeruginosa 
and P. aeruginosa-C. albicans airway colonization. We found that both exogenous and fungally 
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produced ethanol enhanced the production of two phenazine derivatives known for their 
antifungal activity [19,23], 5MPCA and phenazine-1-carboxamide (PCN), through a Wsp-
independent pathway and independent of ethanol catabolism. Because phenazines stimulate 




Ethanol stimulates biofilm formation and suppresses swarming in P. aeruginosa strain 
PA14. Our previously reported findings show that P. aeruginosa produces higher levels of two 
phenazines, PYO and 5MPCA [24,25], when cultured with C. albicans and that phenazines 
stimulate C. albicans ethanol production [18]. Thus, we sought to determine how fungally-
derived ethanol affects P. aeruginosa. A concentration of 1% ethanol (v/v) was chosen for 
these studies based on the detection of comparable levels of ethanol in C. albicans 
supernatants from cultures grown with phenazines [18]. The presence of 1% ethanol in the 
culture medium did not affect P. aeruginosa growth in minimal M63 medium with glucose or LB 
(doubling time of 36±2 min in LB versus 39±2 min in LB with ethanol), or on solid LB medium. 
When we performed a microscopic analysis of the effects of ethanol on P. aeruginosa strain 
PAO1, we observed a significant increase in attachment of cells to the bottom of a titer dish 
well within 1h (15±5 cells per field in vehicle treated compared to 31±6 cells per field in 
cultures with ethanol, p < 0.01) and development of microcolonies was strongly enhanced (Fig. 
E-1A). Ethanol also promoted an increase in the number of attached cells and microcolonies in 
cultures of another P. aeruginosa strain, PA14 (Fig. E-1B). Using two assays that assess 
biofilm-related phenotypes (swarming motility and twitching motility), we sought to gain 
additional insight into how ethanol impacted biofilm formation. Our initial studies focused on 
strain PA14. We found that ethanol repressed swarming motility, a behavior that is inversely 
correlated with biofilm formation (Fig. E-1C).
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Ethanol increases c-di-GMP levels through WspR. Ethanol stimulated attachment and 
biofilm formation on plastic and inhibited swarming motility (Fig. E-1). These two phenotypes 
are positively and negatively regulated by levels of the second messenger molecule c-di-GMP 
[30]. Thus, we measured intracellular levels of this dinucleotide in P. aeruginosa strain PA14 
cells grown on swarm plates with or without 1% ethanol for 16.5h as described previously. We 
found a 2.4-fold increase in c-di-GMP levels in cells exposed to ethanol (Fig. E-2).

To identify the enzyme(s) responsible for this increase, we screened a collection of 31 P. 
aeruginosa strain PA14 mutants [31] defective in different genes predicted to encode proteins 
that may modulate c-di-GMP levels based on the detection of a DGC and/or an EAL domain 
[22,31]. We found that one mutant, ∆wspR, was strikingly resistant to the repression of 
swarming by ethanol (Fig. E-3). As expected, this mutant also had a slight hyper swarming 
phenotype when compared to the wild type in control conditions [31], and both phenotypes 
were complemented by the wild-type wspR allele on an arabinose-inducible plasmid when 
grown in the presence of 0.02% arabinose (Fig. E-3). The empty vector (EV) control exhibited a 
swarming pattern comparable to that of the ∆wspR mutant.

WspR is a response regulator with a GGDEF domain [32], which is associated with diguanylate 
cyclase activity [20]. Consistent with the observation that ∆wspR continued to swarm on 
medium with ethanol, c-di-GMP levels were not different between cultures with and without 
ethanol in the ∆wspR background (Fig. E-2). These data suggest that WspR activity, and thus 
c-di-GMP levels, are enhanced by ethanol.

WspR is known to regulate the production of the Pel polysaccharide [21,22], and production of 
Pel is associated with colony wrinkling and biofilm formation [33]. After 72 hours on swarm 
plates, we also observed that ethanol strongly promoted colony wrinkling while the addition of 
equivalent amounts of other carbon sources, such as glycerol or choline, did not have this 
effect. Furthermore, the colony wrinkling induced by ethanol was less apparent in a ∆wspR 
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strain (not shown) and completely absent in a strain lacking pelA, an enzyme required for Pel 
biosynthesis (Fig. E-4). The ∆pelA mutant, like the ∆wspR mutant, continued to swarm in the 
presence of ethanol (Fig. E-4) suggesting that the repression of swarming in the presence of 
part, due to increased Pel production.

Ethanol induces c-di-GMP signaling in P. aeruginosa strain PAO1 through WspA and 
WspR. As we found that ethanol stimulated biofilm formation in P. aeruginosa wild-type strains 
PA14 and PAO1 (Fig. E-1) and that WspR mediated the ethanol effect in strain PA14, we also 
examined the role of WspR in the ethanol response in strain PAO1. As shown above, PAO1 
wild-type cells had increased early attachment and subsequent microcolony formation on 
plastic when ethanol was added to the medium (Fig. E-5). Consistent with our model that 
ethanol is acting through WspR, ethanol did not stimulate surface colonization in the PAO1 
∆wspR mutant (Fig. E-5). We also examined the ethanol-responsive phenotype for P. 
aeruginosa strain PAO1 ∆wspR, which lacks the membrane bound receptor that is the most 
upstream element described in the Wsp system [20]. Like ∆wspR, ∆wspA did not show 
increased attachment to plastic upon the addition of ethanol (Fig. E-5) suggesting that both the 
MCP sensor and the WspR response regulator were required for the response to ethanol. 
Ethanol also promoted colony wrinkling in strain PAO1, as was observed in strain PA14, 
consistent with the prediction that increased WspR activity would lead to increased matrix 
production.

Ethanol promotes WspR clustering and a functional Wsp system is required for this 
effect. Previous studies have shown that the fluorescently-tagged WspR protein forms 
intracellular clusters when in its active phosphorylated form upon incubation of cells on an agar 
surface, and cluster formation is positively correlated with WspR activity [20]. To complement 
the mutant analyses, we determined if ethanol also promoted WspR-YFP clustering, and if 
known components of the WspR activation system were required for WspR stimulation by 
ethanol. To facilitate these analyses, we used the WspR variant WspRE253A-YFP, which forms 
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larger clusters that are more easily visualized [34]. In these studies, we observed a two fold 
increase in WspR clustering in the presence of ethanol (Fig. E-5C). To determine if WspF, a 
methyl esterase that negatively regulates WspR activity [21], was involved in the regulation of 
WspR in response to ethanol, we also assessed WspR clustering in a ∆wspF background 
where WspR is constitutively active. In ∆wspF, WspR clustering was higher than in the wspF+ 
reference strain, and WspR clustering was not further stimulated by ethanol, lending support 
for the model that ethanol was acting through the Wsp system and not through an independent 
pathway for WspR activation.

C. albicans and ethanol promote airway epithelial cell monolayer colonization. To 
understand the effects of ethanol on P. aeruginosa in a well-established CF-relevant disease 
model, we studied the effects of ethanol on P. aeruginosa strain PAO1 in the context of 
bronchial epithelial cells with the most common CF genotype (homozygous CFTR∆F508) 
[35,36]. We cultured P. aeruginosa strain PAO1 with the epithelial cells in medium without and 
with 1% ethanol, and observed an obvious enhancement in the size of biofilm microcolonies 
(Fig. E-6A) and a 2.2-fold increase in colony forming units (CFUs) on the airway cells with 
ethanol (Fig. 6B). When the same experiment was performed with the ∆wspR or ∆wspA 
mutants, no stimulation by ethanol was observed. Ethanol alone did not impact epithelial cell 
viability as measured by an LDH release assay (9.44%±0.98 LDH release for control and 
10.47%±1.2 LDH release with ethanol, N = 3) and other studies have also found these 
concentrations of ethanol to be well below those that cause overt toxicity to epithelial cells or 
disruption of epithelial barrier integrity [37,38].

When P. aeruginosa PAO1 and C. albicans were co-inoculated into epithelial cell co-cultures, 
4.7-fold more P. aeruginosa CFUs were found to be associated with the monolayer after 6 h 
(Fig. E-7). To determine if C. albicans-derived ethanol contributed to the enhanced colonization 
by P. aeruginosa in the presence of C. albicans, we used a C. albicans adh1/adh1 mutant that 
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produced lower levels of ethanol. We constructed the adh1 null strain and its complemented 
derivative, and confirmed that the absence of ADH1 caused a reduction in ethanol by HPLC 
analysis of culture supernatants, a finding consistent with previously [39]. When P. aeruginosa 
was co-cultured with the C. albicans adh1/adh1 strain, there was a significant decrease in P. 
aeruginosa CFUs recovered, and this defect was corrected upon complementation with the 
ADH1 gene in trans. These data strongly suggest that C. albicans-produced ethanol promotes 
P. aeruginosa colonization of both abiotic and biotic surfaces through activation of the Wsp 
system, which likely exerts these effects through promoting Pel production.

Exogenous and C. albicans-produced ethanol alters P. aeruginosa phenazine production 
through a WspR-independent pathway. In part, these studies were instigated by the finding 
that P. aeruginosa phenazines strongly stimulate C. albicans ethanol production [18]. Thus, we 
were intrigued by the observation that colonies on ethanol-containing swarm plates, but not 
control plates, contained abundant emerald green crystals, similar to those formed by reduced 
phenazine-1-carboxamide (PCN) [40] (Fig. E-8A, Fig. E-4 and Fig. E-9), which could indicate a 
reciprocal relationship between ethanol and phenazines. Phenazine concentrations were 
measured using HPLC in either extracts from P. aeruginosa strain PA14 colonies or extracts 
from the underlying agar. In extracts from wild type colonies, PCN and PCA concentrations 
were 24.2- and 5.8-fold higher, respectively, when ethanol was in the medium (Fig. E-9B); much 
smaller differences in PCN and PCA concentrations were found in extracts of the underlying 
agar (Fig. E-9C). Because PCA is the precursor for all other phenazine derivatives, including 
PCN (Fig. E-9A), we further explored the effect of ethanol on PCA production. For this, we 
measured levels of PCA in a strain lacking all of the PCA modifying enzymes (PhzH, PhzM, and 
PhzS; see Fig. E-9A for pathways) [41]. We found that ∆phzHMS colonies contained 1.7-fold 
more PCA (Fig. E-9D) and released 1.3-fold more PCA into the agar (Fig. E-9E) when grown in 
the presence of ethanol compared to control conditions. These data suggest that ethanol may 
cause a minor increase in PCA, and that it has greater effects on which species of phenazines 
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are formed. The differences in phenazine levels or profiles did not appear to be responsible for 
ethanol effects on swarming as the ∆phz mutant [42], which lacks phzA1-G1 and phzA2-G2, 
was like the wild type in that its swarming was repressed in the presence of ethanol, but it 
swarmed robustly in its absence (Fig. E-9F).

To determine if there was a connection between ethanol effects on Wsp signaling and ethanol 
stimulation of PCN levels, we assessed PCN accumulation in mutants lacking wspR or pelA. 
We found that both strains responded like the wild type in terms of PCN crystal formation upon 
growth with ethanol (Fig. E-4). 

Having observed alterations in the phenazine profile induced by ethanol, we examined the 
impact of ethanol in the production of a fourth phenazine derivative, 5MPCA, which we have 
previously shown to be released by P. aeruginosa when in the presence of C. albicans [19,24]. 
Because P. aeruginosa-produced 5MPCA is converted into a red pigment within C. albicans 
cells, 5MPCA accumulation can be followed by observing the formation of a red color where P. 
aeruginosa and C. albicans are cultured together [19,24]. To examine the effects of ethanol 
production on the accumulation of red 5MCPA derivatives, we again used the C. albicans 
adh1/adh1 mutant and its complemented derivative. Strikingly, when P. aeruginosa was 
cultured on lawns of the C. albicans adh1/adh1 strain, a strong decrease in red pigmentation 
was observed (Fig. E-8B). When ADH1 was provided in trans to the adh1/adh1 mutant, 
accumulation of the red pigment was restored (Fig. 8B).

Together, our data suggest that ethanol only slightly increases total phenazine production (Fig. 
E-9D and E) but more strongly affects the derivatization of phenazines in P. aeruginosa 
colonies (Fig. E-9B and C). Furthermore, C. albicans-produced ethanol stimulated P. 
aeruginosa 5MPCA production, and in turn, phenazines, including 5MPCA analogs, promote 
ethanol production [18]. Thus, it appears that P. aeruginosa-C. albicans interactions include a 
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positive feedback loop that promotes fungal ethanol production and P. aeruginosa Wsp-
dependent biofilm formation when the two species are cultured together.

DISCUSSION 
This paper reports new effects of ethanol on P. aeruginosa virulence-related traits, and 
illustrates that these effects occur through multiple pathways (Fig. E-10). We found that 
ethanol: i) promoted attachment to and colonization of plastic and airway epithelial cells, ii) 
decreased swarming, but not twitching motility, iii) increased Pel-dependent colony wrinkling, 
and iv) increased c-di-GMP levels. All of these responses to ethanol required the diguanylate 
cyclase WspR. WspR is part of the Wsp chemosensory system, which is a member of the 
‘‘alternative cellular function’’ (ACF) chemotaxis family [20,21,43]. The Wsp chemosensory 
system is different from the chemotaxis systems in P. aeruginosa in terms of its localization and 
response to environmental signals [44]. The membrane-bound receptor WspA and the CheA 
homologue WspE are necessary for the Wsp system to function, and WspE activates WspR via 
phosphorylation [44]. Consistent with our hypothesis that the entire Wsp system is required for 
the response to ethanol, we found that a wspA mutant was also insensitive to the effects of 
ethanol on biofilm formation (Fig. E-5). The activation of WspR was independent of ethanol 
catabolism and independent of phenazine production. Ethanol and other alcohols can increase 
the rigidity of cell membranes by promoting an altered composition of fatty acids [45], and 
future studies will determine if the Wsp system, particularly the membrane localized WspA, can 
be activated by changes in the lipid composition or changes in the physical properties of P. 
aeruginosa membranes. Because the Wsp system is also activated upon contact with a 
surface [20], it is intriguing to consider how these stimuli might be similar.

C. albicans and other Candida spp. are commonly detected in the sputum of CF patients, and 
clinical studies suggest that the presence of both P. aeruginosa and C. albicans results in a 
worse prognosis for CF patients [6,46]. In vivo ethanol production by other fungi has been 
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documented [47,48], but a link between Candida spp. and ethanol production in the lung has 
not yet been made. It is important to note, however, that ethanol was one of two metabolites in 
exhaled breath condensate that differentiated CF from non-CF individuals [49]. Thus, 
regardless of the source of ethanol, be it fungal or bacterial, the effect of ethanol on pathogens 
such as P. aeruginosa is likely of biological and clinical relevance. We tested this interaction in 
the context of CF, but this polymicrobial interaction likely occurs in other contexts as well.

As shown above, ethanol promoted biofilm formation and likely concomitant increases in drug 
tolerance. In the airway epithelial cell system, P. aeruginosa CFU recovery was increased 3-fold 
by addition of ethanol (Fig. E-6B) and 4.7-fold by co-culture with C. albicans (Fig. E-7). A two-
fold difference is comparable to the differences in colonization between wild-type P. 
aeruginosa strains and mutants lacking genes known to play a role in virulence in animal 
models. For example, a ∆plcHR mutant lacking hemolytic phospholipase C or a ∆anr strain 
defective in a global regulator have 1.3- to 2.6-fold fewer CFUs recovered from airway cells 
compared to wild type, and notable differences in animal models [50,51]. Hence the presence 
of ethanol may result in increased virulence of P. aeruginosa in the host. Ethanol has also been 
shown to promote P. aeruginosa conversion to a mucoid state [52], in which the 
exopolysaccharide alginate is overproduced; mucoidy is common in CF isolates and is 
correlated with a decline in lung function [53,54]. Ethanol has been shown to enhance virulence 
and biofilm formation by other lung pathogens such as Staphylococcus aureus [55] and 
Acinetobacter baumanii [56–59] via mechanisms that have not yet been described. Like in P. 
aeruginosa, ethanol caused a slight stimulation of growth in A. baumanii [58]. In addition to the 
effects of ethanol on P. aeruginosa, ethanol is an immunosuppressant that negatively influences 
the lung immune response [60–64]. In a mouse model, ethanol inhibits lung clearance of P. 
aeruginosa by inhibiting macrophage recruitment [65]. Together, these observations suggest 
that in mixed infections, P. aeruginosa may promote the production of ethanol by fungi, and 
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that fungally-produced ethanol may in turn enhance the virulence and persistence of co-
existing pathogens, and thus may directly impact the host. It is not yet known how ethanol 
influences the spectrum of P. aeruginosa phenazines produced. In a previous study, we found 
evidence for increased production and release of 5MPCA when P. aeruginosa is grown in co-
culture with C. albicans, and that live C. albicans is required for this effect [19]. More recent 
studies show that C. albicans ethanol production increased in the presence of even very low 
concentrations of the 5MPCA analog phenazine methosulfate [18], that the 5MPCA-like 
compounds were even more effective inhibitors of fungi than PCA and PYO, the two 
phenazines normally produced when P. aeruginosa is grown in mono-culture. Here, our findings 
suggest a feedback loop in which C. albicans-produced ethanol promoted the release of 
phenazines (Fig. E-7) that may promote further ethanol production [18]. It is also important to 
consider that some studies have reported that 5MPCA and PCN have enhanced antifungal 
activity when compared to PCA and PYO [19,23,24]. The ethanol-induced changes in PCA 
were not as dramatic when compared to the ethanol-induced changes in PCN and 5MPCA, 
suggesting that ethanol mainly affected the biosynthetic steps after the formation of PCA 
leading to its conversion to PCN, 5MPCA and PYO. In different settings, such as liquid cultures 
or in clinical isolates lacking activity of LasR, a transcriptional regulator for quorum sensing that 
controls phenazine production, the presence of C. albicans enhanced the production of 
5MPCA and PYO [24,25]. Taken together, all these observations indicate that fungally-
produced ethanol may enhance the conversion of PCA to end products such as PCN, 5MPCA 
and PYO. These studies indicate how microbial species can alter the behavior of one another 
and suggest that the nature of these dynamic interactions can change depending on the 
context. In the rhizosphere, where pseudomonad antagonism of fungi includes the colonization 
of fungal hyphae and phenazine production, the enhancement of fungally-produced ethanol by 
phenazines and stimulation of biofilm formation and phenazine production by ethanol may 
create a cycle that is relevant to biocontrol [23,66,67]. In chronic infections where these two 
species are found together, such as in chronic CF-associated lung disease, this molecular 
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interplay may be synergistic and promote long-term colonization of both species in the host. 
These findings indicate that the treatment of colonizing fungi may be beneficial due to their 
effects on other pathogens even if the fungi themselves are not acting as overt agents of host 
damage.

MATERIALS AND METHODS 
Strains, media, and growth conditions. Bacterial and fungal strains and plasmids used in this 
study are listed in Table E-1. Bacteria and fungi were maintained on LB [68] and YPD (2% 
peptone, 1% yeast extract, and 2% glucose) media, respectively. When stated, ethanol (200-
proof), choline chloride or glycerol was added to the medium (liquid or molten agar) to a final 
concentration of 1%. Control cultures received an equivalent volume of water. When ethanol 
was supplied as a sole carbon source, glucose and amino acids were omitted. Mutants from 
the PA14 Non-Redundant (NR) Library were grown on LB with 30 µg/mL gentamicin [29]. When 
strains for the NR library were used, the location of the transposon insertion was confirmed 
using sets of site-specific primers followed by sequencing of the amplicon. The primers are 
listed in Table E-2.

Growth curve analysis of P. aeruginosa in the presence of ethanol. For growth curves, 
overnight cultures were diluted into 5 ml fresh medium (LB or M63 with 0.2% glucose [69] with 
or without ethanol) to an OD600 nm of ~0.05 and incubated at 37˚C on a roller drum. Culture 
densities below 1.5 were measured directly inthe culture tubes using a Spectronic 20 
spectrophotometer. At higher cell densities, diluted culture aliquots were measured using a 
Genesys 6 spectrophotometer.

Quantification of P. aeruginosa attachment to plastic and airway epithelial cells. To 
measure the attachment of cells to the plastic surface in 6-well or 12-well untreated 
polystyrene plates, wells were inoculated with a suspension of cells at an initial OD600 nm of 
0.002 from overnight cultures. Every 90 minutes, the culture medium was removed and fresh 
medium was supplied. Pictures were taken using an inverted Zeiss Axiovert 200 microscope 
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with a long distance 63 X DIC objective at specified intervals. To quantify the number of cells or 
microcolonies in control cultures compared to cultures with ethanol, images were captured, 
randomized, and analyzed by a researcher who was blind to the identity of the sample at the 
time of analysis. In each experiment, more than 10 fields were counted for each strain. 
Microcolonies were defined as clusters of more than 5 cells in physical contact with one 
another. Biofilm formation on plastic microtiter dishes were performed and analyzed using the 
crystal violet assay as described in [55] and biofilm values were measured by quantification of 
dye as measured absorbance at 650 nm.

The analysis of P. aeruginosa colonization of airway epithelial cells was performed using CFBE 
human bronchial epithelial cells (CFBE410-) with the CFTR∆F508/∆F508 genotype [70] as 
described previously [35,36]. For imaging, cells were grown in 6-well glass bottom dishes 
(MatTek). For quantification of attached cells, CFBEs were grown in 6 or 12 well plates. P. 
aeruginosa strain PAO1 cells were added at an MOI of 30:1, and the medium was exchanged 
every 1.5 hours. For experiments with C. albicans, PAO1 cells and C.albicans were added 
together to CFBE monolayers, where C. albicans was at an MOI of 10:1 with respect to the 
epithelial cells. Pictures were taken using a Zeiss Axiovert 200 microscope with a 63 X DIC 
objective at specified intervals. We performed multiple experiments with technical replicates 
(between three and six) on different days and analyzed the data with a one-way analysis of 
variance and Tukey’s post hoc t-test using Graph Pad Prism 6. We observed that cells from 
different passages had differences in the mean attachment across all samples from that day. 
Thus, we normalized values to the mean across all samples from each experiment. LDH release 
was measured after six hours using the Promega CytoTox96 Non-Radioactive Cytotoxicity kit 
as described in the manufacturer’s instructions.

Analysis of P. aeruginosa swarming and twitching motility. Swarming motility was tested by 
inoculating 2.5 mL of overnight cultures on fresh M8 (M8 salts without trace elements 
supplemented with 0.2% glucose, 0.5% casamino acids, and 1 mM MgSO4) containing 0.5% 
 240
agar as described previously [71]. Plates were incubated face up at 37˚C with 70–80% humidity 
in stacks of no more than 4 for 16.5 hrs. To quantify the degree of swarming, percent coverage 
of the plate was measured using ImageJ software [72]. Twitching motility was analyzed as 
described previously [26].

Cyclic-di-GMP measurements. Cells were collected from swarm plates after incubation at 
37˚C for 16.5 h and placed in pre-weighed 1.5 mL Eppendorf tubes. Tubes were centrifuged at 
5,000 rpm for 4 minutes. The pellets were then resuspended in 250 mL of extraction buffer by 
vigorous vortexing (extraction buffer: MeOH/acetonitrile/dH2O 40:40:20+0.1 N formic acid 
stored at -20˚C). The extractions were incubated at -20˚C for 30 minutes in an upright position. 
The tubes were then centrifuged at 13,000 rpm for 5 minutes at 4˚C. 200 mL of the extraction 
were recovered into new Eppendorf tubes and neutralized with 4 mL of 15% NH4HCO3 per 100 
mL of sample. The tubes with cell debris were left to dry and reweighed for normalization of 
cell numbers from swarm plates. 150 mL of samples were sent to the RTSF Mass 
Spectrometry and Metabolomics Core at Michigan State University for LC-MS analysis.

Microscopic analysis of WspR. Sample preparation and microscopy were performed as 
previously described [20,34]. To analyze liquid-grown cells, cultures were grown at 37˚C while 
shaking to an optical density at 600 nm (OD600) of 0.3 in M9 medium (16M9 salts pH 7.4, 2 
mM MgSO4, 0.1 mM CaCl2, 0.2% glycerol, 0.2% casamino acids and 10 mg/ml thiamine HCl). 
induction of wspR, and 1% ethanol was added when comparing its effect on WspR clustering. 
From each culture, 3 ml were spotted onto a 0.8% agarose PBS pad on a microscope slide 
and then covered with a coverslip. More than 100 cells were counted for each condition.

P. aeruginosa-C. albicans co-cultures. Preformed lawns of C. albicans CAF2 and adh1/adh1 
were prepared by spreading 700 mL of a YPD-grown overnight culture onto a YPD 1.5% agar 
plate followed by incubation at 30˚C for 48 hr. Exponential phase P. aeruginosa liquid cultures 




Analysis of phenazines. Overnight cultures of P. aeruginosa PA14 wild-type and 
∆phzH∆phzM∆phzS strains were grown in LB at 37˚C (shaken at 250 rpm). Ten microliters of 
each culture were spotted onto a track-etched membrane (Whatman 110606; pore size 0.2 
mm; diameter 2.5 cm) that was placed on a 1.5% agar M8 medium supplemented with either 
vehicle (water) or 1% v/v ethanol. Plates contained 3 ml of medium in a 35610 mm agar plate 
(Falcon). The colonies were incubated at 37˚C for 24 hours and then at room temperature for 72 
hours, after which phenazines were extracted from the colonies and agar separately. Each 
track-etched membrane with a colony was lifted off the agar plates and nutated in 5 mL of 
100% methanol overnight at room temperature. Similarly, the agar was nutated overnight in 5 
mL of 100% methanol. Colony and agar extracts were filtered (0.2 mm pore) and phenazines in 
the extraction volume (5 mL) were quantified by high-performance liquid chromatography as 
previously described [41] at a flow rate of 0.4 mL/min.

Statistical analyses. All data were analyzed using Graph Pad Prism 6. The data represent the 
mean standard deviation of at least three independent experiments with multiple replicates 






Figure E-1. Ethanol represses swarming and stimulates biofilm formation by P. aeruginosa. A. P. 
aeruginosa strain PAO1 attachment to the bottom of a polystyrene plastic well after 6 hours in medium 
with and without 1% ethanol (EtOH). B. P. aeruginosa strain PA14 attachment to plastic as assessed by 
quantification of microcolonies per field in wells containing medium with or without ethanol for 7 h. Error 
bars represent the standard deviation (p < 0.01 as determined by a student’s t-test, N= 12). C. P. 
aeruginosa strain PA14 swarming in the absence and presence of 1% ethanol. Images are 
representative of results in more than ten independent experiments. doi:10.1371/journal.ppat.
1004480.g001
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Figure E-2. Ethanol increases c-di-GMP levels in P. aeruginosa strain PA14 WT but not in a 
∆wspR mutant. c-di-GMP levels from cultures grown on swarm plates without (black) or with 1% 
ethanol (grey) were measured by LC-MS. Error bars represent one standard deviation (*, p < 0.05, N= 
5); ns, not significant). doi:10.1371/journal.ppat.1004480.g002
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Figure E-3. P. aeruginosa ∆wspR shows loss of swarm repression in the presence of ethanol. P. 
aeruginosa strain PA14 WT, ∆wspR, and ∆wspR strains containing either plasmid-borne wspR or the 
empty vector were analyzed on swarm medium with and without 1% ethanol (EtOH) and with 0.02% 
arabinose (to induce wspR expression in the complemented strain). Images are representative of at 
least 5 experiments for each strain. doi:10.1371/journal.ppat.1004480.g003
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Figure E-4. Pel production in response to ethanol. P. aeruginosa strain PA14 WT and ∆pelA swarm 
colonies on medium with and without 1% ethanol (EtOH) after 72 h. The bottom panels show an 
enlarged view (6X) of swarm tendrils of the colonies grown with ethanol (indicated by a black box). 
Enlarged images demonstrate the yellow/green PCN crystals in both strains and colony wrinkles in the 
WT that form upon growth on ethanol. doi:10.1371/journal.ppat.1004480.g004
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Figure E-5. Ethanol acts through the Wsp system. A. Attachment of P. aeruginosa strain PAO1 WT, 
∆wspR and ∆wspA mutants to the bottom of a polystyrene dish during growth in M63 medium with 
glucose and casamino acids, and with vehicle (Control) or with 1% ethanol for 6 hours. B. The number 
of cells per field for each condition was enumerated. Images and data are representative of results from 
more than three separate experiments. Significance determination was based on an ordinary one-way 
ANOVA followed by Sidak’s multiple comparisons test for each intrastrain comparison; ***, P < 0.001. C. 
∆wspR and ∆wspFR strains expressing WspR-E253A-YFP were grown without and with 1% EtOH, and 
the number of cells with fluorescent clusters were counted out of a total of approximately 100 cells 
examined per condition across two experiments. doi:10.1371/journal.ppat.1004480.g005
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Figure E-6. Ethanol significantly increases P. aeruginosa strain PAO1 WT biofilm formation on 
airway cells. A. PAO1 WT, ∆wspR or ∆wspA were co-cultured with a monolayer of ∆F508 CFTR-CFBE 
cells at an MOI of 30:1 in medium with or without 1% ethanol and imaged after 6 h. Pictures are 
representative of at least 3 separate experiments with similar results. B. The number of CFUs from 
cultures determined as described above. Significance determination was based on an ordinary one-way 
ANOVA followed by Sidak’s multiple comparisons test for each intrastrain comparison; ***, P < 0.001. 
Error bars represent one standard deviation. doi:10.1371/journal.ppat.1004480.g006
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Figure E-7. C. albicans promotes P. aeruginosa strain PAO1 WT biofilm formation on airway 
epithelial cells in part through ethanol production. P. aeruginosa PAO1 WT was cultured with a 
monolayer of ∆F508 CFTR-CFBE cells alone or with C. albicans CAF2 (reference strain), the C. 
albicans adh1/adh1 mutant (adh1), and its complemented derivative, adh1/adh1+ADH1 (adh1-R). Data 
are combined from three independent experiments with 3–5 technical replicates per experiment, (* 
represents a statistically significant difference (p < 0.05) between indicated strains). Error bars 
represent one standard deviation. doi:10.1371/journal.ppat.1004480.g007
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Figure E-8. Ethanol leads to higher levels of PCN crystal formation and 5MPCA derivatives. A. P. 
aeruginosa strain PA14 wild type (WT) was grown on medium without and with 1% ethanol. With 
ethanol, PCN crystals form and the colony has a yellowish color likely attributed to reduced PCN. B. P. 
aeruginosa strain PA14 WT was cultured on lawns of C. albicans CAF2 (WT reference strain), the C. 
albicans adh1/adh1 mutant, and its complemented derivative (adh1/adh1+ADH1); the PA14 ∆phz 
mutant defective in phenazine production was plated on the C. albicans CAF2 for comparison. doi:
10.1371/journal.ppat.1004480.g008
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Figure E-9. Ethanol stimulates PCN production but not PCA production in P. aeruginosa strain 
PA14. A. Phenazine biosynthetic pathway and enzymes necessary for phenazine modifications. B–E. 
Concentrations of PCN and PCA in 5 ml extracts from the colony (B) or the underlying agar (C). In B 
and C, the wild type (WT) was grown without and with 1% ethanol. In D and E, PA14 ΔphzHMS, which 
lacks the ability to transform PCA into phenazine derivatives, was used. The error bars represent 
standard deviations for the phenazines extracted from 6 samples; *, P > 0.05; **, P ≤ 0.05; ***, P ≤0.01, 
****, P ≤ 0.001; ns, P > 0.05. F. Swarm phenotype of the Δphz mutant without and with 1% ethanol. doi:
10.1371/journal.ppat.1004480.s007
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Figure E-10. Our proposed model for the impacts of fungally-produced ethanol on P. aeruginosa 
behaviors. Our previous work has shown that P. aeruginosa phenazines increase fungal ethanol 
production. Here, we show that ethanol stimulates the Wsp system, leading to a WspR-dependent 
increase in c-di-GMP levels and a concomitant increase in Pel production and biofilm formation on 
plastic and on airway epithelial cells. In addition, ethanol altered phenazine production by promoting 
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